Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3037551	s-ca12-5	u/ml (u/ml)	12009	37114	0.00%
3037551	p-ca12-5	u/ml (u/ml)	8848	26471	0.02%
3037551	s-ca12-5	— (—)	973	1937	100.00%	Distribution not available
3037551	p-ca12-5	— (—)	382	528	100.00%	Distribution not available
3037551	ca12-5antigeeni	u/ml (u/ml)	107	139	0.00%
3037551	p-ca12-5antigeeni	u/ml (u/ml)	64	81	0.00%
3037551	s-ca12-5antigeeni	u/ml (u/ml)	28	33	0.00%
3037551	-ca12-5	u/ml (u/ml)	15	15	0.00%	Distribution not available
3037551	vertca12-5	u/ml (u/ml)	13	15	0.00%
3037551	s-ca125kj	u/ml (u/ml)	11	12	0.00%	Distribution not available
3037551	p-ca-12-5	u/ml (u/ml)	5	6	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Ovarian cyst

5490

4010

10.45

307.65

2.1

5.0

26.20

77.84

u/ml

8.19

5299

3870

Malignant neoplasm, wide definition for exclusion

5131

9530

3.38

307.65

4.9

1.5

61.55

23.71

u/ml

22.39

4991

9130

Malignant neoplasm of ovary, including Hilmo

1756

1175

46.75

307.65

14.3

1.5

152.16

25.74

u/ml

16.40

1729

1113

Malignant neoplasm of corpus uteri

1522

1332

20.91

307.65

4.8

1.5

39.46

25.55

u/ml

2.22

1498

1252

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

1549

2369

7.37

307.65

6.0

1.5

98.35

25.77

u/ml

16.15

1520

2249

Benign neoplasm of ovary

1662

5404

3.67

307.65

2.4

3.9

33.71

66.09

u/ml

4.75

1624

5196

Any event in cancer register

5404

10495

3.24

307.65

4.8

1.5

59.07

27.29

u/ml

17.42

5246

10084

Postmenopausal bleeding

1998

3172

3.77

307.65

3.3

5.6

48.73

91.23

u/ml

3.18

1930

3059

Female infertility, cervical, vaginal, other or unspecified origin

1677

3353

3.54

307.65

2.6

5.0

33.32

69.82

u/ml

3.45

1619

3240

Endometriosis ASRM stages 3,4

1963

7594

2.94

307.65

2.6

3.3

46.39

53.41

u/ml

0.68

1907

7318

Malignant neoplasm of breast, including Hilmo

2978

7538

2.79

307.65

2.9

1.5

61.91

23.15

u/ml

3.49

2886

7209

Unspecified/other endometriosis

830

1402

7.04

307.65

2.1

4.4

36.78

54.07

u/ml

1.70

808

1351

Neoplasms

3408

5074

3.73

307.65

3.1

1.4

41.75

22.11

u/ml

10.83

3309

4834

Ascites

810

1000

10.57

307.65

13.1

2.9

302.40

37.26

u/ml

16.54

800

960

Female infertility

1788

3422

3.43

307.65

2.7

5.0

33.02

70.09

u/ml

3.66

1732

3305

Malignant neoplasm of breast, ER-positive, including Hilmo

2336

6267

3.19

307.65

2.9

1.5

46.87

23.23

u/ml

8.69

2260

5979

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

780

443

80.80

307.65

19.5

1.5

263.21

22.29

u/ml

6.79

773

417

Malignant neoplasm of corpus uteri, including Hilmo

1795

1591

20.71

307.65

4.7

1.5

45.83

24.75

u/ml

1.81

1766

1497

Malignant neoplasm of breast

2924

7412

2.81

307.65

3.0

1.5

62.27

23.13

u/ml

3.45

2833

7087

Medicines for HER+ breast cancer

2681

11539

2.42

307.65

4.5

3.5

52.27

59.34

u/ml

0.66

2599

11119

Oxycodone

1863

6237

2.87

307.65

7.1

3.1

127.98

52.46

u/ml

7.28

1817

6003

Any gastric operation

3725

6828

2.85

307.65

3.6

1.5

55.23

25.26

u/ml

12.14

3603

6562

Noninflammatory disorders of female genital tract

2397

4090

3.14

307.65

2.5

4.9

45.70

76.97

u/ml

2.99

2315

3942

GASTRO-related operations

3725

6828

2.85

307.65

3.6

1.5

55.23

25.26

u/ml

12.14

3603

6562

Malignant neoplasm of breast, HER2-negative, including Hilmo

2977

7538

2.79

307.65

2.9

1.5

61.92

23.15

u/ml

3.49

2885

7209

Malignant neoplasm of breast, HER-positive

2289

6189

3.20

307.65

2.9

1.4

47.26

23.21

u/ml

8.67

2215

5904

Solid cancers, helper endpoint

4929

9197

3.39

307.65

5.2

1.5

68.22

23.64

u/ml

9.35

4791

8813

Malignant neoplasm of breast, HER2-negative

2875

7304

2.82

307.65

3.0

1.5

62.85

23.10

u/ml

3.45

2788

6984

Endometriosis of pelvic peritoneum

1310

2814

5.11

307.65

2.4

4.9

42.77

75.35

u/ml

2.02

1282

2716

Endometriosis

2814

3955

4.71

307.65

2.7

5.0

42.54

78.64

u/ml

4.03

2738

3818

malignant neoplasm of female genital organs

3439

2866

24.59

307.65

10.4

1.4

118.73

25.65

u/ml

11.79

3381

2715

Polyp of the female genital tract

2095

3689

3.59

307.65

2.9

5.2

42.76

82.39

u/ml

3.22

2027

3562

Other medical care

2664

7632

3.40

307.65

8.6

2.6

155.87

36.49

u/ml

21.50

2606

7335

Exclusions for E4_PCOS_CONSORTIUM

5241

12729

2.80

307.65

4.5

2.3

63.19

40.10

u/ml

2.83

5095

12248

Malignant neoplasm

4951

9258

3.39

307.65

5.2

1.5

61.69

23.64

u/ml

21.96

4811

8870

Endometriosis of ovary

1700

3117

6.43

307.65

2.6

5.1

47.83

79.47

u/ml

2.35

1653

3012

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

1353

1855

8.55

307.65

9.9

1.4

167.38

24.26

u/ml

17.49

1325

1750

Family history of malignant neoplasm

1050

2971

4.20

307.65

4.7

3.1

26.77

46.73

u/ml

4.55

1009

2870

Other symptoms and signs involving the digestive system and abdomen

1666

3771

5.28

307.65

5.1

2.7

73.43

44.77

u/ml

1.97

1629

3642

Serous carcinoma of ovary, including Hilmo

928

560

63.34

307.65

19.5

1.5

173.69

23.46

u/ml

12.19

916

528

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

279

201

24.45

307.65

17.1

1.5

266.47

23.86

u/ml

6.95

274

193

Malignant neoplasm of ovary

1293

828

50.68

307.65

15.2

1.5

155.80

22.89

u/ml

12.04

1268

781

Congenital malformations of ovaries, fallopian tubes and broad ligaments

696

1586

5.81

302.37

2.0

2.8

20.55

41.24

u/ml

4.80

668

1535

Excessive, frequent and irregular menstruation

1947

4072

2.77

299.95

2.5

4.9

42.72

77.00

u/ml

3.28

1862

3927

Congenital ovarian cysts

600

1253

6.63

291.80

2.0

2.6

20.29

38.55

u/ml

3.48

578

1215

Congenital malformations of genital organs

834

2239

4.36

279.82

2.0

2.6

20.89

40.59

u/ml

6.78

802

2168

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

644

1415

4.93

275.10

7.8

1.5

103.22

24.38

u/ml

8.34

634

1342

Pain and other conditions associated with female genital organs and menstrual cycle

1073

3142

3.37

264.36

2.3

4.7

25.74

70.45

u/ml

4.55

1028

3033

Other noninflammatory disorders of uterus, except cervix

1309

3058

3.15

260.02

3.3

5.6

40.29

91.55

u/ml

4.50

1266

2947

Benign neoplasms

3683

10803

1.93

255.09

2.7

3.4

39.09

51.34

u/ml

2.93

3559

10408

L02BG Aromatase inhibitors

2090

9675

2.37

253.03

4.9

3.7

54.45

62.51

u/ml

0.67

2026

9315

Complications of surgical and medical care, not elsewhere classified

4178

16198

1.82

251.62

3.7

3.1

48.62

51.10

u/ml

0.12

4037

15640

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

328

427

10.28

249.34

2.7

5.1

32.92

61.66

u/ml

1.02

316

415

Complications of procedures, not elsewhere classified

3524

15957

1.89

246.79

3.5

3.1

45.63

51.47

u/ml

0.29

3405

15413

Symptoms and signs involving the digestive system and abdomen

3570

9523

1.93

240.41

3.8

2.5

59.27

40.52

u/ml

2.87

3434

9192

Endometroid carcinoma of ovary, including Hilmo

203

153

35.31

239.64

12.1

1.5

44.15

23.43

u/ml

1.13

197

148

Appendectomy

2998

15410

1.93

228.50

6.3

2.6

54.95

46.00

u/ml

1.26

2920

14873

Persons encountering health services for specific procedures and health care

4370

15355

1.75

226.23

5.3

2.4

95.18

32.54

u/ml

10.44

4227

14817

L02BA Anti-estrogens

1316

5327

2.80

220.06

3.7

3.5

47.99

57.84

u/ml

0.67

1283

5132

Any death

2284

7947

2.14

219.65

7.8

3.0

193.71

29.34

u/ml

18.74

2223

7627

Menorrhagia

1653

3845

2.52

212.56

2.6

5.1

44.21

80.27

u/ml

3.31

1594

3708

Malignant neoplasm of digestive organs

1117

3170

2.89

211.05

2.5

1.4

89.84

25.10

u/ml

12.43

1081

2992

Liquid cancers, helper endpoint

1175

3836

2.78

211.05

5.5

1.5

105.53

24.85

u/ml

2.64

1151

3634

Endometriosis diagnosis and infertility diagnosis occurring together

939

3290

3.32

209.24

2.4

2.8

40.51

39.46

u/ml

0.07

915

3184

Procreative management

1621

5998

2.38

203.68

4.7

3.0

34.02

46.01

u/ml

2.65

1553

5808

Abdominal and pelvic pain

3397

9522

1.83

197.71

3.5

2.5

53.40

40.52

u/ml

1.58

3271

9191

Hernia of abdominal wall, postoperative

665

1915

3.66

194.69

4.7

1.6

42.83

29.29

u/ml

1.27

643

1837

Secondary uncertain malignant neoplasm

478

1109

4.61

190.09

4.1

1.5

156.69

23.19

u/ml

9.10

468

1047

Endometriosis ASRM stages 1,2

1346

5880

2.54

188.99

2.4

3.1

42.35

41.68

u/ml

0.05

1314

5680

Genitourinary diseases

1211

2265

2.73

184.37

2.7

4.3

46.06

71.70

u/ml

2.41

1174

2188

Torsion of ovary, ovarian pedicle and fallopian tube

237

309

9.85

178.74

2.0

5.2

44.24

58.75

u/ml

0.31

224

303

Leiomyoma of uterus

3883

13415

1.72

178.53

2.8

3.5

43.81

54.74

u/ml

1.73

3759

12947

Malignant neoplasm of colon, including Hilmo

586

1654

3.73

176.46

3.3

1.5

63.21

25.24

u/ml

5.24

573

1555

Endometriosis of rectovaginal septum and vagina

517

1370

4.28

176.13

2.6

5.3

47.31

98.40

u/ml

1.48

505

1316

Complications of medical and surgical care

3032

16367

1.76

170.12

3.8

3.2

48.94

51.99

u/ml

0.11

2920

15813

Adenomyosis (Endometriosis of uterus)

751

2564

3.20

169.71

2.8

5.4

46.02

85.29

u/ml

2.39

735

2471

Malignant neoplasm of cervix uteri, including Hilmo

279

468

7.98

169.35

5.3

1.4

110.33

23.57

u/ml

0.95

274

446

Colorectal cancer

633

1986

3.25

154.37

2.7

1.4

54.34

26.30

u/ml

3.98

616

1874

Intestinal stricture

1194

5332

2.35

152.54

8.3

3.3

90.99

67.50

u/ml

1.43

1161

5114

Dysplasia of cervi uteri

1061

3220

2.51

146.34

2.3

4.9

64.70

72.09

u/ml

0.14

1027

3111

Hydronephrosis

544

1703

3.46

141.67

8.9

3.3

105.28

53.22

u/ml

2.61

533

1637

Malignant neoplasm of colon

455

1264

3.79

140.71

2.7

1.5

61.54

26.35

u/ml

3.62

445

1179

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2420

14038

1.76

137.00

3.5

3.2

51.29

55.08

u/ml

0.11

2330

13552

Abnormal findings on diagnostic imaging of other body structures

758

2942

2.81

134.97

3.3

3.7

46.81

58.70

u/ml

0.63

718

2837

Deep endometriosis

710

2755

2.92

129.53

2.5

3.4

47.17

53.42

u/ml

0.47

692

2653

Malignant neoplasm of breast, ER-negative, including Hilmo

1035

4466

2.35

128.42

3.3

1.4

91.22

24.42

u/ml

1.62

1011

4243

Other abnormal uterine and vaginal bleeding

1027

3235

2.40

127.58

3.1

5.4

69.06

86.83

u/ml

0.50

984

3114

Inflammatory diseases of female pelvic organs

3524

16920

1.59

127.00

2.8

3.3

40.43

50.87

u/ml

1.26

3382

16369

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2244

13371

1.73

120.55

3.4

3.3

49.12

53.11

u/ml

0.11

2161

12907

Malignant neoplasm of breast, HER-negative

910

3975

2.39

118.49

3.4

1.5

95.34

24.73

u/ml

1.45

890

3771

Paralytic ileus and intestinal obstruction

973

4429

2.29

118.36

8.3

3.4

92.22

76.61

u/ml

0.65

944

4271

Anaemias

955

2706

2.40

118.32

3.6

1.6

43.46

23.94

u/ml

2.13

926

2619

Other or unspecified ileus, impaction or obstruction

697

2786

2.63

114.14

8.7

3.5

103.80

86.52

u/ml

0.49

674

2679

Female infertility, associated with anovulation

357

997

3.84

110.57

2.1

3.7

25.55

36.54

u/ml

1.97

344

963

Other menopausal disorders

1221

3394

2.13

107.98

2.3

5.4

43.56

80.76

u/ml

1.90

1176

3288

Pleural effusion

499

1755

2.99

105.01

10.4

3.5

202.22

59.33

u/ml

4.52

491

1683

Nausea and vomiting

992

4728

2.13

101.29

5.3

2.6

73.13

48.58

u/ml

1.50

950

4549

Uterine polyps

512

1893

2.94

100.18

2.9

5.5

34.19

89.52

u/ml

2.72

501

1829

Salpingitis and oophoritis

1140

5960

2.07

99.84

2.9

3.7

50.31

53.86

u/ml

0.10

1112

5765

Opioids

3594

12622

1.51

99.26

3.7

2.6

51.23

39.60

u/ml

2.12

3459

12209

Bacterial infection, other or unspecified

1713

8708

1.75

95.67

5.1

3.3

83.33

55.03

u/ml

0.92

1660

8379

Fever of other and unknown origin

1987

10813

1.67

94.80

5.0

3.1

54.42

45.86

u/ml

0.97

1932

10435

Other diseases of intestines

3732

14645

1.47

94.78

3.6

2.9

44.17

49.72

u/ml

0.66

3592

14162

Persons encountering health services for other counselling and medical advice, not elsewhere classified

3883

14680

1.46

93.64

3.6

3.0

44.66

49.90

u/ml

0.72

3765

14158

Pain in joint

1934

7399

1.70

93.08

2.5

3.2

36.64

50.04

u/ml

2.55

1850

7168

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2195

12425

1.62

91.29

3.4

3.6

52.28

59.94

u/ml

0.68

2103

11994

Bacterial infection, other or unspecified

1858

9513

1.69

91.27

5.0

3.3

80.54

53.75

u/ml

0.95

1798

9165

Fentanyl

421

1467

3.04

90.39

7.8

3.4

171.08

75.43

u/ml

0.73

408

1399

Cystitis

3385

13924

1.47

86.27

3.1

39.96

50.33

u/ml

1.19

3271

13468

Colorectal adenocarcinoma

432

1563

2.85

85.03

2.6

1.5

59.13

25.45

u/ml

3.13

419

1470

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

3515

16093

1.45

83.10

3.6

3.1

47.44

50.71

u/ml

0.21

3375

15566

Malignant neoplasm, without specification of site

124

183

7.38

81.28

4.2

1.5

256.57

26.76

u/ml

3.75

124

176

Female infertility, tubal origin

279

822

3.74

80.98

3.0

5.4

32.58

55.66

u/ml

1.62

274

795

Colon adenocarcinoma

290

895

3.38

76.21

2.6

1.5

68.68

23.64

u/ml

2.95

282

839

Female genital prolapse

1144

3523

1.90

75.85

3.0

5.3

45.02

84.74

u/ml

3.07

1101

3400

Follow-up examination after treatment for malignant neoplasms

477

1975

2.57

73.64

5.6

4.1

66.81

72.75

u/ml

0.07

458

1901

First line medication for Crohn's disease

3749

14623

1.41

73.47

4.4

2.5

53.28

44.97

u/ml

1.29

3628

14107

General symptoms and signs

3757

13615

1.40

71.61

3.7

3.0

61.77

43.58

u/ml

1.33

3624

13166

Agranulocytosis

507

2198

2.47

70.98

8.3

3.5

60.61

55.36

u/ml

0.25

489

2121

Venous thromboembolism

1741

10724

1.60

70.93

5.4

3.3

89.87

57.81

u/ml

2.28

1675

10336

Drug-induced neutropenia

366

1370

2.92

70.55

9.2

3.5

62.59

60.18

u/ml

0.08

354

1321

Other noninflammatory disorders of vulva and perineum

409

1622

2.68

69.07

2.6

5.1

71.84

89.19

u/ml

0.18

400

1560

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

3358

16718

1.41

69.04

4.4

3.0

55.27

48.76

u/ml

0.57

3234

16152

Non-Hodgkin lymphoma, all, including Hilmo

321

1120

2.98

68.36

2.6

1.5

73.85

25.61

u/ml

2.77

310

1056

Pulmonary heart disease

951

5227

1.88

68.23

5.8

3.6

116.51

68.45

u/ml

1.83

923

5014

Other disorders of urethra and urinary system

2707

13645

1.46

68.20

3.6

3.1

48.44

50.82

u/ml

0.14

2602

13206

Other bacterial diseases

3068

14677

1.43

68.14

4.7

3.1

76.70

48.01

u/ml

1.93

2958

14170

Pulmonary embolism

951

5232

1.88

68.02

5.8

3.6

116.51

68.32

u/ml

1.83

923

5019

Non-invasive ventilation

994

4955

1.86

66.95

4.4

3.6

38.72

43.93

u/ml

0.52

906

4833

Medical treatment for female infertility

1183

6990

1.77

66.73

2.3

2.4

30.20

31.25

u/ml

0.18

1148

6766

Persons encountering health services in other circumstances, wide

3874

14699

1.38

66.14

3.6

3.0

56.71

49.91

u/ml

0.36

3743

14177

Postmenopausal atrophic vaginitis

1052

3240

1.86

64.66

2.5

5.6

29.06

89.51

u/ml

6.87

1005

3131

Follow-up examination after treatment for conditions other than malignant neoplasms

1731

7361

1.59

64.36

2.8

3.3

38.57

50.85

u/ml

1.98

1674

7132

Parasetamol

2335

7997

1.50

64.11

3.1

2.7

44.33

47.66

u/ml

0.23

2261

7724

Other diseases of urinary system

3412

13968

1.39

64.01

3.2

3.1

40.90

50.37

u/ml

1.45

3288

13511

DVT of lower extremities and pulmonary embolism

1300

7914

1.68

63.53

5.7

3.4

101.13

62.56

u/ml

2.07

1254

7608

Examination and observation for other reasons

1949

7408

1.55

63.37

3.0

3.3

44.27

50.86

u/ml

0.41

1867

7176

Other bacterial diseases

3387

15732

1.39

62.99

4.5

3.0

71.69

46.25

u/ml

1.87

3273

15186

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

158

369

4.49

62.30

2.3

1.5

139.52

22.47

u/ml

3.21

152

349

Pulmonary heart disease, diseases of pulmonary circulation

982

5649

1.79

60.35

5.7

3.6

120.14

67.81

u/ml

2.16

953

5421

Congenital malformations, deformations and chromosomal abnormalities

2096

13704

1.49

60.19

2.4

3.1

44.64

44.45

u/ml

0.00

2022

13252

Disorders of the thyroid gland

3281

15705

1.38

59.89

3.0

3.2

42.41

48.36

u/ml

0.58

3160

15156

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1164

3408

1.74

58.62

3.0

2.2

51.16

29.53

u/ml

2.64

1123

3321

Other pleural conditions

300

1102

2.85

58.44

11.0

3.4

285.54

58.94

u/ml

2.98

294

1063

Congenital malformations, deformations and chromosomal abnormalities

2280

14787

1.45

57.01

2.4

3.1

43.35

46.03

u/ml

0.07

2198

14294

Malignant neoplasm of skin

1144

4684

1.70

56.84

3.5

1.4

58.37

24.35

u/ml

4.35

1101

4441

Other noninflammatory disorders of vagina

346

1398

2.63

56.43

2.7

5.2

51.37

95.25

u/ml

1.04

334

1346

Malignant neoplasm of bronchus and lung, including Hilmo

386

1360

2.43

53.96

2.7

1.5

72.81

24.06

u/ml

4.33

370

1285

Irregular menses

2490

14207

1.42

53.93

2.3

3.2

37.49

43.83

u/ml

0.48

2397

13757

Other diseases of blood and blood-forming organs, wide

762

4263

1.85

52.13

6.5

3.5

50.91

56.70

u/ml

0.43

737

4103

Secondary and unspecified malignant neoplasm of lymph nodes

216

706

3.20

51.93

3.0

1.5

90.80

24.82

u/ml

3.78

209

672

Hypothyroidism, other/unspecified

3169

15623

1.35

51.21

3.0

3.2

44.78

48.47

u/ml

0.29

3054

15081

Colectomy operation

529

2656

2.07

50.31

5.3

3.8

78.98

66.46

u/ml

0.34

514

2550

Malignant neoplasm of rectum, including Hilmo

250

902

2.86

50.02

3.4

1.5

37.62

22.70

u/ml

2.03

243

850

Personal history of malignant neoplasm

393

1792

2.39

49.90

2.5

3.6

32.56

61.40

u/ml

2.92

379

1725

Tramadol

2585

11556

1.39

49.79

3.7

2.7

50.55

40.80

u/ml

1.19

2484

11183

Hypothyreosis and Thyroxine purchase for inclusion criteria

3315

16482

1.34

49.68

3.0

3.2

48.22

49.13

u/ml

0.06

3196

15915

Any reimbursement code in KELA

2057

7167

1.46

49.29

3.4

1.6

45.05

28.90

u/ml

3.37

1993

6914

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

111

236

4.92

49.24

2.1

1.5

173.14

22.66

u/ml

2.67

105

222

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

1059

4367

1.67

49.21

3.6

1.4

59.60

24.49

u/ml

4.28

1019

4142

Hypothyroidism and >3 levothyroxin purchases

869

2806

1.79

49.00

2.5

1.6

31.02

23.97

u/ml

1.48

838

2713

Hypothyroidism, levothyroxine purchases

869

2806

1.79

49.00

2.5

1.6

31.02

23.97

u/ml

1.48

838

2713

Misadventures to patients during surgical and medical care

533

2720

2.05

48.75

3.7

3.4

35.20

56.89

u/ml

3.02

512

2617

Other malignant neoplasms of skin (=non-melanoma skin cancer)

980

4018

1.70

48.60

3.7

1.4

59.85

24.44

u/ml

3.83

942

3804

Non-small cell lung cancer, including Hilmo

278

1006

2.67

48.47

2.6

1.5

65.48

26.12

u/ml

2.18

267

949

Hypothyroidism (congenital or acquired)

868

2810

1.78

48.36

2.5

1.6

30.94

23.96

u/ml

1.45

836

2717

Artificial opening status

210

710

3.17

48.34

7.9

3.4

84.39

70.50

u/ml

0.22

205

684

Malignant neoplasm of pancreas, including Hilmo

194

623

3.24

47.95

2.1

1.5

165.61

25.55

u/ml

4.57

186

587

Basal cell carcinoma

938

3870

1.71

47.15

3.6

1.4

62.50

24.71

u/ml

3.79

902

3664

Headache

2334

13587

1.39

46.66

2.6

3.0

31.44

43.60

u/ml

2.85

2240

13140

Pain in limb

2727

13569

1.36

46.50

3.0

3.2

56.28

49.81

u/ml

0.21

2612

13129

Septicaemia

1091

6458

1.61

45.71

4.8

3.4

95.27

60.97

u/ml

0.65

1053

6208

Other functional intestinal disorders

1493

9399

1.50

45.55

3.8

3.2

53.86

59.88

u/ml

0.38

1426

9094

All kidney diseases

3281

17215

1.32

44.97

4.3

3.0

70.96

44.62

u/ml

2.04

3183

16606

Diverticular disease of intestine

2149

9866

1.41

44.85

3.1

3.4

35.07

59.27

u/ml

4.70

2059

9549

Benign leiomyoma with endometriosis

836

5073

1.74

44.33

3.0

3.8

43.03

66.25

u/ml

2.07

808

4882

Polycystic ovarian syndrome, consortium definition

3625

16769

1.31

43.96

2.7

3.3

49.85

49.17

u/ml

0.04

3484

16211

Basal cell carcinoma, including avohilmo

973

4119

1.65

43.58

3.6

1.4

60.63

24.96

u/ml

3.66

937

3902

Malignant melanoma, including Hilmo

378

1760

2.21

43.52

2.5

1.5

37.62

24.41

u/ml

1.01

362

1666

Pain (limb, back, neck, head abdominally)

2071

7408

1.42

42.63

3.2

3.3

54.04

49.78

u/ml

0.31

1986

7174

Right hemicolectomy

214

784

2.91

42.55

6.7

3.6

101.93

71.87

u/ml

0.46

209

753

Constipation

2853

15024

1.33

41.94

3.6

3.3

60.89

51.24

u/ml

0.40

2739

14525

Enlarged lymph nodes

530

2834

1.93

41.88

3.5

3.1

58.99

53.78

u/ml

0.16

515

2732

Renal tubulo-interstitial diseases

2831

16060

1.33

41.72

4.6

3.0

76.82

46.06

u/ml

2.10

2745

15483

Depression medications

924

2812

1.68

41.12

2.4

1.6

39.24

23.94

u/ml

2.15

890

2719

Other septicaemia

958

5838

1.61

40.18

4.6

3.4

102.37

60.14

u/ml

0.73

923

5608

Ventral hernia

778

4727

1.69

39.53

4.2

3.7

42.72

65.45

u/ml

1.60

752

4546

Malignant neoplasm of respiratory system and intrathoracic organs

336

1272

2.24

39.33

2.1

1.5

79.01

25.02

u/ml

4.16

323

1204

Malignant melanoma

315

1428

2.27

38.88

2.6

1.4

41.81

22.08

u/ml

1.50

302

1348

Persons encountering health services in circumstances related to reproduction

1770

8527

1.42

38.67

4.0

3.3

37.69

46.72

u/ml

1.53

1702

8251

Malignant neoplasm of pancreas

148

461

3.33

38.58

1.6

1.5

197.55

25.99

u/ml

4.09

140

434

Amenorrhoea

221

863

2.67

38.38

1.7

4.4

83.48

42.71

u/ml

0.31

213

830

Explicit Sepsis

1201

7543

1.51

38.23

4.5

3.4

88.61

58.70

u/ml

0.62

1160

7279

Other female pelvic inflammatory diseases

827

5189

1.67

38.19

3.3

3.6

42.36

58.61

u/ml

1.38

780

5005

Intestinal adhesions without obstruction

301

1368

2.31

37.57

7.6

3.4

54.84

70.24

u/ml

0.54

292

1316

Other diseases of pleura

993

5640

1.57

37.19

7.7

3.4

167.00

64.84

u/ml

4.66

966

5403

Codeine

2973

12535

1.30

36.17

2.8

2.7

47.36

39.70

u/ml

0.70

2860

12124

140

450

3.48

36.04

4.2

2.1

37.85

41.71

u/ml

0.10

134

439

Malignant neoplasm of bronchus and lung

296

1104

2.27

35.75

2.2

1.5

84.68

25.26

u/ml

3.92

283

1041

Lower back pain or/and sciatica

3381

17521

1.27

35.54

2.7

3.3

47.11

50.40

u/ml

0.20

3234

16945

Fistulae involving female genital tract

101

265

4.35

35.46

5.3

5.6

47.14

61.38

u/ml

0.33

255

Disorders of gallbladder, biliary tract and pancreas

3169

15750

1.28

35.09

3.2

3.3

52.23

49.06

u/ml

0.26

3054

15228

Malignant neoplasm of stomach

106

287

3.83

34.27

3.1

1.5

83.80

21.16

u/ml

2.60

106

271

Certain infectious and parasitic diseases

3287

13007

1.28

34.16

3.6

2.9

58.43

43.47

u/ml

0.88

3155

12590

Other complications of surgical and medical care, not elsewhere classified

373

1921

2.03

33.54

7.1

3.3

48.48

57.59

u/ml

0.45

360

1849

Oedema, not elsewhere classified

1007

6648

1.53

33.46

4.2

3.2

69.23

53.54

u/ml

0.50

973

6413

Hypothyroidism, strict autoimmune

2648

13526

1.30

33.44

3.2

3.3

47.02

47.15

u/ml

0.01

2556

13070

All chronic kidney diseases

1404

8133

1.43

33.36

5.4

3.2

93.05

55.16

u/ml

1.03

1353

7825

Other soft tissue disorders, not elsewhere classified

2967

13665

1.29

33.25

2.8

3.2

51.99

49.75

u/ml

0.07

2853

13219

Fenamates

532

2034

1.83

33.24

2.5

3.4

41.21

87.82

u/ml

2.97

514

1969

Low back pain

2450

13581

1.31

32.67

2.6

3.3

46.45

51.55

u/ml

0.25

2346

13142

Diffuse large B-cell lymphoma, including Hilmo

117

351

3.50

32.66

1.8

1.5

133.72

24.41

u/ml

2.22

112

328

Diffuse large B-cell lymphoma

117

351

3.50

32.66

1.8

1.5

133.72

24.41

u/ml

2.22

112

328

Diffuse large B-cell lymphoma, helper endpoint

117

351

3.50

32.66

1.8

1.5

133.72

24.41

u/ml

2.22

112

328

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

178

676

2.70

32.43

3.6

1.4

48.56

23.62

u/ml

1.86

167

640

Benzodiazepine use

3188

17515

1.27

32.24

3.5

3.1

66.72

46.80

u/ml

1.18

3067

16921

Hernia of abdominal wall

1174

8181

1.46

31.59

3.8

3.3

40.62

57.98

u/ml

1.97

1133

7880

Cholelithiasis

2828

15398

1.28

31.44

3.2

3.3

54.26

49.50

u/ml

0.30

2727

14883

Cholelithiasis, broad definition with cholecystitis

2892

15458

1.27

30.58

3.2

3.3

54.61

49.47

u/ml

0.34

2791

14943

Hypothyroidism, strict autoimmune, 3 medication purchases required

3043

16426

1.27

30.57

3.2

50.34

49.30

u/ml

0.06

2939

15862

Malignant neoplasm of urinary organs

163

614

2.72

30.21

3.4

1.4

48.22

21.79

u/ml

1.96

153

583

Pain, not elsewhere classified

938

6343

1.51

29.82

2.9

3.0

52.18

46.38

u/ml

0.15

886

6114

Non-small cell lung cancer

154

564

2.77

29.56

2.0

1.5

82.32

22.35

u/ml

1.95

147

528

Diseases of peritoneum

337

1750

2.00

29.52

3.3

65.39

60.35

u/ml

0.18

323

1688

Malignant melanoma of skin, including Hilmo

289

1419

2.09

29.14

2.2

1.4

37.51

25.17

u/ml

0.66

278

1343

Cholecystectomy

2411

16343

1.29

29.00

3.4

3.3

53.76

51.93

u/ml

0.09

2325

15780

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2934

15065

1.26

28.25

3.7

3.2

53.50

48.39

u/ml

0.38

2838

14548

In situ neoplasms

1298

9418

1.41

28.18

2.8

3.5

68.31

55.95

u/ml

0.21

1246

9068

Other specific joint derangements/joint disorders

2394

12128

1.29

28.00

2.4

3.2

33.36

50.51

u/ml

3.91

2289

11749

Other nutritional deficiencies

2224

16392

1.29

27.93

2.7

3.2

37.51

48.80

u/ml

2.19

2129

15856

Dysphagia

623

3905

1.63

27.84

3.0

2.8

40.29

47.43

u/ml

0.31

596

3763

Malignant neoplasm of kidney, except renal pelvis

149

562

2.72

27.60

3.5

1.5

43.83

22.39

u/ml

1.56

140

533

Paracetamol or NSAID medication

379

1005

1.93

26.86

2.4

2.7

36.78

55.97

u/ml

1.33

361

970

Postprocedural endocrine and metabolic disorders, not elsewhere classified

547

3389

1.68

26.49

3.3

3.4

36.01

50.23

u/ml

1.07

529

3268

Aplastic and other anaemias

1145

7634

1.42

26.42

4.7

3.5

83.04

67.51

u/ml

0.48

1100

7338

Other anaemias

1059

7107

1.44

26.41

4.2

3.6

82.68

67.31

u/ml

0.43

1017

6829

Malignant neoplasm of rectum

167

681

2.52

26.38

2.1

1.4

32.22

22.28

u/ml

1.02

160

646

Hypothyroidism, drug reimbursement

512

2162

1.71

26.23

2.7

1.6

26.56

22.41

u/ml

0.63

495

2100

Abnormal findings on diagnostic imaging of lung

1176

8128

1.41

25.97

3.4

3.8

53.18

67.47

u/ml

1.18

1137

7841

Other diseases of intestine

396

2249

1.81

25.92

4.0

3.6

60.41

65.11

u/ml

0.12

381

2165

Other metabolic disorders

571

3596

1.65

25.81

3.3

3.4

35.21

50.44

u/ml

1.26

552

3472

Inflammatory disease of uterus

669

4378

1.59

25.74

2.5

3.1

35.13

42.02

u/ml

0.35

642

4241

Gastrointestinal diseases

1951

7506

1.32

25.51

3.1

2.9

50.07

47.51

u/ml

0.14

1884

7270

Diseases of oesophagus, stomach and duodenum

3308

16238

1.23

25.34

2.8

3.3

46.51

51.81

u/ml

0.54

3175

15719

Other and unspecified anaemias

1038

7035

1.43

24.88

3.9

3.6

77.30

67.62

u/ml

0.25

997

6758

Medical observation and evaluation for suspected diseases and conditions

1886

7410

1.31

24.63

2.8

3.3

56.08

50.86

u/ml

0.27

1808

7178

Cardiovascular diseases (excluding rheumatic etc)

2231

10146

1.28

23.98

3.2

2.6

43.65

34.63

u/ml

1.49

2152

9831

Abnormalities of breathing

2847

13450

1.24

23.80

3.7

3.0

57.03

48.16

u/ml

0.59

2738

13047

Sequelae of external causes of morbidity and mortality

733

4942

1.51

23.80

3.5

3.6

61.92

62.90

u/ml

0.02

714

4756

Sequelae with surgical and medical care as external cause

595

3844

1.59

23.70

3.5

3.7

42.84

60.44

u/ml

1.77

583

3687

Adenocarcinoma and papillary adenocarcinoma of stomach

125

4.66

23.56

3.4

1.5

56.44

25.41

u/ml

1.22

119

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

2322

14750

1.27

23.54

2.6

3.1

36.93

45.61

u/ml

0.71

2236

14266

Malignant melanoma of skin

219

1053

2.13

23.52

2.3

1.4

42.17

22.63

u/ml

0.94

213

992

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

159

669

2.43

23.49

2.5

1.4

40.70

22.23

u/ml

1.75

153

633

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

287

1533

1.96

23.42

3.9

3.3

32.03

55.04

u/ml

2.19

279

1481

Dermatitis and eczema

3384

17407

1.21

23.35

3.0

3.2

37.98

52.40

u/ml

3.70

3262

16805

Malignant neoplasm of thyroid gland, including Hilmo

231

1148

2.09

23.05

2.2

1.5

37.32

22.77

u/ml

1.06

225

1092

Unspecific neurodegenerative disorder

432

4830

0.60

23.04

2.4

4.1

124.20

90.04

u/ml

0.43

406

4639

Acute renal failure

444

2689

1.68

22.84

4.9

3.8

123.18

78.88

u/ml

1.60

420

2575

Obesity due to excess calories

1555

11966

1.32

22.72

2.8

3.2

37.68

46.32

u/ml

1.07

1490

11569

Persons encountering health services in other circumstances

1195

8846

1.36

21.98

3.3

3.0

53.08

50.05

u/ml

0.15

1154

8522

Primary_lymphoid and hematopoietic malignant neoplasms

544

3501

1.58

21.85

2.6

3.9

126.07

71.38

u/ml

0.48

529

3359

Dyspnoea

2720

16485

1.23

21.83

4.2

3.1

64.74

48.47

u/ml

1.34

2608

15928

472

2955

1.64

21.69

4.9

3.0

105.24

51.08

u/ml

0.40

454

2863

Need for other prophylactic measures

183

857

2.23

21.46

6.4

3.4

36.97

58.16

u/ml

1.30

173

826

Intestinal infectious diseases

3528

16911

1.20

21.35

3.1

3.2

49.04

50.62

u/ml

0.11

3393

16337

Obesity

2076

16085

1.26

21.25

2.7

3.1

37.81

48.98

u/ml

2.02

1991

15553

Alzheimer disease, including avohilmo

356

4203

0.59

21.11

2.6

4.0

176.74

89.41

u/ml

1.04

333

4023

Obesity and other hyperalimentation

2082

16136

1.26

20.99

2.7

3.1

37.73

49.02

u/ml

2.06

1997

15602

Other noninflammatory disorders of cervix uteri

194

951

2.15

20.45

3.4

5.6

68.08

109.67

u/ml

0.57

183

917

Disorders of thyroid, IBD co-morbidities

674

3211

1.51

20.31

2.7

3.7

38.50

47.67

u/ml

0.69

647

3147

Cardiovascular diseases

2050

8799

1.27

20.12

2.8

2.6

38.69

35.24

u/ml

0.42

1976

8538

Degenerative diseases of the nervous system

329

4078

0.58

20.09

2.5

4.0

193.84

90.13

u/ml

1.19

305

3900

Anxiety disorders

2948

17115

1.21

20.06

3.1

3.2

52.05

47.98

u/ml

0.15

2836

16544

Neurotic, stress-related and somatoform disorders

2925

17054

1.21

19.87

3.1

3.2

52.32

47.84

u/ml

0.17

2814

16486

Dementia

493

5204

0.64

19.84

2.7

4.1

102.69

86.53

u/ml

0.21

466

4993

Gastro-oesophageal reflux disease

2044

14219

1.25

19.83

2.8

3.5

40.95

54.57

u/ml

1.72

1957

13757

Adenocarcinoma and papilloma adenocarcinoma of rectum

146

640

2.33

19.72

2.4

1.4

40.30

21.66

u/ml

1.61

141

606

Symptoms and signs involving the circulatory and respiratory systems

3209

13450

1.20

19.69

3.2

3.0

38.84

48.16

u/ml

1.59

3081

13047

Anxiety disorders, excluding more controls

2736

14763

1.22

19.38

3.2

3.3

54.20

47.47

u/ml

0.25

2630

14296

Major coronary heart disease event excluding revascularizations

861

7919

0.72

19.36

3.2

4.0

77.54

68.30

u/ml

0.22

823

7621

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

161

738

2.21

19.33

2.9

1.5

53.95

25.25

u/ml

1.00

154

686

Contraceptive management

1295

6932

1.33

19.17

2.7

3.1

30.34

41.57

u/ml

2.13

1250

6723

Other disorders of skin and subcutaneous tissue

2045

14727

1.25

19.02

3.1

3.5

56.92

54.41

u/ml

0.11

1954

14223

Disorders of eyelid, lacrimal system and orbit

2641

16647

1.22

18.96

2.9

3.3

41.18

53.05

u/ml

1.21

2553

16068

Malaise and fatigue

1434

8968

1.30

18.82

3.8

3.2

82.80

48.89

u/ml

2.15

1370

8662

Benign neoplasm of colon, rectum, anus and anal canal

1657

11397

1.28

18.81

3.0

3.8

44.95

64.17

u/ml

2.52

1593

10987

N06DA Anticholinesterases

332

4319

0.60

18.68

2.3

4.1

118.88

93.26

u/ml

0.24

314

4131

Use of anticholinesterases

332

4319

0.60

18.68

2.3

4.1

118.88

93.26

u/ml

0.24

314

4131

Follow-up care involving plastic surgery

173

845

2.18

18.60

2.4

2.5

34.81

37.25

u/ml

0.10

168

816

Other diseases of peritoneum

184

920

2.12

18.50

2.8

3.3

38.24

50.92

u/ml

0.55

176

889

Unspecified misadventure during surgical and medical care

174

853

2.13

18.23

2.7

3.1

36.55

54.84

u/ml

1.05

162

820

Alzheimer disease

294

3639

0.58

18.20

2.6

4.0

215.23

95.25

u/ml

1.25

272

3472

Acute tubulo-interstitial nephritis

1904

13285

1.25

18.07

3.7

3.1

79.78

48.56

u/ml

1.09

1850

12794

Phlebitis and thrombophlebitis (not including DVT)

667

4683

1.45

17.74

4.3

3.3

78.36

63.36

u/ml

0.31

645

4508

Codeine or tramadol medication

3495

16298

1.18

17.64

2.7

3.3

50.17

49.82

u/ml

0.02

3363

15752

Myocardial infarction

593

6024

0.68

17.57

3.5

4.1

97.18

73.28

u/ml

0.45

565

5789

Myocardial infarction, strict

512

5411

0.67

17.56

3.4

4.1

99.94

77.17

u/ml

0.36

488

5192

Dementia, including avohilmo

551

5544

0.68

17.55

2.8

4.1

96.84

84.60

u/ml

0.17

520

5323

Atrophic disorders of skin

589

4070

1.49

17.46

2.8

3.7

58.17

67.01

u/ml

0.14

565

3922

Heartburn

298

1755

1.74

17.36

2.9

2.7

45.16

33.99

u/ml

0.41

289

1692

Malignant neoplasm of endocrine gland

202

1060

1.97

17.36

2.0

1.5

39.88

23.31

u/ml

1.05

196

1008

Dorsalgia

3025

13663

1.19

17.27

2.8

3.3

46.76

51.40

u/ml

0.28

2896

13219

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

285

1677

1.75

16.81

4.2

3.4

59.32

57.78

u/ml

0.03

272

1615

Benign neoplasm: Colon

1357

10184

1.29

16.71

3.0

3.9

46.49

66.86

u/ml

2.21

1301

9817

Renal failure

873

5709

1.37

16.43

4.4

3.7

96.08

72.67

u/ml

1.21

830

5471

Migraine

1951

12968

1.24

16.39

2.4

3.2

29.59

44.33

u/ml

6.48

1868

12573

Hypertension, essential

2427

11430

1.21

16.36

3.5

3.1

36.31

46.64

u/ml

2.31

2356

11056

Non-follicular lymphoma

221

1217

1.87

16.27

2.4

3.6

93.43

73.38

u/ml

0.42

213

1169

Any dementia

428

4488

0.65

16.05

2.9

4.0

130.55

86.71

u/ml

0.60

404

4297

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

289

1735

1.72

15.90

7.3

3.2

44.74

58.52

u/ml

0.74

283

1672

Malignant neoplasm of thyroid gland

192

1022

1.95

15.87

2.0

1.5

41.09

23.13

u/ml

1.11

187

973

Other antidepressants

2943

12773

1.19

15.81

3.0

3.3

52.91

50.81

u/ml

0.07

2834

12347

Behavioural syndromes associated with physiological disturbances and physical factors

2909

17549

1.18

15.77

2.3

3.3

34.82

52.43

u/ml

2.88

2814

16944

Ovarian dysfunction

332

2078

1.66

15.73

2.5

2.4

25.78

36.02

u/ml

1.69

321

2014

Organic, including symptomatic, mental disorders

663

6548

0.71

15.64

2.8

4.0

88.05

76.64

u/ml

0.20

632

6293

Migraine, single triptan purchase ok & required. ICD-code if available is included

2705

15507

1.19

15.60

2.5

3.3

33.50

47.86

u/ml

3.09

2622

14994

Triptan medication for migraine, single purchase ok

2705

15507

1.19

15.60

2.5

3.3

33.50

47.86

u/ml

3.09

2622

14994

Alzheimer’s disease, strict definition

217

3116

0.57

15.31

2.7

4.0

230.45

87.39

u/ml

1.12

203

2971

Metabolic disorders

2786

14417

1.19

15.30

3.9

3.2

54.77

50.27

u/ml

0.39

2675

13951

Bacterial Sepsis

1012

6632

1.32

14.87

4.2

3.6

75.51

63.91

u/ml

0.76

967

6391

Other embolism and thrombosis

353

2265

1.59

14.73

4.7

3.6

68.11

61.92

u/ml

0.20

341

2174

Other and unspecified drugs and medicaments

273

1651

1.71

14.68

7.7

3.4

45.93

57.72

u/ml

0.56

267

1597

Sleep disorders

2821

17421

1.18

14.56

2.3

3.3

34.04

52.46

u/ml

3.02

2731

16819

Other diseases of anus and rectum

783

5824

1.36

14.47

3.6

3.3

46.61

68.86

u/ml

1.54

759

5616

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1573

8036

1.25

14.43

3.7

2.8

45.68

36.39

u/ml

1.24

1517

7793

Depression or dysthymia

1927

8774

1.22

14.16

2.9

3.5

64.80

53.50

u/ml

0.30

1852

8506

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

699

5168

1.39

14.08

2.5

3.1

26.04

44.52

u/ml

6.42

673

4997

Abnormal findings in secretions and smears from cervix uteri vagina vulva

2272

14501

1.20

14.08

2.6

3.1

36.79

44.71

u/ml

0.61

2189

14032

Coxibs

602

2236

1.43

13.88

2.9

3.2

46.17

84.38

u/ml

2.24

576

2162

Injuries to the head

2547

18337

0.85

13.67

3.0

3.2

40.82

51.01

u/ml

1.69

2448

17712

Lung cancer and mesothelioma

403

2302

1.52

13.63

2.7

3.8

71.79

57.90

u/ml

0.59

387

2209

Hypertensive diseases (excluding secondary)

1725

8224

1.23

13.62

3.3

2.8

38.35

36.08

u/ml

0.22

1671

7977

Other reaction to severe stress, and adjustment disorders

1246

9966

1.27

13.61

3.8

2.9

73.00

40.37

u/ml

0.74

1206

9639

Acute peritonitis

151

781

1.99

13.59

3.9

3.1

97.33

56.11

u/ml

1.38

145

752

Polycystic ovarian syndrome, broad definition

470

3271

1.48

13.56

2.0

2.2

23.63

31.15

u/ml

2.84

454

3163

Other disorders of fluid, electrolyte and acid-base balance

781

5595

1.35

13.53

4.4

3.7

88.82

71.06

u/ml

0.70

745

5382

Any dementia, excluding more controls

409

4137

0.67

13.48

2.9

4.1

135.46

80.76

u/ml

0.78

387

3988

Alzheimer’s disease (Late onset)

194

2827

0.57

13.46

2.6

4.0

181.07

83.19

u/ml

1.12

182

2689

Alzheimer’s disease (Late onset), excluding more controls

146

1801

0.52

13.44

2.8

4.9

90.97

82.80

u/ml

0.13

138

1744

Iron deficiency anaemia

1204

9456

1.27

13.44

2.8

3.4

73.22

60.86

u/ml

0.31

1153

9109

Insomnia

2786

17456

1.17

13.35

2.3

3.3

33.50

51.98

u/ml

3.00

2696

16851

Other special examinations and investigations of persons without complaint or reported diagnosis

1780

7411

1.22

13.28

2.8

3.3

39.08

50.89

u/ml

1.88

1710

7179

Disorders of breast

2224

17158

1.19

13.16

3.2

3.3

53.58

49.88

u/ml

0.10

2152

16574

Benign neoplasm of other and ill-defined parts of digestive system

521

3705

1.44

13.14

2.8

3.8

53.61

63.39

u/ml

0.14

492

3565

Excluding asthma or asthma-COPD overlap

2542

10833

1.18

13.13

3.4

3.0

49.85

43.19

u/ml

0.83

2449

10480

Diarrhoea and gastroenteritis of presumed infectious origin

3003

17121

1.16

13.09

2.8

3.2

47.84

50.36

u/ml

0.17

2894

16538

Erysipelas

1235

8738

1.26

13.07

3.5

3.3

72.42

55.13

u/ml

0.78

1188

8411

Dental caries

626

4403

1.38

13.03

3.4

3.6

46.99

63.37

u/ml

0.90

609

4284

COPD/asthma/ILD related infections

3374

14699

1.16

13.01

3.5

3.1

58.23

48.45

u/ml

0.47

3250

14214

COPD/asthma related infections

3374

14699

1.16

13.01

3.5

3.1

58.23

48.45

u/ml

0.47

3250

14214

Major coronary heart disease event

1695

12346

0.82

12.95

3.2

3.8

59.18

56.97

u/ml

0.09

1638

11924

Certain infectious and parasitic diseases

2312

9791

1.19

12.84

3.4

3.1

46.56

47.40

u/ml

0.07

2223

9478

Streptococcal septicaemia

184

1033

1.82

12.78

5.1

3.1

49.02

58.62

u/ml

0.38

179

992

Endocrine, nutritional and metabolic diseases

2408

10350

1.19

12.78

3.0

3.1

39.25

43.99

u/ml

0.53

2330

10030

Anosmia

303

2.59

12.76

3.9

1.5

39.23

21.24

u/ml

0.69

296

Coronary atherosclerosis

1105

8799

0.79

12.74

3.2

4.0

64.55

64.94

u/ml

0.01

1062

8482

Acute upper respiratory infections

3185

17068

1.16

12.72

3.1

3.2

45.86

51.60

u/ml

0.25

3059

16499

Lichen sclerosus et atrophicus

410

2826

1.50

12.56

2.9

3.9

67.12

61.87

u/ml

0.06

397

2724

Recurrent or chronic depression

1322

7510

1.25

12.56

2.7

3.5

54.18

48.26

u/ml

0.10

1279

7288

Nutritional anaemias

1361

10691

1.24

12.40

3.0

3.4

71.18

59.52

u/ml

0.33

1307

10305

Asthma, unspecified (mode), excluding more controls

1628

10078

1.22

12.34

3.1

48.49

41.62

u/ml

0.34

1567

9758

Acetic acid derivatives and related substances

595

2223

1.40

12.28

2.9

3.2

45.54

84.75

u/ml

2.36

576

2149

General examination and investigation of persons without complaint and reported diagnosis

1717

7409

1.22

12.25

3.3

59.08

50.86

u/ml

0.19

1672

7177

Depression

2937

17282

1.16

12.25

2.7

3.3

52.53

47.69

u/ml

0.18

2822

16707

Mesothelioma

9.20

12.23

1.9

1.7

101.60

17.11

u/ml

0.73

Asthma, unspecified (mode)

1661

10381

1.22

12.21

3.1

48.33

43.68

u/ml

0.21

1596

10046

Other and unspecified iron deficiency

941

7371

1.29

12.20

2.7

3.4

72.72

62.28

u/ml

0.20

901

7087

Selective serotonin reuptake inhibitors

2835

12780

1.16

12.18

2.9

3.3

53.01

50.79

u/ml

0.07

2730

12354

Faecal incontinence

302

1964

1.58

12.12

3.2

2.9

91.38

59.21

u/ml

0.32

291

1888

ILD differential diagnosis

2522

10816

1.18

12.09

3.4

3.0

49.23

43.42

u/ml

0.69

2428

10467

COPD differential diagnosis

2522

10817

1.18

12.08

3.4

3.0

49.23

43.41

u/ml

0.69

2428

10468

Factors influencing health status and contact with health services

595

2155

1.40

11.97

3.1

2.4

66.07

41.20

u/ml

1.29

572

2092

Other symptoms and signs involving the urinary system

201

1182

1.73

11.88

3.8

3.3

56.78

65.98

u/ml

0.13

194

1142

DVT of lower extremities

466

3305

1.43

11.87

5.6

3.6

68.03

65.56

u/ml

0.08

446

3167

Pain in throat and chest

2518

13005

1.17

11.75

3.0

39.01

48.91

u/ml

1.44

2413

12625

Explicit bacterial Sepsis

225

1369

1.67

11.71

4.7

3.2

49.96

65.62

u/ml

0.77

219

1317

Other degenerative diseases of the nervous system

451

4725

0.70

11.67

2.3

4.1

99.91

60.65

u/ml

0.63

428

4587

Other pulmonary diagnosis

2518

10833

1.17

11.63

3.4

3.0

48.73

43.19

u/ml

0.65

2428

10480

Renal cell carcinoma of kidney

193

2.88

11.38

4.5

1.5

44.71

24.74

u/ml

0.98

188

Persons with potential health hazards related to communicable diseases

1116

8931

1.25

11.23

2.9

2.7

25.79

38.76

u/ml

6.73

1075

8620

Use of other anti-dementia drugs

252

3245

0.64

11.21

2.4

4.1

191.94

92.22

u/ml

0.78

226

3100

Use of memantine

252

3245

0.64

11.21

2.4

4.1

191.94

92.22

u/ml

0.78

226

3100

Alzheimer disease, excluding more controls

214

2279

0.61

11.21

2.8

4.7

177.60

78.67

u/ml

0.79

200

2213

Implicit bacterial Sepsis

930

6342

1.28

11.05

4.0

3.6

75.19

65.57

u/ml

0.54

883

6113

Caries of dentine

538

3844

1.38

11.05

3.4

3.6

48.42

66.78

u/ml

0.88

521

3738

Other noninfective gastroenteritis and colitis

659

4992

1.34

11.05

2.9

3.5

71.93

63.57

u/ml

0.15

640

4807

Brain meningioma, including Hilmo

132

704

1.94

11.00

2.3

1.4

26.73

21.31

u/ml

0.35

125

670

Other diseases of the digestive system

606

4539

1.35

10.91

3.1

3.5

51.22

76.72

u/ml

1.94

587

4340

Viral infections characterized by skin and mucous membrane lesions

2490

18477

1.16

10.82

2.8

3.2

35.67

51.71

u/ml

4.70

2398

17842

Brain meningioma

129

688

1.94

10.77

2.4

1.5

24.88

21.42

u/ml

0.21

122

655

Other dorsopathies, not elsewhere classified

2985

13669

1.15

10.75

2.9

3.3

41.68

51.38

u/ml

1.00

2863

13225

Coagulation defects, purpura and other haemorrhagic conditions

497

3629

1.39

10.73

5.3

3.2

68.66

53.72

u/ml

0.56

479

3493

Mood [affective] disorders

3072

17502

1.14

10.70

2.8

3.3

54.40

48.96

u/ml

0.22

2951

16917

Oxicams

494

2014

1.41

10.66

2.9

3.4

58.17

89.99

u/ml

1.16

472

1950

Asthma (mode)

2346

10816

1.17

10.66

2.8

3.0

45.03

43.42

u/ml

0.09

2261

10467

Other chronic obstructive pulmonary disease, including avohilmo

706

7551

0.77

10.60

2.8

3.9

68.79

66.78

u/ml

0.07

669

7270

Mood disorders

3075

17507

1.14

10.56

2.8

3.3

54.36

48.96

u/ml

0.21

2954

16921

Benign neoplasm: Adrenal gland

218

1365

1.64

10.37

2.6

3.7

33.89

58.15

u/ml

2.12

209

1314

Stroke, including SAH

1017

9135

0.80

10.37

3.0

3.8

111.37

63.09

u/ml

0.81

961

8814

Emergency coronary revascularization (for ACS)

1705

12246

0.84

10.36

3.0

3.8

60.13

58.11

u/ml

0.08

1640

11824

Papillary adenocarcinoma of thyroid gland

144

808

1.84

10.28

1.9

1.5

41.62

21.01

u/ml

0.93

139

768

Symptoms and signs involving the skin and subcutaneous tissue

2091

17636

1.17

10.26

2.8

3.3

40.91

52.27

u/ml

1.84

2013

17036

Coronary revascularization (ANGIO or CABG)

1616

11728

0.84

10.26

3.0

3.8

58.85

57.18

u/ml

0.06

1559

11332

Implicit bacterial Sepsis

824

5741

1.28

10.24

4.1

3.7

81.13

68.14

u/ml

0.70

784

5524

Care involving use of rehabilitation procedures

1680

13076

1.19

10.23

3.1

2.5

67.21

33.39

u/ml

1.03

1596

12607

Other diseases of pancreas

197

1205

1.68

10.22

2.5

3.8

35.59

59.25

u/ml

2.04

191

1159

Percutaneous Coronary Intervention

1614

11722

0.84

10.20

3.0

3.8

57.77

57.20

u/ml

0.02

1556

11326

Disorders of conjunctiva

2603

18273

1.15

10.18

2.7

3.2

50.46

49.38

u/ml

0.03

2515

17640

Other diseases of biliary tract

232

1479

1.61

10.17

4.2

3.9

99.27

60.43

u/ml

0.75

222

1426

Dementia in Alzheimer disease

143

2089

0.57

10.03

2.3

4.0

242.90

92.99

u/ml

1.25

131

1983

Functional dyspepsia

856

6810

1.27

10.01

2.9

3.5

42.61

58.44

u/ml

1.05

820

6584

Disorders of calcium metabolism

192

1176

1.68

10.01

3.1

3.5

60.95

70.11

u/ml

0.21

185

1132

Neurological diseases, wide definition

887

3506

1.28

9.99

2.3

3.5

31.80

45.56

u/ml

1.92

851

3426

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

105

3.74

9.74

3.7

2.4

48.49

41.73

u/ml

0.14

100

Other CVD

394

2812

1.42

9.72

2.9

3.8

88.17

86.02

u/ml

0.02

385

2681

Irritable bowel syndrome

909

7309

1.26

9.70

2.3

3.1

34.18

57.04

u/ml

2.58

861

7068

COPD

556

5995

0.75

9.66

2.7

4.0

64.55

73.17

u/ml

0.32

528

5770

Other chronic obstructive pulmonary disease

522

5723

0.75

9.66

2.7

4.0

66.91

74.32

u/ml

0.25

495

5506

Angina pectoris

948

7824

0.80

9.65

3.1

4.1

63.04

67.92

u/ml

0.12

906

7533

Diseases of arteries, arterioles and capillaries

1037

9390

0.81

9.65

2.8

3.8

49.17

67.29

u/ml

1.74

1003

9034

Infections of the skin and subcutaneous tissue

1409

11714

1.20

9.55

3.3

3.1

37.55

51.64

u/ml

2.00

1354

11303

Diseases of the digestive system

1023

8290

1.24

9.51

3.7

3.4

51.10

63.27

u/ml

1.02

989

7973

Hypertension

2379

11696

1.16

9.40

3.3

3.1

37.82

46.25

u/ml

1.52

2305

11314

Other postsurgical states

177

1079

1.69

9.38

3.6

3.3

29.33

60.13

u/ml

2.94

170

1038

Hypertensive diseases

2377

11704

1.15

9.22

3.4

3.1

37.84

46.23

u/ml

1.51

2303

11320

Fissure and fistula of anal and rectal regions

593

4549

1.32

9.21

3.0

3.1

36.74

57.07

u/ml

1.61

565

4391

Acute pharyngitis

333

2311

1.45

9.20

2.2

2.6

38.82

43.56

u/ml

0.16

321

2240

Cirrhosis of liver, NAS

112

602

1.91

9.15

2.3

3.6

215.43

71.82

u/ml

3.19

106

581

Covid-19 confirmed case

854

6856

1.26

9.14

3.6

3.2

43.83

63.34

u/ml

1.94

818

6594

Colonic or urogenital fistula

668

5215

1.30

9.10

3.2

3.5

39.22

51.56

u/ml

1.39

639

5032

Ischaemic heart disease, wide definition

1502

10977

0.84

9.10

3.3

3.9

58.14

60.67

u/ml

0.09

1442

10589

Stroke, excluding SAH

932

8377

0.81

9.08

3.0

3.9

121.75

64.80

u/ml

0.90

878

8075

3500

16163

1.12

9.06

3.1

3.2

53.52

49.82

u/ml

0.15

3362

15626

Erosion and ectropion of cervix uteri

496

2.02

9.00

3.7

5.8

60.15

67.21

u/ml

0.11

478

Disorders of mineral metabolism

226

1479

1.56

8.90

3.2

3.5

58.78

69.17

u/ml

0.29

216

1428

Symptoms and signs concerning food and fluid intake

252

1683

1.52

8.87

2.5

3.3

87.98

56.89

u/ml

0.41

240

1618

Polycystic ovarian syndrome

225

1479

1.57

8.85

1.7

2.3

20.92

33.12

u/ml

3.10

216

1430

GI-bleeding

578

4449

1.31

8.68

3.1

3.5

52.63

78.24

u/ml

1.86

559

4248

Asthma (diagnoses ohter than nonallergic)

2511

18381

1.14

8.64

2.8

3.2

46.76

50.35

u/ml

0.22

2420

17746

Osteopathies and chondropathies

1602

12777

1.18

8.64

3.2

3.5

49.81

58.52

u/ml

0.74

1534

12329

Use of hypnotics and sedatives

3047

15575

1.13

8.60

3.4

3.1

47.30

49.05

u/ml

0.15

2935

15057

Other bacterial intestinal infections

438

3252

1.37

8.60

3.9

3.4

67.99

65.79

u/ml

0.07

418

3133

Episodal and paroxysmal disorders

3304

15024

1.12

8.60

2.7

3.3

49.12

50.78

u/ml

0.06

3170

14546

All dysplastic lesions of the cervix uteri, vagina or vulva

1258

10445

1.20

8.54

2.4

2.8

40.76

38.61

u/ml

0.07

1217

10111

Purpura and other haemorrhagic conditions

312

2195

1.44

8.50

7.2

3.2

90.83

55.98

u/ml

1.01

302

2118

Use of donepezil

190

2811

0.64

8.49

2.1

3.9

119.44

92.24

u/ml

0.15

178

2668

Ischemic heart diseases

1795

12467

0.86

8.42

3.2

3.7

57.86

55.36

u/ml

0.11

1731

12048

Haemorrhoids and perianal venous thrombosis

792

6357

1.25

8.38

3.1

3.4

35.17

68.85

u/ml

4.85

764

6134

Other bacterial intestinal infections

580

4503

1.30

8.31

3.6

3.5

57.05

66.82

u/ml

0.41

554

4345

Sciatica+with lumbago

1542

12153

1.18

8.29

2.6

3.5

50.01

53.48

u/ml

0.12

1464

11760

Other headache syndromes

1468

12548

1.18

8.18

2.3

3.4

34.12

50.53

u/ml

3.93

1400

12150

Use of rivastigmine

129

2152

0.59

8.17

2.6

4.0

57.37

96.69

u/ml

1.49

123

2035

Inguinal hernia

577

4961

0.77

8.13

3.0

3.3

47.60

66.72

u/ml

0.63

557

4770

Hypokalaemia

332

2384

1.42

8.13

4.2

3.7

64.44

70.38

u/ml

0.19

320

2289

Codes for special purposes

1407

11973

1.18

8.11

3.3

3.1

37.73

53.64

u/ml

2.89

1352

11544

Provisional assignment of new diseases of uncertain etiology

1405

11956

1.18

8.10

3.3

3.1

37.65

53.68

u/ml

2.93

1350

11528

Coronary artery bypass grafting

144

1749

0.61

7.95

3.2

3.9

197.80

95.22

u/ml

0.55

136

1658

Other obstructive and reflux uropathy

120

691

1.79

7.93

5.5

2.4

46.95

38.39

u/ml

0.33

114

661

Cerebrovascular diseases

1347

11116

0.85

7.89

2.9

3.8

93.69

58.20

u/ml

0.78

1286

10723

Mood disorders, excluding more controls

2782

14800

1.13

7.85

2.9

3.3

57.22

47.62

u/ml

0.39

2672

14330

All anxiety disorders

1933

13341

1.15

7.85

2.7

3.0

53.00

43.34

u/ml

0.26

1866

12903

Diseases of liver

800

6495

1.24

7.83

3.1

3.6

89.71

54.37

u/ml

2.26

759

6269

Chronic kidney disease

482

3602

1.32

7.83

3.7

67.26

74.26

u/ml

0.28

457

3444

Asthma

2327

10745

1.14

7.80

2.8

3.0

43.22

43.25

u/ml

0.00

2241

10397

Varicose veins

1821

11963

1.16

7.80

3.5

3.4

72.60

53.18

u/ml

0.79

1754

11546

HSIL lesion of the cervix uteri, vagina or vulva

838

6878

1.24

7.67

2.2

2.8

44.69

38.21

u/ml

0.16

812

6642

Persons encountering health services for examination and investigation

1713

7411

1.16

7.62

3.0

3.3

45.02

50.89

u/ml

0.57

1655

7179

Carcinoma in situ of cervix uteri, endocervix

328

2.22

7.61

1.7

2.5

21.26

36.36

u/ml

1.09

317

Other gastritis (incl. Duodenitis)

525

4072

1.30

7.61

2.7

3.8

52.70

71.71

u/ml

0.75

504

3924

Injuries to the wrist and hand

2337

18244

0.88

7.59

2.6

3.2

41.02

49.11

u/ml

0.96

2241

17635

Propionic acid derivatives

580

2256

1.30

7.58

2.8

3.2

52.38

84.01

u/ml

1.49

560

2180

Benign neoplasm: Colon, unspecified

519

4021

1.30

7.58

2.8

4.0

39.32

74.49

u/ml

2.77

496

3856

Ischaemic Stroke, excluding all haemorrhages

853

7729

0.82

7.55

2.8

3.9

91.35

69.17

u/ml

0.59

802

7449

Retention of urine

475

2973

1.32

7.49

3.2

3.5

41.07

74.85

u/ml

4.07

456

2851

Candidiasis

891

7360

1.22

7.48

2.7

3.3

43.40

55.55

u/ml

0.71

855

7097

Antihypertensive medication - note that there are other indications

1916

8859

1.15

7.47

2.5

2.8

38.09

41.21

u/ml

0.32

1850

8591

Nontoxic goitre/thyroid nodule

1046

8788

1.21

7.41

2.7

3.8

46.38

63.08

u/ml

0.67

1009

8472

COPD, early/later onset

522

5633

0.78

7.38

2.7

3.9

66.91

71.65

u/ml

0.15

495

5410

Spondylopathies in diseases classified elsewhere

139

2.81

7.36

1.7

3.4

244.38

65.07

u/ml

0.69

132

Other disorders of the genitourinary system

443

3391

1.33

7.33

3.5

3.8

34.29

59.47

u/ml

3.58

430

3259

Endometriosis in cutaneous scar

4.70

7.28

2.7

3.6

28.00

71.50

u/ml

0.41

Chronic diseases of tonsils and adenoids

2443

13733

1.13

7.27

2.6

3.4

32.88

50.71

u/ml

4.67

2347

13291

COPD (mode)

388

4050

0.75

7.25

2.7

3.6

75.51

54.31

u/ml

0.85

366

3895

Certain disorders involving the immune mechanism

468

3604

1.32

7.23

3.2

3.5

45.99

54.08

u/ml

0.44

445

3474

Soft tissue disorders

2960

13678

1.12

7.23

2.9

3.2

45.60

49.73

u/ml

0.31

2841

13231

Hard cardiovascular diseases

1896

12871

0.87

7.17

3.2

3.6

70.23

51.24

u/ml

0.59

1825

12452

Noninfectious colitis NAS

358

2658

1.37

7.17

3.2

3.4

93.37

55.94

u/ml

0.48

349

2562

Infections, IBD-co-morbidities

439

2382

1.33

7.12

4.0

4.1

56.64

54.83

u/ml

0.06

419

2330

Oral corticosteroids

3080

16475

1.11

7.09

2.8

3.3

46.99

50.88

u/ml

0.39

2969

15924

Placenta praevia

206

1402

1.52

7.05

2.4

2.3

35.57

33.37

u/ml

0.14

197

1358

COPD, hospital admissions

518

5578

0.78

7.05

2.7

3.9

67.56

72.08

u/ml

0.14

492

5358

Cough

1187

9558

1.18

7.04

3.4

3.3

49.12

55.50

u/ml

0.38

1134

9265

Bacterial intestinal infections, IBD co-morbidities

430

3285

1.33

7.04

4.0

3.4

69.62

62.76

u/ml

0.24

409

3164

Benign neoplasm of other and unspecified endocrine glands

347

2574

1.37

7.03

2.7

3.6

115.64

56.95

u/ml

0.30

332

2477

Nerve, nerve root and plexus disorders

3048

16838

1.11

7.01

2.7

3.3

46.81

51.83

u/ml

0.39

2908

16296

Asthma, excluding more controls

2259

10434

1.13

6.99

2.8

3.0

43.26

41.27

u/ml

0.11

2178

10101

Ulcer of vagina/vulva

109

640

1.79

6.98

3.0

3.3

25.45

55.62

u/ml

2.04

617

Umbilical hernia

486

3773

1.30

6.98

2.7

3.2

35.82

50.32

u/ml

1.69

469

3637

Asthma (only as main-diagnosis)

2102

10745

1.14

6.93

2.6

3.0

43.92

43.25

u/ml

0.03

2022

10397

Melanocytic naevi

830

6863

1.22

6.91

2.4

3.2

44.70

44.69

u/ml

0.00

808

6614

Scar conditions and fibrosis of skin

144

908

1.64

6.91

2.7

3.3

33.28

52.29

u/ml

0.84

134

884

Dorsopathies

2990

13682

1.12

6.91

2.8

3.3

40.13

51.39

u/ml

1.30

2873

13238

796

8504

0.82

6.90

2.4

3.2

54.47

47.89

u/ml

0.37

767

8206

Other disorders of breast

526

4158

1.29

6.87

2.8

3.4

35.36

53.19

u/ml

2.58

513

4011

Unstable angina pectoris

439

4489

0.77

6.86

2.4

4.0

76.94

83.22

u/ml

0.07

416

4300

Diaphragmatic hernia

960

8051

1.20

6.85

3.1

3.7

47.47

64.52

u/ml

1.12

923

7755

Cardiac arrhythmias

1971

11296

1.14

6.82

2.8

3.2

40.49

38.58

u/ml

0.16

1880

10961

Asthma (only as main-diagnosis), excluding more controls

2066

10434

1.14

6.80

2.6

3.0

44.08

41.27

u/ml

0.15

1992

10101

Nontoxic multinodular goitre

704

5748

1.24

6.80

2.8

3.9

52.60

65.07

u/ml

0.28

676

5535

Benign neoplasm: Rectum

379

2862

1.34

6.76

2.8

4.0

45.17

65.12

u/ml

1.20

367

2747

Special screening examination for infectious and parasitic diseases

644

3809

1.26

6.75

2.4

2.6

27.71

41.18

u/ml

2.13

616

3684

Complications following infusion, transfusion and therapeutic injection

233

2.31

6.73

8.7

2.7

67.21

48.25

u/ml

0.29

222

Benign neoplasm: Rectum, anus and anal canal

427

3283

1.32

6.69

2.7

3.9

45.78

64.83

u/ml

1.26

412

3147

Substance abuse, excluding more controls

853

8732

0.83

6.65

2.5

3.2

42.68

42.67

u/ml

0.00

822

8457

Other benign neoplasms of uterus

203

1396

1.51

6.62

3.4

3.9

105.46

72.11

u/ml

0.23

196

1334

Unspecified lump in breast

635

5154

1.26

6.59

3.9

3.7

90.08

55.41

u/ml

0.34

623

4962

Carcinoma in situ of cervix uteri

364

2760

1.35

6.52

2.3

2.6

31.99

38.97

u/ml

0.65

349

2677

Peripheral artery disease

492

4973

0.78

6.52

2.7

3.9

46.23

83.36

u/ml

3.71

475

4753

Anxiety (asthma-related co-morbidities)

1903

13019

1.14

6.47

2.7

3.1

53.53

44.30

u/ml

0.25

1837

12602

Implicit Sepsis

1857

12359

1.14

6.47

3.6

3.4

75.94

52.94

u/ml

1.71

1756

11949

Sulfonylureas

371

3880

0.76

6.44

2.9

4.1

115.15

83.07

u/ml

0.39

352

3719

Implicit viral Sepsis

649

5270

1.24

6.42

3.3

3.5

52.54

62.65

u/ml

0.54

611

5075

Other joint disorders

2568

12154

1.12

6.39

2.6

3.2

44.45

50.53

u/ml

0.43

2458

11773

ILD medications: prednisolone, methylprednisolone, prednisone

3155

16018

1.11

6.36

2.8

3.3

49.23

50.12

u/ml

0.06

3044

15478

Heart failure and coronary heart disease

517

4611

0.79

6.33

2.8

4.2

113.34

85.65

u/ml

0.48

503

4424

HSIL lesion of the cervix uteri

750

6215

1.23

6.32

2.2

2.7

47.55

37.21

u/ml

0.24

726

6005

Other/unspecified dorsalgia

1102

9338

1.18

6.31

3.2

3.5

54.50

56.36

u/ml

0.05

1055

9016

Glucosamine medication

1302

8980

1.17

6.30

3.6

4.1

54.15

71.27

u/ml

1.27

1244

8652

Benign neoplasm: Sigmoid colon

396

3041

1.32

6.29

2.7

3.9

51.85

64.13

u/ml

0.36

380

2915

Nephropathy related operations

195

1333

1.48

6.28

2.6

3.6

70.09

61.71

u/ml

0.22

186

1285

Other heart diseases, wide

2764

15264

1.11

6.28

3.0

3.2

44.60

46.68

u/ml

0.18

2636

14790

Cutaneous abscess, furuncle and carbuncle

579

4662

1.25

6.23

3.1

34.82

47.12

u/ml

1.68

561

4504

Diarrhoea and gastroenteritis of presumed infectious origin

1878

15009

1.13

6.15

3.0

3.1

57.96

49.04

u/ml

0.49

1809

14494

Polyneuropathies and other disorders of the peripheral nervous system

380

2911

1.32

6.12

4.7

3.7

173.31

68.59

u/ml

0.64

371

2789

Personal history of other diseases and conditions

345

2604

1.34

6.11

2.9

2.6

34.95

40.85

u/ml

0.36

334

2520

Melanocytic naevi, other sites/unspecified

212

1489

1.45

6.04

2.1

3.2

50.22

44.49

u/ml

0.13

204

1436

Sequelae of cerebrovascular disease

442

4847

0.78

6.02

2.4

3.8

136.81

70.70

u/ml

0.47

423

4650

Benign lipomatous neoplasm

750

6230

1.22

6.01

2.7

3.6

32.48

62.51

u/ml

4.89

726

5999

Fibrosis and cirrhosis of liver

178

1212

1.50

5.96

2.2

3.7

177.60

64.07

u/ml

2.46

167

1165

Other anxiety disorders

1414

10710

1.15

5.91

2.6

2.8

53.14

40.59

u/ml

0.25

1362

10358

Pain associated with micturition

311

2336

1.35

5.88

2.4

3.6

30.40

61.24

u/ml

5.11

298

2249

Gout, idiopatic and unspecified

283

2087

1.37

5.88

3.5

3.7

54.45

81.62

u/ml

1.03

275

2000

Transplanted organ and tissue status

183

1254

1.48

5.87

2.0

3.4

61.18

60.47

u/ml

0.01

171

1207

Convalescence

159

1064

1.53

5.86

3.3

2.5

31.02

34.57

u/ml

0.18

152

1022

Acute pancreatitis

361

2765

1.32

5.85

2.8

3.8

60.09

56.15

u/ml

0.10

344

2663

Gout, FINNGEN

343

2598

1.32

5.84

3.3

3.9

52.04

82.52

u/ml

1.59

332

2483

Portal vein thrombosis

201

2.28

5.82

4.7

2.9

134.77

57.02

u/ml

0.69

194

Carcinoma in situ of breast, intraductal

344

2639

1.34

5.81

2.7

4.0

128.95

59.42

u/ml

0.37

329

2541

Sleep disorders (combined)

3303

15842

1.10

5.77

2.6

3.4

40.43

54.01

u/ml

1.79

3185

15305

Other intervertebral disc disorders

2360

12786

1.12

5.77

2.9

3.4

45.26

53.09

u/ml

0.86

2262

12380

Other heart diseases

1390

7923

1.15

5.70

3.0

2.8

47.32

36.74

u/ml

1.18

1337

7682

Conjunctivitis

2406

18164

1.11

5.68

2.7

3.2

50.03

49.11

u/ml

0.03

2330

17535

Single delivery by forceps and vacuum extractor

427

3256

0.78

5.67

2.3

2.7

26.83

36.20

u/ml

1.62

419

3166

All dysplastic lesions of the cervix uteri

1065

9111

1.17

5.63

2.2

2.7

43.68

36.54

u/ml

0.24

1029

8824

Atherosclerosis, excluding cerebral and coronary sclerosis

448

4469

0.79

5.62

2.7

3.9

47.21

86.35

u/ml

3.48

432

4269

Other problems related to primary support group, including family circumstances

326

2416

1.33

5.59

2.5

2.7

121.72

38.87

u/ml

0.45

319

2337

Triptan medication for migraine, min. 3 purchases

2083

14275

1.12

5.59

2.3

3.1

30.47

42.84

u/ml

2.38

2011

13811

Vulvovaginal ulceration/inflammation in other diseases

225

1626

1.42

5.59

2.3

2.8

48.39

44.80

u/ml

0.06

215

1571

Abnormalities of heart beat

1008

8479

1.17

5.55

3.2

3.3

50.47

56.17

u/ml

0.16

976

8219

Dentofacial anomalies [including malocclusion]

2250

16298

1.11

5.55

2.2

3.2

31.93

46.50

u/ml

3.34

2166

15767

Adjustment and management of implanted device

277

2059

1.36

5.53

2.7

2.8

47.28

44.45

u/ml

0.16

262

1955

Erysipelas

1699

11506

1.13

5.52

3.6

3.3

66.78

52.19

u/ml

0.90

1642

11090

Other disorders of kidney and ureter

258

1902

1.37

5.50

3.1

3.7

38.22

67.28

u/ml

2.90

249

1831

Diseases of the skin and subcutaneous tissue

2882

13155

1.10

5.49

3.0

3.2

49.68

51.86

u/ml

0.13

2791

12702

Single spontaneous delivery

1339

8095

0.87

5.49

3.3

3.5

62.56

57.68

u/ml

0.24

1284

7819

Autoimmune diseases related-to ILD

2352

18197

1.11

5.49

2.5

3.3

45.32

50.68

u/ml

0.50

2267

17577

Other diseases of upper respiratory tract

3124

14883

1.10

5.45

2.9

3.4

39.10

55.71

u/ml

2.43

3012

14383

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

217

1558

1.41

5.40

2.6

3.8

158.35

66.43

u/ml

3.55

208

1499

Care involving dialysis

119

758

1.59

5.40

2.7

40.64

42.42

u/ml

0.07

114

730

Insulin medication

1019

9949

0.86

5.39

2.7

3.5

65.95

55.64

u/ml

0.32

973

9597

COPD related to multimorbidity

415

4427

0.79

5.39

2.6

4.0

73.40

78.10

u/ml

0.11

394

4250

Other diseases of liver

453

3618

1.27

5.37

2.7

3.6

72.94

51.22

u/ml

0.89

424

3486

Enterocolitis due to Clostridium difficile

232

1690

1.39

5.35

4.3

3.4

77.59

68.65

u/ml

0.23

222

1632

Noninfective enteritis and colitis

1176

10228

1.16

5.31

2.6

3.3

59.85

52.27

u/ml

0.24

1140

9860

Status post-ami

202

2147

0.71

5.29

2.7

3.9

144.95

94.18

u/ml

0.34

191

2041

Kela-code for severe mental illness

639

7684

0.83

5.28

2.4

3.2

43.40

45.58

u/ml

0.12

604

7420

Other viral diseases

703

5862

1.20

5.27

2.6

2.9

44.11

42.28

u/ml

0.07

673

5660

Unspecified haematuria

676

4658

1.21

5.23

3.2

3.6

46.06

72.77

u/ml

2.04

646

4489

Other arthrosis

1404

8554

1.14

5.23

2.8

3.7

55.17

59.08

u/ml

0.12

1346

8281

Benign neoplasm of breast

468

3778

1.26

5.22

3.0

3.7

32.93

57.56

u/ml

4.34

455

3634

Inflammatory disease of cervix uteri

240

1776

1.39

5.22

2.8

3.8

67.08

59.60

u/ml

0.15

232

1712

Pure hypercholesterolaemia

1798

10478

1.12

5.17

4.1

3.6

56.46

58.10

u/ml

0.10

1723

10130

741

7938

0.84

5.14

2.4

3.2

53.61

49.49

u/ml

0.21

712

7660

COPD, hospital admissions 1, only main diagnosis

345

3790

0.77

5.13

2.3

4.0

66.27

78.23

u/ml

0.37

326

3639

Androgenic alopecia

250

2.13

5.12

2.1

2.8

22.25

36.02

u/ml

0.70

238

Anti-inflammatory and antirheumatic products, non-steroids

554

2256

1.24

5.12

2.4

3.2

50.92

84.01

u/ml

1.55

530

2180

Migraine without aura

725

6109

1.20

5.12

2.1

2.9

26.87

39.29

u/ml

3.90

699

5918

Parkinson's disease, strict definition, excluding more controls

127

1813

0.66

5.12

2.4

4.7

54.38

80.14

u/ml

0.40

122

1757

Iron deficiency anaemia secondary to blood loss (chronic)

384

3027

1.28

5.10

3.0

3.5

99.80

68.32

u/ml

0.37

369

2902

Calculus of kidney and ureter

479

3867

1.25

5.09

2.8

3.5

50.49

52.96

u/ml

0.09

460

3725

Gastroduodenal ulcer

464

3723

1.25

5.09

2.8

3.9

48.43

80.91

u/ml

2.32

442

3577

Implicit Sepsis

2086

13754

1.11

5.06

3.6

3.3

68.73

50.36

u/ml

1.47

1982

13294

Dialysis, with operation codes

195

1392

1.42

5.06

2.6

3.5

67.38

61.38

u/ml

0.15

185

1344

Parkinson's disease, excluding more controls

142

1957

0.68

5.04

2.3

4.7

71.54

78.92

u/ml

0.09

137

1899

Intestinal infectious diseases

2595

17970

1.10

5.00

3.1

3.2

55.00

49.54

u/ml

0.37

2492

17353

Spondylosis

1411

10167

1.14

4.99

2.7

3.8

37.67

58.65

u/ml

3.74

1360

9827

Acute pancreatitis (for exclusion)

361

2829

1.29

4.99

2.8

3.6

60.09

60.70

u/ml

0.01

344

2720

Supervision of high-risk pregnancy

828

4235

1.19

4.98

2.2

2.6

23.03

36.64

u/ml

5.87

805

4115

Polyuria

391

3096

1.27

4.96

2.2

3.6

32.18

63.60

u/ml

3.53

372

2982

Gout, unspecified

223

1632

1.38

4.95

3.2

3.8

57.31

87.65

u/ml

0.88

216

1563

Thrombocytopenia, unspecified

146

995

1.49

4.93

7.3

3.2

85.88

53.21

u/ml

0.86

140

956

Other infectious diseases

185

1318

1.42

4.91

3.8

3.2

68.70

58.03

u/ml

0.16

180

1270

Phobic anxiety disorders

338

2634

1.30

4.88

3.0

2.6

40.58

39.68

u/ml

0.04

330

2548

Inflammatory bowel disease treatment related agents

3254

16766

1.09

4.87

2.8

3.2

45.06

50.43

u/ml

0.67

3136

16204

Collagenous colitis

252

1894

1.35

4.86

2.9

3.5

44.69

61.24

u/ml

0.71

244

1825

External causes of morbidity and mortality

2090

9448

1.11

4.83

3.2

36.95

51.77

u/ml

3.37

2015

9165

Urolithiasis

499

4073

1.23

4.81

2.7

3.5

53.46

52.94

u/ml

0.02

480

3923

Temporomandibular joint disorders, including avohilmo

1510

13291

1.13

4.73

2.2

3.1

33.00

44.09

u/ml

1.38

1447

12851

Unspecified mental disorder

768

8982

0.85

4.66

2.4

3.2

81.01

45.30

u/ml

0.43

730

8677

Injuries to the shoulder and upper arm

1747

15629

0.90

4.65

2.8

3.4

53.93

54.13

u/ml

0.01

1686

15075

Sarcoidosis

313

2439

1.30

4.62

3.4

3.5

50.14

56.51

u/ml

0.22

298

2346

Other disorders of bladder

175

1247

1.42

4.62

2.2

3.6

40.01

66.41

u/ml

1.55

165

1210

Asthma, including avohilmo

3317

17214

1.09

4.62

2.6

3.3

43.06

51.51

u/ml

0.86

3190

16633

Viral Sepsis

404

3242

1.26

4.62

3.3

3.6

52.82

70.09

u/ml

0.70

381

3111

Somatoform disorder

483

3961

1.23

4.59

2.5

3.2

23.43

47.05

u/ml

8.22

458

3824

Implicit viral Sepsis

403

3236

1.26

4.58

3.3

3.6

52.91

70.17

u/ml

0.70

380

3106

Haemorrhage from respiratory passages

704

5377

1.19

4.55

3.2

3.5

59.27

66.34

u/ml

0.25

673

5199

Diagnoses used for exclusion with ILD

493

4048

1.23

4.54

3.3

3.6

56.11

60.92

u/ml

0.19

474

3894

Volume depletion

171

1219

1.42

4.53

4.1

3.4

65.75

84.56

u/ml

0.49

166

1174

Symptoms and signs involving the urinary system

1878

12926

1.11

4.51

3.1

3.5

40.67

59.96

u/ml

3.40

1802

12479

Complications of other internal prosthetic devices, implants and grafts

101

651

1.59

4.51

5.8

3.3

79.73

71.53

u/ml

0.07

101

628

Chronic gastritis

659

5570

1.19

4.48

2.8

3.9

46.82

75.74

u/ml

2.40

627

5368

Contact with and exposure to communicable diseases

868

7467

1.17

4.48

2.3

2.6

24.43

37.07

u/ml

5.52

839

7209

Gout, strict definition

181

1305

1.40

4.45

3.5

3.7

53.55

88.89

u/ml

1.48

176

1255

Heart failure, not strict

1790

10958

1.11

4.44

3.4

3.8

86.97

55.34

u/ml

1.90

1726

10575

Obesity, other/unspecified

1046

9174

1.15

4.41

2.4

3.1

38.83

44.96

u/ml

0.54

1000

8862

Pain in thoracic spine

452

3700

1.24

4.39

2.5

3.6

26.88

54.77

u/ml

6.83

434

3570

COPD, hospital admission 2, with asthma infections

314

3419

0.78

4.37

2.6

3.9

59.87

72.46

u/ml

0.53

301

3286

Myelodysplastic syndrome

3.42

4.36

5.9

1.4

36.93

35.59

u/ml

0.02

Disorders of skin appendages

1308

11626

1.13

4.34

2.4

3.2

44.75

46.40

u/ml

0.09

1257

11225

Disturbances of skin sensation

817

7052

1.17

4.33

2.3

3.1

40.15

44.49

u/ml

0.27

786

6807

Abnormal results of function studies

204

1513

1.37

4.32

3.0

3.2

74.36

55.10

u/ml

0.32

192

1462

Implicit fungal Sepsis

169

1218

1.41

4.30

3.6

3.4

92.00

60.75

u/ml

0.42

164

1172

Hypo-osmolality and hyponatraemia

398

3201

1.25

4.30

4.3

3.7

105.68

84.60

u/ml

0.42

379

3067

Injury, poisoning and certain other consequences of external causes

1733

7816

1.12

4.28

3.1

43.13

52.78

u/ml

1.11

1673

7577

Syncope and collapse

1008

7548

1.15

4.28

2.8

3.2

52.06

52.09

u/ml

0.00

967

7289

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

184

1346

1.39

4.26

2.6

3.7

60.99

72.38

u/ml

0.28

178

1296

All influenza

495

4093

1.22

4.26

3.8

3.3

79.67

58.59

u/ml

0.36

479

3936

Delivery

1371

8104

0.88

4.26

3.3

3.5

61.79

57.67

u/ml

0.20

1315

7827

Adenocarcinoma of small intestine

6.43

4.25

6.2

1.8

61.00

16.73

u/ml

—

Weight loss

218

1639

1.35

4.22

2.4

3.4

85.83

62.03

u/ml

0.26

208

1573

Sequelae of other external causes

131

905

1.47

4.21

4.1

3.2

152.47

52.56

u/ml

0.50

125

874

Migraine without aura and triptan purchases

586

4945

1.20

4.18

1.9

2.8

25.52

38.66

u/ml

3.66

567

4771

Other diseases of appendix

217

2.03

4.18

2.4

25.74

67.88

u/ml

1.11

208

Gestational diabetes (for exclusion)

1241

9695

0.88

4.17

2.1

2.5

24.84

32.44

u/ml

4.01

1193

9401

Caries of enamel

2582

17149

1.09

4.16

2.8

3.2

30.61

49.84

u/ml

6.21

2491

16568

Condition for Implicit Sepsis (Organ dysfunction codes)

2397

15160

1.09

4.15

3.5

3.2

71.36

45.99

u/ml

2.07

2300

14654

Other infectious diseases

152

1082

1.42

4.13

3.9

3.2

77.98

55.83

u/ml

0.30

147

1044

Oter anti-inflammatory and antirheumatic agents, non-steroids

404

1796

1.25

4.11

3.0

3.6

63.04

97.30

u/ml

1.11

390

1740

Other disorders of lacrimal gland

1084

9581

1.14

4.11

2.7

3.6

46.28

60.18

u/ml

0.55

1042

9245

Other specified/unspecified bacterial intestinal infections

157

1127

1.42

4.10

3.9

3.3

72.74

68.04

u/ml

0.08

148

1086

Migraine with aura

860

7488

1.16

4.09

2.4

3.1

25.50

43.57

u/ml

5.82

820

7238

Benign neoplasm: Ascending colon

283

2217

1.29

4.06

3.2

4.1

42.25

68.43

u/ml

2.06

271

2131

Malignant neoplasm of other and unspecified urinary organs, including Hilmo

5.17

4.05

3.1

1.4

42.40

57.66

u/ml

0.14

All dysplastic lesions of the vagina

113

771

1.52

4.05

2.8

3.0

27.91

53.51

u/ml

1.72

108

743

Benign mammary dysplasia

529

4450

1.21

4.00

3.3

3.9

46.68

65.10

u/ml

1.21

511

4280

Other viral diseases

975

8502

1.14

3.99

2.5

2.8

40.23

39.83

u/ml

0.02

935

8206

Intracranial trauma

1361

10678

0.89

3.99

2.7

3.4

40.19

46.54

u/ml

0.67

1307

10380

Diabetes mellitus in pregnancy

1109

8003

0.88

3.96

2.2

2.5

24.71

31.78

u/ml

3.26

1067

7778

Disorders of lacrimal system

1325

11852

1.12

3.93

2.8

3.6

46.79

59.91

u/ml

0.61

1274

11421

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1015

8966

1.14

3.90

2.7

3.4

83.00

51.92

u/ml

0.47

977

8663

Viral infections characterized by skin and mucous membrane lesions

1004

8847

1.14

3.90

3.0

3.3

35.71

57.19

u/ml

3.83

970

8519

ILD medications

3202

16137

1.08

3.89

2.8

3.3

45.55

49.94

u/ml

0.52

3083

15593

Other and unspecified glaucoma

151

1090

1.41

3.83

4.6

3.9

48.29

77.37

u/ml

1.74

143

1049

Secondary hypertension

155

1111

1.39

3.78

5.2

3.4

32.90

57.68

u/ml

1.85

144

1070

Nontraumatic intracranial haemmorrhage

244

3122

0.78

3.76

3.5

4.0

178.69

76.51

u/ml

0.39

234

2980

Melanocytic naevi of other and unspecified parts of face

165

1216

1.38

3.74

2.4

3.2

83.50

46.31

u/ml

0.54

159

1175

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, including Hilmo

7.09

3.74

2.5

1.2

75.88

93.96

u/ml

—

Mental and behavioural disorders due to psychoactive substance use

884

9327

0.87

3.73

2.5

3.2

42.98

47.60

u/ml

0.30

851

8998

Other viral diseases, not elsewhere classified

410

3373

1.22

3.71

3.0

50.48

46.40

u/ml

0.10

395

3260

Abnormal weight loss

191

1440

1.34

3.69

2.3

3.4

89.34

60.55

u/ml

0.27

181

1388

Diseases of the respiratory system

2044

9370

1.10

3.68

3.4

3.1

52.51

45.83

u/ml

0.66

1971

9075

Congenital absence, atresia and stenosis of large intestine

8.72

3.68

1.3

13.86

13.78

u/ml

—

Tonsillectomy and adenotomy

1661

10502

1.11

3.66

2.2

2.7

25.95

37.35

u/ml

7.60

1594

10172

Viral and other specified intestinal infections

628

5191

1.17

3.66

2.7

2.8

48.48

46.30

u/ml

0.08

593

5014

Other benign neoplasm of uterus: Cervix uteri

195

2.07

3.65

2.5

3.0

19.25

34.21

u/ml

1.07

186

Benign neoplasm: Pancreas

422

1.66

3.65

1.9

3.6

28.19

75.82

u/ml

2.49

407

Diseases of tongue

178

1334

1.36

3.63

3.2

4.0

33.82

74.20

u/ml

2.43

169

1295

LSIL lesion of the cervix uteri, vagina or vulva

553

4713

1.19

3.62

2.5

2.9

31.06

39.30

u/ml

1.16

528

4569

Benign neoplasm: Stomach

248

1945

1.29

3.62

3.0

3.9

80.02

65.21

u/ml

0.10

232

1874

Prolonged pregnancy

438

4577

0.83

3.60

2.8

2.5

27.36

35.02

u/ml

1.64

428

4446

Symptoms and signs involving cognition, perception, emotional state and behaviour

2684

16973

1.08

3.60

2.8

3.3

50.88

49.82

u/ml

0.05

2572

16413

Other benign neoplasms of skin

951

8411

1.14

3.60

2.8

3.6

42.96

62.29

u/ml

2.40

920

8100

Localized swelling, mass and lump of skin and subcutaneous tissue

790

6904

1.15

3.59

3.0

3.5

41.47

57.72

u/ml

1.37

763

6665

Exposure to other specified factors

1666

16760

0.91

3.57

2.8

3.1

34.81

49.98

u/ml

3.38

1604

16187

Urticaria

891

7855

1.14

3.57

3.0

3.1

40.97

47.82

u/ml

0.44

849

7584

Immunodeficiencies

124

879

1.44

3.56

3.5

3.2

39.16

54.18

u/ml

0.71

118

847

Atrial fibrillation and flutter

756

4256

1.16

3.55

3.4

54.09

44.14

u/ml

0.51

730

4121

Seborrhoeic dermatitis

176

1319

1.35

3.53

2.1

3.2

29.88

56.92

u/ml

2.75

167

1276

Chronic pancreatitis

182

1370

1.34

3.53

2.1

3.7

46.82

60.91

u/ml

0.69

174

1315

Type 1 diabetes, wide definition

306

3779

0.80

3.51

2.5

3.2

81.31

48.20

u/ml

0.36

296

3650

Abnormal findings on examination of blood, without diagnosis

731

5832

1.16

3.50

2.8

3.5

45.12

64.14

u/ml

1.28

703

5610

Alzheimer’s disease (Atypical or mixed), excluding more controls

955

0.65

3.50

2.0

4.7

132.10

90.54

u/ml

0.32

919

Nonalcoholic fatty liver disease

231

1803

1.30

3.49

2.5

3.4

71.52

52.92

u/ml

0.38

219

1741

Other and unspecified urticaria

562

4804

1.18

3.49

2.9

3.2

44.21

47.59

u/ml

0.15

532

4635

Candidiasis

363

2987

1.23

3.45

3.2

3.4

58.53

53.35

u/ml

0.11

344

2878

Neurological diseases

2569

11958

1.08

3.44

2.7

3.4

38.70

45.85

u/ml

1.15

2469

11618

Dislocation, sprain and strain of joints and ligaments of knee

1357

13809

0.90

3.44

2.8

3.1

30.53

46.47

u/ml

4.18

1297

13358

Other neurological diseases

1488

12865

0.91

3.43

3.0

3.5

74.46

56.52

u/ml

0.37

1424

12410

Post-traumatic stress disorder

245

1933

1.28

3.42

2.1

2.4

22.41

35.92

u/ml

3.58

231

1875

Second line medication for Crohn's disease

1335

14732

0.90

3.39

2.4

3.4

45.60

51.51

u/ml

0.45

1276

14236

Cellulitis

427

3572

1.20

3.37

3.3

3.4

47.47

54.19

u/ml

0.23

408

3440

Other and unspecified local infections of skin and subcutaneous tissue

199

1532

1.31

3.34

4.3

3.1

34.11

58.34

u/ml

1.97

192

1474

Unspecified dementia

1206

0.68

3.33

3.4

3.9

100.81

103.21

u/ml

0.02

1151

Dizziness and giddiness

2075

15174

1.09

3.32

2.8

3.4

52.54

52.25

u/ml

0.01

1993

14666

Migraine with aura and triptan purchases

539

4616

1.18

3.32

2.1

2.9

28.36

39.87

u/ml

1.46

510

4455

Disorders of other endocrine glands

1213

10754

1.12

3.32

2.8

3.3

46.01

57.69

u/ml

0.46

1163

10361

Hyperkalaemia

616

1.50

3.30

5.7

3.4

102.23

85.85

u/ml

0.27

596

Vascular dementia (undefined)

365

0.40

3.29

3.1

3.0

31.27

89.02

u/ml

2.56

353

Tongue abnormality

162

1218

1.35

3.28

3.4

3.6

33.71

60.06

u/ml

1.19

154

1171

L04AX Other immunosuppressants

1295

14285

0.90

3.28

2.5

3.4

41.07

52.45

u/ml

1.51

1238

13805

Panic disorder

405

3389

1.21

3.24

2.9

2.7

43.60

40.17

u/ml

0.13

392

3276

Parkinson's disease

142

1911

0.74

3.23

2.3

4.1

71.54

79.94

u/ml

0.10

137

1826

Other local infections of skin and subcutaneous tissue

207

1611

1.30

3.22

4.2

3.1

34.70

56.94

u/ml

1.81

199

1550

Transient ischemic attack

930

8454

0.89

3.20

3.2

3.8

65.76

66.46

u/ml

0.01

885

8150

Parkinson's disease, strict definition

127

1733

0.73

3.18

2.4

4.0

54.38

78.71

u/ml

0.37

122

1655

Viral and other specified intestinal infections

418

3428

1.20

3.15

2.6

41.30

48.07

u/ml

0.40

393

3311

STROKE

1305

9781

0.90

3.15

3.3

3.8

89.15

53.11

u/ml

0.78

1248

9468

Shoulder lesions

2078

11630

1.09

3.13

3.1

3.5

55.29

53.20

u/ml

0.05

2006

11251

Sub-endpoint used in defining T1D endpoints

383

4501

0.83

3.13

2.8

3.1

82.06

57.44

u/ml

0.32

366

4338

Obstructed labour due to malposition and malpresentation of fetus

728

7702

0.87

3.12

2.1

2.7

24.70

34.67

u/ml

4.22

704

7470

Mental and behavioural disorders due to alcohol

642

7079

0.87

3.11

2.4

3.1

48.02

44.11

u/ml

0.21

618

6830

Zoster [herpes zoster]

420

3540

1.20

3.11

3.6

3.8

35.66

71.09

u/ml

5.98

410

3399

Gastric ulcer

318

2609

1.23

3.10

2.4

4.0

51.75

76.98

u/ml

1.77

304

2515

Myocardial infarction, unclassifiable

161

1891

0.76

3.10

3.3

3.6

98.01

92.57

u/ml

0.07

151

1801

Parkinson's disease, including avohilmo

149

1975

0.75

3.08

2.4

4.1

69.07

78.42

u/ml

0.12

144

1887

Condition for Implicit Sepsis (Organ dysfunction codes)

2180

14262

1.08

3.07

3.6

3.3

78.80

47.78

u/ml

2.41

2077

13788

Urticaria and erythema

1070

9633

1.12

3.05

2.9

3.2

43.55

48.83

u/ml

0.36

1022

9302

Alcohol use disorder, Swedish definition

702

7328

0.88

3.05

2.4

3.2

58.25

43.96

u/ml

1.05

677

7070

Schizophrenia

199

2535

0.78

3.04

3.0

3.2

56.81

46.94

u/ml

0.23

186

2451

Subjective visual disturbances

677

5934

1.15

3.04

2.9

3.5

33.85

57.62

u/ml

1.86

641

5718

Nonorganic sleeping disorders, excluding more controls

509

4369

1.17

3.04

2.7

3.0

34.63

41.09

u/ml

0.65

495

4229

COPD, hospital admissions 3, with asthma pneumonia sepsis

247

2627

0.80

3.03

2.6

4.0

64.04

74.64

u/ml

0.34

235

2526

Schizophrenia, schizotypal and delusional disorders

547

6326

0.86

3.03

2.5

3.2

57.23

46.37

u/ml

0.45

517

6112

Disorders of lipoprotein metabolism and other lipidaemias

2024

11589

1.08

3.01

4.0

3.5

54.45

55.09

u/ml

0.04

1947

11213

Abnormal findings on diagnostic imaging of central nervous system

120

874

1.40

3.00

3.0

59.06

50.21

u/ml

0.17

113

850

Malignant neoplasm of gallbladder

3.41

3.00

3.3

1.4

54.83

40.34

u/ml

0.19

Covid-19 suspected case

582

5053

1.16

2.99

2.8

2.9

27.97

42.26

u/ml

3.30

561

4888

Benign neoplasm: Caecum

218

1727

1.28

2.98

3.7

4.0

74.04

67.50

u/ml

0.09

210

1664

Chronic rhinitis, nasopharyngitis and pharyngitis

906

8103

1.12

2.93

2.7

3.4

29.84

53.63

u/ml

4.63

870

7834

Chronic apical periodontitis

3183

17040

1.07

2.93

3.3

3.1

43.55

51.48

u/ml

1.01

3048

16469

Nonorganic sleeping disorders

509

4383

1.17

2.93

2.7

3.0

34.63

43.06

u/ml

0.91

495

4241

Other viral diseases, not elsewhere classified

650

5663

1.15

2.92

2.7

2.9

41.89

41.46

u/ml

0.01

626

5475

Melanoma in situ

635

1.46

2.91

3.4

3.6

36.63

63.16

u/ml

1.20

612

Schizophrenia or delusion, excluding more controls

547

6238

0.86

2.89

2.5

3.2

55.17

46.44

u/ml

0.35

517

6037

Fibromyalgia

348

2915

1.21

2.88

2.1

3.3

50.11

47.52

u/ml

0.06

330

2819

Adverse effects, not elsewhere classified

542

4699

1.16

2.87

2.9

3.1

34.58

45.64

u/ml

1.42

524

4546

Seborrhoeic keratosis

530

4588

1.16

2.86

3.1

3.9

56.67

73.01

u/ml

0.54

504

4412

Rhabdomyosarcoma

9.52

2.84

2.0

1.8

15.00

19.67

u/ml

—

Schizophrenia or delusion

547

6292

0.86

2.84

2.5

3.2

55.17

45.93

u/ml

0.38

517

6078

Familial hypercholesterolemia

256

2076

1.24

2.84

3.8

3.9

112.62

88.60

u/ml

0.18

250

1994

Oesophageal varices

417

1.56

2.83

2.5

3.6

164.10

74.64

u/ml

1.44

400

Long labour

797

7640

0.89

2.79

2.6

2.8

32.75

36.22

u/ml

0.34

779

7405

Substance abuse

853

8960

0.89

2.78

2.5

3.2

42.68

47.05

u/ml

0.27

822

8644

2593

14695

1.07

2.78

3.7

3.1

55.65

48.46

u/ml

0.57

2508

14210

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2593

14695

1.07

2.78

3.7

3.1

55.65

48.46

u/ml

0.57

2508

14210

Visual disturbances and blindness

1348

12333

1.10

2.77

3.0

3.4

37.98

56.37

u/ml

2.56

1292

11891

Other skin changes

400

3396

1.19

2.77

2.8

3.6

37.19

62.60

u/ml

2.67

385

3260

Follicular cysts of skin and subcutaneous tissue

384

3250

1.19

2.75

3.0

3.5

46.69

53.47

u/ml

0.26

369

3135

Paroxysmal tachycardia

578

4219

1.15

2.75

2.7

3.2

73.88

43.02

u/ml

0.68

556

4085

Haemorrhage, not elsewhere classified

502

1.50

2.74

2.5

3.1

85.68

73.06

u/ml

0.13

487

Acute bronchitis

910

8013

1.12

2.72

2.8

3.3

51.53

59.14

u/ml

0.42

870

7716

HSIL lesion of the vulva

450

1.55

2.72

2.6

2.9

231.28

55.08

u/ml

0.43

431

Cervicobrachial syndrome

659

5816

1.14

2.72

2.6

3.6

25.47

56.26

u/ml

5.64

629

5620

Osteoporosis

745

6191

1.13

2.70

3.8

3.9

61.91

78.74

u/ml

0.80

711

5945

Malignant neoplasm of oral cavity, including Hilmo

334

1.60

2.70

4.5

1.4

40.32

23.38

u/ml

0.52

315

Crohn disease

281

2317

1.22

2.69

1.9

3.1

46.48

49.19

u/ml

0.09

270

2229

Alzheimer’s disease (Atypical or mixed)

1211

0.71

2.65

2.0

3.7

125.61

99.47

u/ml

0.20

1154

Crohn's disease of small intestine

153

1179

1.31

2.65

2.0

3.0

39.50

49.76

u/ml

0.32

145

1139

Pruritus

311

2598

1.21

2.64

2.4

3.4

49.80

55.08

u/ml

0.13

303

2503

Exclusions for E4_PCOS_BROAD

380

3225

1.19

2.64

2.9

3.2

104.90

49.28

u/ml

0.32

362

3116

Myocardial infarction, without ST-elevation

430

4564

0.86

2.63

2.8

3.8

75.74

83.18

u/ml

0.18

410

4371

Other acute lower respiratory infections

1157

10044

1.10

2.61

2.9

3.2

49.69

54.99

u/ml

0.35

1105

9669

Other general symptoms and signs

128

955

1.35

2.61

2.8

2.7

78.43

46.72

u/ml

0.36

123

926

Acne vulgaris

168

1312

1.29

2.61

2.2

27.92

33.66

u/ml

0.48

161

1265

Type 1 diabetes, wide definition, subgroup 1

297

3557

0.83

2.61

2.6

3.2

83.25

47.08

u/ml

0.39

287

3438

Spondylopathies

2084

11596

1.08

2.61

2.8

3.6

38.18

55.24

u/ml

2.92

2012

11222

Other congenital malformations of respiratory system

3.85

2.59

7.9

4.0

29.26

99.63

u/ml

—

Disorders of synovium and tendon

1533

12392

1.09

2.58

2.8

3.4

56.40

51.08

u/ml

0.10

1481

11995

Exposure to other specified electric current

356

0.47

2.58

1.5

2.3

15.00

35.32

u/ml

2.03

340

Maternal care for other conditions predominantly related to pregnancy

668

7366

0.88

2.57

2.2

2.7

26.53

33.69

u/ml

1.26

641

7151

Mycoses

2275

18525

1.07

2.56

2.7

3.2

47.38

50.11

u/ml

0.14

2196

17882

Cyclic neutropenia

3.45

2.55

6.8

3.0

18.40

49.40

u/ml

—

Pregnancy examination and test

591

3222

1.15

2.55

1.8

2.4

32.54

36.68

u/ml

0.21

573

3124

Mental and behavioural disorders due to tobacco

181

1434

1.28

2.53

3.1

3.2

43.28

49.59

u/ml

0.20

176

1387

Smoking dependency

181

1434

1.28

2.53

3.1

3.2

43.28

47.69

u/ml

0.14

176

1386

Other mental disorders due to brain damage and dysfunction and to physical disease

137

1780

0.76

2.53

2.7

3.7

85.09

82.78

u/ml

0.02

129

1696

Coxarthrosis, primary, with hip surgery

860

8929

0.90

2.52

3.1

4.0

64.94

70.48

u/ml

0.12

823

8590

Hypertrophy of breast

685

6106

1.13

2.50

2.6

3.2

33.36

45.13

u/ml

1.14

655

5907

Abnormal serum enzyme levels

233

1848

1.23

2.50

2.6

3.2

51.32

61.55

u/ml

0.22

223

1785

Seropositive rheumatoid arthritis

602

6779

0.88

2.49

3.0

3.9

54.69

65.57

u/ml

0.47

579

6544

Cyst of Bartholin Gland

136

1047

1.33

2.47

2.0

3.1

23.21

46.92

u/ml

2.82

129

1016

Cholecystitis

259

2138

1.22

2.47

2.6

3.7

49.55

63.04

u/ml

0.45

251

2054

Extreme obesity with alveolar hypoventilation

657

1.41

2.46

2.0

3.4

32.51

58.07

u/ml

1.46

635

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

316

2662

1.20

2.46

2.2

3.6

28.30

56.65

u/ml

5.75

306

2561

Insulin, fast-acting (human)

185

2309

0.80

2.45

2.7

2.8

32.47

47.59

u/ml

1.33

179

2237

Gout

343

2552

1.19

2.45

3.3

4.3

52.04

98.51

u/ml

1.98

332

2455

Other congenital malformations

205

1655

1.25

2.44

2.1

2.7

25.13

45.58

u/ml

3.62

199

1595

Hypertrophy of breast in women and men

686

6121

1.13

2.44

2.6

3.2

33.43

45.15

u/ml

1.14

656

5921

Ethmoidectomy

281

2344

1.21

2.43

2.4

3.3

32.85

49.33

u/ml

1.03

273

2257

Other coagulation defects

189

1515

1.26

2.43

2.3

3.0

31.13

44.89

u/ml

1.25

180

1463

Rickettsioses

3.91

2.43

3.0

1.9

37.45

95.23

u/ml

—

Insulin, combination of fast acting with intermediate-acting or long-acting

1019

10228

0.91

2.43

2.7

3.4

65.95

57.64

u/ml

0.25

973

9854

Chronic mastoiditis

329

1.58

2.43

4.3

3.2

81.34

59.51

u/ml

0.20

315

Other arrhythmias

1807

12688

1.08

2.42

2.9

3.4

50.00

49.51

u/ml

0.02

1716

12282

Pneumocystosis

228

1.71

2.42

4.3

3.3

48.11

62.93

u/ml

0.20

219

Other CVD (FINNGEN)

228

1441

1.24

2.40

3.1

3.9

50.21

61.88

u/ml

0.29

221

1393

Anogenital herpesviral [herpes simplex] infection

297

2496

1.20

2.40

2.0

2.5

19.39

36.41

u/ml

7.46

289

2422

Later onset COPD

263

2519

0.83

2.37

3.0

4.3

84.89

89.52

u/ml

0.08

250

2411

Hypotension

269

2239

1.21

2.36

2.9

3.7

62.32

88.41

u/ml

0.64

261

2132

Primary gonarthrosis, bilateral

1246

9807

1.09

2.36

3.0

4.0

55.85

66.23

u/ml

0.39

1187

9463

Disorders of muscles

225

1844

1.23

2.35

3.5

3.4

100.77

56.18

u/ml

0.36

220

1781

Undetermined asthma, excluding more controls

329

2795

1.19

2.32

2.4

3.4

85.25

48.47

u/ml

0.41

318

2699

Psoriatic arthropathies

163

2044

0.79

2.31

2.7

3.7

33.80

52.63

u/ml

0.94

158

1968

Kidney transplant status

588

1.41

2.30

2.1

3.1

27.56

53.42

u/ml

1.63

566

Zoster [herpes zoster]

1280

11614

1.09

2.30

3.2

3.6

36.32

62.75

u/ml

6.31

1240

11200

Acute lymphadenitis

130

1002

1.31

2.30

2.7

2.9

31.88

49.44

u/ml

1.20

123

968

Visual disturbances

1253

11545

1.09

2.30

3.1

3.4

35.82

56.13

u/ml

2.99

1203

11135

Fall on same level

2925

16870

0.94

2.29

3.0

3.2

43.28

49.26

u/ml

0.73

2800

16334

Reimbursement for rheumatic diseases

1416

15215

0.92

2.29

2.8

3.5

49.50

54.38

u/ml

0.31

1356

14693

Benign neoplasm: Transverse colon

191

1543

1.25

2.29

2.6

3.8

33.27

68.64

u/ml

3.69

184

1485

All influenza (not pneumonia)

251

2083

1.21

2.29

3.2

3.1

93.40

55.75

u/ml

0.35

245

2008

Diplopia

276

2314

1.20

2.29

3.3

3.4

60.86

61.09

u/ml

0.00

269

2222

Sicca syndrome [Sjögren]

274

2302

1.21

2.28

2.4

3.7

27.35

57.59

u/ml

5.33

263

2214

Undefined dementia

1169

0.74

2.28

3.3

3.6

99.06

112.80

u/ml

0.16

1115

L04AD Calcineurin inhibitors

201

1635

1.24

2.26

2.8

3.2

56.64

52.54

u/ml

0.10

191

1580

Intracerebral haemorrhage

124

1604

0.77

2.25

4.0

3.9

321.11

85.92

u/ml

0.48

119

1537

Generalized anxiety disorder

424

3687

1.16

2.24

2.3

2.7

41.03

39.91

u/ml

0.05

412

3562

Type 1 diabetes

365

4233

0.86

2.24

2.8

3.2

83.18

50.46

u/ml

0.43

352

4089

Presence of cardiac and vascular implants and grafts

533

4491

0.88

2.24

2.5

3.9

112.99

87.30

u/ml

0.32

505

4313

Early onset COPD

260

3104

0.83

2.24

2.3

3.8

49.13

57.19

u/ml

0.30

246

2982

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

805

7193

1.11

2.23

2.3

2.6

68.52

37.58

u/ml

0.39

780

6944

Rheumatoid arthritis, including avohilmo

901

9896

0.91

2.23

3.0

3.6

50.25

59.32

u/ml

0.55

867

9536

Undetermined asthma

329

2807

1.18

2.22

2.4

3.3

85.25

49.62

u/ml

0.40

318

2710

Acne

209

1708

1.23

2.22

2.1

2.2

43.91

33.37

u/ml

0.24

202

1645

Rickettsioses

3.99

2.22

1.1

2.0

35.66

107.95

u/ml

—

Use of levodopa decarboxylase inhibitor

132

1690

0.78

2.21

2.7

4.1

74.24

83.06

u/ml

0.10

126

1614

Crohn's disease NAS

135

1052

1.30

2.21

1.5

2.9

52.76

48.02

u/ml

0.11

129

1015

Other disorders of veins

1205

11045

1.09

2.21

2.8

3.4

60.61

53.92

u/ml

0.16

1163

10659

Flatulence and related conditions

122

1.94

2.21

1.7

2.2

30.52

51.06

u/ml

0.39

117

Rhabdomyosarcoma, including Hilmo

4.60

2.20

3.0

1.4

21.00

83.11

u/ml

—

FESS (DNB20)

270

2269

1.20

2.20

2.4

3.3

33.57

49.07

u/ml

0.89

262

2183

Chronic sinusitis

1194

10994

1.09

2.20

2.5

3.4

34.36

54.64

u/ml

2.81

1144

10629

Mycoses

585

5203

1.13

2.19

3.2

3.5

75.96

57.47

u/ml

0.30

561

5016

Bacterial, viral and other infectious agents

143

1123

1.28

2.19

1.8

3.1

33.22

46.86

u/ml

0.85

135

1087

Stomatitis and related lesions

470

4125

1.15

2.18

3.3

45.83

51.57

u/ml

0.20

442

3969

Bacterial, viral and other infectious agents

159

1267

1.27

2.16

2.2

3.0

33.93

45.71

u/ml

0.74

151

1228

Congenital absence of the vagina

4.00

2.16

3.7

1.4

33.29

28.90

u/ml

—

Delivery, wide proxy

1150

6638

0.91

2.16

3.3

3.4

62.35

59.92

u/ml

0.10

1098

6405

Nontoxic single thyroid nodule

223

1849

1.22

2.15

2.8

3.7

89.12

56.21

u/ml

0.25

215

1787

Other/unspecified seropositive rheumatoid arthritis

591

6616

0.89

2.13

3.0

3.8

55.03

64.80

u/ml

0.40

569

6375

Other and unspecified polyneuropathies, also in other diseases

289

2449

1.19

2.12

3.0

3.7

163.40

66.30

u/ml

0.45

281

2347

Systemic connective tissue disorders

1004

9205

1.10

2.12

2.8

3.6

45.56

60.30

u/ml

1.10

968

8875

Carpal tunnel syndrome

1812

14964

1.07

2.11

2.8

3.5

50.89

54.16

u/ml

0.15

1742

14479

Other inflammatory liver diseases

145

1149

1.28

2.10

4.6

3.4

38.38

53.04

u/ml

0.91

136

1104

Moderate visual impairment, binocular

415

1.47

2.10

3.1

2.9

99.17

84.92

u/ml

0.11

400

Benign neoplasm of other and unspecified female genital organs

154

1235

1.27

2.09

2.0

3.6

25.96

60.93

u/ml

3.44

149

1196

Recurrent aphthous stomatitis , including avohilmo

341

2937

1.17

2.09

3.4

50.63

54.12

u/ml

0.08

323

2824

Seropositive rheumatoid arthritis, strict definition

306

3571

0.85

2.08

3.0

3.8

63.00

56.29

u/ml

0.14

293

3432

Otitis externa

494

4365

1.14

2.08

3.0

3.3

64.85

48.39

u/ml

0.57

468

4206

Hyperhidrosis

619

1.38

2.07

2.3

2.6

16.18

46.19

u/ml

3.36

601

Isolated growth hormone deficiency

2.47

2.06

2.5

3.0

49.33

24.32

u/ml

0.62

Heart failure and antihypertensive medication

512

2957

1.14

2.05

3.2

3.9

80.44

62.88

u/ml

0.67

491

2861

Lactose intolerance

595

1.39

2.04

2.0

3.0

25.34

57.45

u/ml

2.27

570

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

3.19

2.04

1.4

1.5

10.25

55.17

u/ml

—

Type 1 diabetes, wide definition, subgroup 2

179

0.38

2.04

2.1

2.7

22.71

71.68

u/ml

—

173

Diseases of pulp and periapical tissues, including avohilmo

2969

14601

1.06

2.04

3.1

3.2

43.27

53.90

u/ml

1.44

2837

14128

Other benign neoplasm of uterus: Other parts/unspecified

128

1007

1.30

2.04

3.7

4.2

139.19

82.63

u/ml

0.25

123

967

Diseases of appendix

1941

16449

1.07

2.03

2.7

3.2

39.20

48.07

u/ml

0.95

1876

15904

Hernia

2513

15939

1.06

2.03

3.4

3.3

46.43

53.52

u/ml

0.64

2421

15388

Voice disturbances

737

6683

1.11

2.00

3.0

3.5

47.18

53.67

u/ml

0.31

704

6451

Other shoulder lesions

242

2036

1.20

1.99

2.6

3.5

79.71

54.58

u/ml

0.19

237

1967

Congenital malformation of biliary tract

3.13

1.98

2.0

3.5

134.00

40.22

u/ml

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

586

6529

0.89

1.98

3.0

3.8

55.37

64.38

u/ml

0.35

564

6291

Osteonecrosis

131

1035

1.28

1.97

4.5

3.8

74.68

64.24

u/ml

0.14

125

995

Benign neoplasm: Descending colon

126

990

1.29

1.97

2.3

3.7

36.72

60.59

u/ml

1.42

120

952

Other abnormal findings of blood chemistry

729

1.33

1.95

4.1

3.0

30.48

55.74

u/ml

1.91

702

Other and/or unspecified nontoxic goitre

258

2192

1.19

1.94

2.1

4.0

75.09

61.59

u/ml

0.11

252

2109

Malignant neoplasm of oral cavity

234

1.60

1.94

5.8

1.4

50.08

21.92

u/ml

0.64

222

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

649

7186

0.90

1.94

2.2

2.9

29.87

39.04

u/ml

1.53

622

6940

LSIL lesion of the cervix uteri

413

3635

1.15

1.94

2.2

2.7

32.18

37.12

u/ml

0.45

392

3523

Gonarthrosis, primary, with knee surgery

1352

10015

1.08

1.93

2.9

4.0

47.41

66.39

u/ml

1.80

1300

9657

Seropositive rheumatoid arthritis, wide

602

6688

0.90

1.93

3.0

3.8

54.69

67.06

u/ml

0.54

579

6446

Transport accidents

1075

10012

0.92

1.93

2.7

3.2

36.42

54.45

u/ml

2.33

1032

9697

Acute appendicitis, no complications

1409

13082

1.08

1.92

2.5

3.1

38.08

45.29

u/ml

0.57

1360

12651

Disorders of continuity of bone

238

2007

1.20

1.92

2.6

3.4

34.30

52.88

u/ml

1.78

222

1936

Subarachnoid haemorrhage

136

1698

0.79

1.91

3.0

3.9

29.77

70.65

u/ml

5.19

131

1639

Fracture of rib(s), sternum and thoracic spine

485

4306

1.13

1.90

3.0

3.7

49.19

68.32

u/ml

1.53

465

4132

Other and unspecified nonorganic psychotic disorders

311

3599

0.86

1.90

2.5

3.0

46.98

44.49

u/ml

0.08

291

3477

Other disorders of eye and adnexa

353

3075

1.16

1.89

2.6

3.2

43.56

52.23

u/ml

0.35

339

2964

Atrial fibrillation and flutter with reimbursement

556

3157

1.13

1.89

3.1

3.7

46.75

49.05

u/ml

0.09

536

3053

Other disorders of bone

458

4058

1.14

1.89

2.7

3.2

32.94

47.01

u/ml

1.48

445

3910

Diseases of salivary glands

859

7870

1.10

1.88

2.8

3.4

59.36

53.85

u/ml

0.13

832

7593

Infectious mononucleosis

176

1445

1.23

1.88

1.7

2.2

30.87

32.56

u/ml

0.07

169

1393

Malignant neoplasm of eye, brain and central nervous system

391

1.45

1.87

1.6

1.5

23.08

23.74

u/ml

0.06

371

Congenital malformations and deformations of the musculoskeletal system

191

1573

1.22

1.87

2.3

2.7

19.93

41.76

u/ml

4.97

185

1521

Infection of intervertebral disc (pyogenic)

115

1.86

3.4

2.7

48.67

57.27

u/ml

0.09

108

Malignant neoplasm of other and ill-defined sites

4.30

1.84

1.2

1.5

297.60

101.18

u/ml

—

Dislocation, sprain and strain of joints and ligaments at neck level

348

3035

1.15

1.84

2.3

2.8

31.60

42.31

u/ml

1.25

337

2936

Other and unspecified coagulation defects

127

1011

1.27

1.83

2.0

2.7

32.74

46.80

u/ml

0.79

121

977

Radiculopathy

361

3157

1.15

1.83

3.0

3.9

40.91

78.65

u/ml

2.47

346

3035

Benign neoplasm of urinary organs

100

772

1.31

1.83

2.9

3.6

40.55

62.11

u/ml

0.86

744

Labour and delivery complicated by fetal stress [distress]

800

5726

0.91

1.82

2.1

2.4

26.77

32.47

u/ml

1.44

771

5553

Congenital malformations and deformations of the musculoskeletal system

245

2070

1.19

1.82

2.3

2.9

38.99

43.59

u/ml

0.10

236

1997

Other epidermal thickening

668

1.33

1.81

2.5

3.4

19.65

55.31

u/ml

4.15

647

Any mental disorder

3106

14835

1.05

1.81

3.1

3.3

60.13

47.76

u/ml

0.61

2974

14363

Rheumatism, unspecified

497

4446

1.13

1.81

2.6

3.9

43.39

58.24

u/ml

0.70

480

4291

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

192

1599

1.21

1.81

3.0

3.6

28.11

58.93

u/ml

3.80

182

1542

Primary angle-closure glaucoma

721

1.32

1.81

3.2

3.9

42.41

80.46

u/ml

1.81

695

Acute laryngitis and tracheitis

237

1976

1.19

1.80

2.5

2.6

30.23

42.24

u/ml

1.15

226

1916

Sleep apnoea

2279

15552

0.95

1.80

2.6

3.5

37.52

51.63

u/ml

2.36

2184

15039

Aneurysms, operations, SAH

282

3269

0.86

1.79

2.9

3.8

30.67

64.47

u/ml

5.26

275

3146

Carcinoma in situ of vagina

141

1.81

1.79

2.4

2.5

20.67

53.40

u/ml

1.09

135

Heterophoria

191

1593

1.21

1.77

2.2

3.0

31.48

46.35

u/ml

1.18

183

1535

Other systemic involvement of connective tissue

780

7145

1.10

1.75

2.9

3.6

40.61

62.85

u/ml

2.15

754

6877

Carcinoma in situ of other/unspecified female genital organs

4.51

1.74

3.2

5.2

46.80

89.43

u/ml

—

Dermatitis

1636

15343

1.07

1.74

3.3

49.07

54.78

u/ml

0.45

1580

14810

Viral warts

476

4252

1.13

1.74

2.5

3.2

25.45

48.53

u/ml

7.55

457

4104

Crohn disease (strict definition, all UC cases excluded)

106

831

1.29

1.73

2.1

2.7

47.97

48.10

u/ml

0.00

799

Malignant neoplasm of other and unspecified urinary organs

3.98

1.73

3.4

1.2

34.60

85.69

u/ml

—

Other maternal disorders predominantly related to pregnancy

2200

14527

0.95

1.73

2.6

3.3

31.38

46.31

u/ml

3.40

2131

14061

Postmenopausal osteoporosis with pathological fracture

198

1665

1.21

1.73

4.0

4.1

42.19

88.71

u/ml

2.96

191

1592

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

151

1214

1.24

1.72

2.6

2.3

28.90

36.63

u/ml

0.70

146

1171

Obesity related asthma

859

7909

1.09

1.71

2.6

3.5

37.32

56.59

u/ml

1.90

825

7642

Pneumonia due to other infectious organisms, not elsewhere classified

459

1.39

1.71

3.1

3.3

223.49

43.01

u/ml

0.44

440

Sequelae of poliomyelitis

119

1.82

1.70

5.4

3.5

26.95

41.92

u/ml

0.61

114

Drug-induced systemic lupus erythematosus

166

1.71

1.70

1.5

2.9

47.91

53.59

u/ml

0.10

160

Myalgia

699

6383

1.10

1.69

2.5

3.4

40.13

51.86

u/ml

1.01

673

6170

Glucagon-like peptide-1 (GLP-1) analogues

656

5970

1.10

1.69

2.5

3.6

41.03

51.73

u/ml

0.50

631

5772

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

656

5970

1.10

1.69

2.5

3.6

41.03

51.73

u/ml

0.50

631

5772

Soft tissue disorders related to use, overuse and pressure

692

6316

1.10

1.69

2.7

3.7

71.67

57.70

u/ml

0.22

661

6091

Spirochaetal infections, other/unspecified

191

1602

1.20

1.69

3.2

3.6

47.46

55.60

u/ml

0.13

181

1547

Multiple gestation

352

3102

1.15

1.68

2.2

2.6

34.36

34.50

u/ml

0.01

340

3005

Otosclerosis

120

1491

0.80

1.67

4.0

3.6

103.60

62.57

u/ml

0.45

115

1437

Benign neoplasm of bone and articular cartilage

186

1557

1.21

1.67

2.6

3.1

27.48

46.31

u/ml

2.51

178

1502

Carcinoma in situ of rectum

135

1.75

1.66

2.2

3.5

44.99

40.52

u/ml

0.07

130

Other appendicitis

189

1586

1.20

1.66

2.3

3.4

33.94

54.97

u/ml

1.37

179

1536

Mantle cell lymphoma

2.84

1.66

2.4

1.2

16.71

50.94

u/ml

—

Cytomegaloviral pneumonitis

3.78

1.65

6.6

2.2

65.20

77.21

u/ml

—

Unspecified urinary incontinence

251

2162

1.17

1.64

2.7

3.9

40.93

71.67

u/ml

2.00

239

2079

Glomerulonephritis

165

1368

1.21

1.64

2.6

3.3

219.23

54.09

u/ml

0.44

158

1320

Methotrexate

311

3549

0.87

1.63

2.5

3.7

49.13

63.41

u/ml

0.52

300

3423

Benign neoplasm: Skin of eyelid, including canthus

370

3275

1.14

1.62

2.8

3.8

45.92

60.64

u/ml

1.08

361

3149

Vaginal lichen planus

138

1.77

1.62

1.9

3.2

15.26

35.91

u/ml

1.27

132

Disorders of vitreous body and globe

1304

11739

1.07

1.61

3.2

3.8

42.59

59.98

u/ml

2.37

1266

11311

Abnormal findings in nipple discharge synovial fluid wound secretions

256

1.52

1.60

3.8

2.7

47.56

54.09

u/ml

0.10

246

Other infective otitis externa

120

966

1.25

1.60

3.4

3.2

99.59

50.08

u/ml

0.68

113

933

Unspecified acute lower respiratory infection

237

2033

1.17

1.59

3.8

3.0

48.21

54.49

u/ml

0.27

227

1966

Rash and other nonspecific skin eruption

233

2000

1.17

1.59

3.3

3.4

58.27

53.05

u/ml

0.10

222

1930

Spondyloarthritis

364

3222

1.13

1.57

2.5

3.3

58.56

52.56

u/ml

0.14

350

3115

Injuries to the abdomen, lower back, lumbar spine and pelvis

841

7683

1.09

1.57

2.7

3.4

39.99

61.52

u/ml

1.28

803

7395

Used for control exclusion in common control thyroid runs

2737

13207

1.05

1.57

2.9

3.3

41.96

47.24

u/ml

0.70

2643

12756

Herpesviral [herpes simplex] infections

284

2477

1.16

1.56

2.8

3.3

40.69

53.69

u/ml

0.61

276

2392

Hereditary motor and sensory neuropathy

140

0.42

1.56

1.5

2.8

20.83

38.73

u/ml

—

133

Carbimazole or st.post thyroidectomy, condition for graves disease

646

5908

1.10

1.56

2.8

3.4

57.25

54.80

u/ml

0.06

625

5695

Nephrotic syndrome

348

1.43

1.56

2.8

2.9

39.46

53.25

u/ml

0.43

335

470

0.66

1.55

1.5

3.4

221.94

64.64

u/ml

1.19

450

Appendicitis, broad definition

1906

16358

1.06

1.55

2.7

3.2

39.46

47.18

u/ml

0.78

1841

15817

Presence of other devices

453

4051

1.12

1.54

2.7

3.6

50.33

81.02

u/ml

1.52

435

3882

Ocular pain

215

1840

1.18

1.54

2.4

3.3

32.60

52.20

u/ml

1.21

206

1770

Hallux valgus (acquired)

1160

7800

1.07

1.53

3.3

3.9

46.24

61.04

u/ml

0.64

1102

7556

Scoliosis

217

1861

1.18

1.51

3.1

3.6

32.60

58.95

u/ml

2.40

210

1801

Later onset COPD, excluding more controls

260

2311

0.87

1.50

3.0

3.8

85.04

69.29

u/ml

0.36

247

2217

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

317

2710

1.14

1.49

2.5

3.2

37.88

50.07

u/ml

0.86

309

2609

Glomerular diseases

278

2429

1.15

1.48

2.5

3.4

146.82

59.02

u/ml

0.38

266

2340

Trochanteric bursitis

469

4238

1.11

1.48

2.6

3.8

90.76

61.41

u/ml

0.33

447

4081

Guttate psoriasis

253

0.54

1.48

2.5

2.4

14.36

41.68

u/ml

1.95

243

Fracture of skull and facial bones

373

3322

1.13

1.48

2.8

3.4

44.46

56.57

u/ml

0.59

365

3193

Arthropathies

2514

12163

1.05

1.48

2.7

3.2

43.30

50.52

u/ml

0.85

2421

11782

Diabetes, insulin treatment (Kela reimbursement)

2510

15853

0.95

1.47

3.0

3.4

60.49

50.66

u/ml

0.74

2413

15316

Inflammatory bowel disease

691

6352

1.09

1.47

2.1

3.2

49.02

45.36

u/ml

0.17

670

6131

Infections with a predominantly sexual mode of transmission

885

8209

1.08

1.47

2.4

2.8

29.92

38.83

u/ml

2.18

856

7930

Systemic disorders of connective tissue in diseases classified elsewhere (FG)

2.87

1.46

1.3

3.2

18.50

36.11

u/ml

—

Autoimmune hyperthyroidism

197

1684

1.18

1.46

2.8

3.4

71.84

51.88

u/ml

0.40

190

1627

Psoriatic arthropathies, ICD10

161

1913

0.84

1.46

2.5

3.3

34.00

50.39

u/ml

0.75

156

1844

Congenital malformations of heart and great arteries

223

1861

1.17

1.46

2.7

3.0

37.84

48.70

u/ml

0.55

216

1788

Infections with a predominantly sexual mode of transmission

1126

9826

1.07

1.45

2.2

2.7

28.70

38.25

u/ml

2.74

1090

9493

Other and unspecified effects of external causes

682

6273

1.09

1.45

2.7

3.0

32.56

43.86

u/ml

2.01

657

6059

Acute alcohol intoxication

252

2894

0.87

1.45

2.5

3.2

30.07

49.24

u/ml

2.72

243

2783

Dislocation, sprain and strain of joints and ligaments of head

747

1.27

1.44

2.6

2.9

56.20

52.93

u/ml

0.04

719

Superficial injury of forearm

198

1693

1.18

1.43

2.1

2.8

41.98

53.06

u/ml

0.34

193

1629

Thyrotoxicosis with toxic multinodular goitre

169

1429

1.20

1.43

2.9

3.7

104.76

65.09

u/ml

0.22

164

1377

Carcinoma in situ of breast, other/unspecified

374

1.41

1.43

2.1

3.6

21.51

66.31

u/ml

2.35

360

Symptoms and signs involving speech and voice

861

8001

1.08

1.43

3.1

3.5

50.38

56.31

u/ml

0.26

820

7722

Other congenital malformations of upper alimentary tract

1.83

1.43

2.7

2.9

20.29

67.78

u/ml

1.05

Malignant neoplasm of other and unspecified major salivary glands

2.50

1.41

1.6

1.7

17.84

47.19

u/ml

—

Other psoriatic arthropathies

157

1863

0.84

1.41

2.5

3.3

34.54

50.25

u/ml

0.69

152

1795

Malignant neoplasm of tongue

126

1.69

1.41

3.4

1.5

28.24

24.81

u/ml

0.09

120

Perforation of tympanic membrane

201

1724

1.17

1.41

3.4

52.58

53.17

u/ml

0.01

190

1664

Unspecified privation

205

1761

1.17

1.41

3.7

3.2

44.11

54.30

u/ml

0.22

198

1703

Acute upper respiratory infections of multiple and unspecified sites

2050

14478

1.05

1.41

3.1

35.55

49.25

u/ml

4.26

1976

13995

Concussion

1207

10469

0.94

1.38

2.5

3.5

39.61

46.78

u/ml

0.71

1164

10180

Hydrocephalus

1137

0.79

1.38

3.3

3.5

372.01

71.64

u/ml

0.43

1094

Congenital malformations of the circulatory system

258

2189

1.15

1.38

2.4

3.1

148.87

51.12

u/ml

0.40

251

2109

Superficial injury of ankle and foot

252

2203

1.15

1.37

2.3

2.8

52.78

40.69

u/ml

0.29

243

2130

Benign neoplasm: Skin of other and unspecified parts of face

225

1952

1.16

1.37

2.5

3.4

44.24

60.23

u/ml

0.64

216

1881

Spinal stenosis

1127

8028

1.07

1.37

2.9

4.1

41.37

65.59

u/ml

3.25

1074

7746

Dental pulpitis, including avohilmo

2502

15553

1.05

1.36

2.4

3.2

31.64

46.24

u/ml

4.05

2404

15047

Suicide or other Intentional self-harm

474

5217

0.90

1.36

2.3

3.0

34.12

42.37

u/ml

0.83

454

5041

Gonarthrosis [arthrosis of knee](FG)

1823

11141

0.95

1.36

3.0

3.6

45.17

56.60

u/ml

0.72

1750

10779

Primary coxarthrosis, bilateral

499

5477

0.91

1.35

3.1

4.0

87.01

77.90

u/ml

0.12

470

5253

Viral conjunctivitis

763

1.26

1.35

2.9

2.8

33.65

48.21

u/ml

0.46

733

Bipolar affective disorders

375

4175

0.89

1.35

2.2

3.0

36.59

39.67

u/ml

0.13

362

4053

Disorders of vitreous body

1270

11571

1.06

1.34

3.3

3.8

42.84

60.37

u/ml

2.32

1232

11149

Asthma and allergy

357

3155

1.12

1.33

1.8

2.7

31.17

38.37

u/ml

0.49

346

3039

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2402

15103

0.96

1.33

3.0

3.4

59.26

49.86

u/ml

0.66

2307

14604

Disorders of myoneural junction and muscle in diseases classified elsewhere

194

1.55

1.33

2.2

2.9

38.48

46.09

u/ml

0.14

188

Thyrotoxicosis, other and/or unspecified

607

5586

1.09

1.32

3.2

3.5

63.76

59.62

u/ml

0.09

583

5399

Other disorders of eyelid

1110

9934

1.07

1.32

3.0

3.9

38.77

66.90

u/ml

4.42

1069

9558

Problems related to lifestyle

174

1484

1.18

1.32

2.3

2.7

41.98

46.63

u/ml

0.14

168

1438

Monoamine oxidase A inhibitors

274

2418

1.14

1.32

2.7

3.8

41.27

55.43

u/ml

0.65

264

2329

Allergic rhinitis

733

7810

0.92

1.31

2.4

2.9

34.34

40.74

u/ml

0.63

710

7532

Asthma and allergy, excluding more controls

357

3159

1.12

1.31

1.8

2.7

31.17

38.18

u/ml

0.47

346

3047

Diabetic retinopathy

473

3245

0.91

1.31

2.9

3.0

92.06

56.58

u/ml

0.59

452

3105

Haemophilus septicemia

2.90

1.30

10.0

2.2

19.40

28.38

u/ml

—

Biological medication for rheuma

315

3531

0.89

1.30

2.1

3.1

43.59

44.44

u/ml

0.03

303

3415

Other congenital malformations

296

2626

1.13

1.30

2.4

3.0

25.46

44.69

u/ml

5.08

286

2537

Carcinoma in situ, bladder

177

1.54

1.29

3.9

3.1

22.29

60.07

u/ml

0.96

171

Sacroiliitis, not elsewhere classified

117

966

1.22

1.29

2.5

2.9

24.74

40.21

u/ml

1.54

111

939

Other symptoms and signs involving the circulatory and respiratory systems

134

1120

1.21

1.29

2.4

3.2

38.31

60.85

u/ml

1.36

127

1084

Speech therapy

617

5687

1.09

1.29

2.7

3.6

65.30

64.88

u/ml

0.01

599

5477

Coxarthrosis [arthrosis of hip](FG)

1158

8651

0.94

1.28

3.1

3.9

53.47

65.08

u/ml

0.42

1115

8355

Diseases of external ear

705

6533

1.08

1.28

3.2

3.4

53.87

59.00

u/ml

0.18

668

6299

Alcohol dependence

253

2874

0.88

1.28

2.4

3.4

42.51

49.52

u/ml

0.31

244

2772

Abscess of Bartholin gland

717

1.26

1.27

2.2

2.8

27.14

46.81

u/ml

1.17

692

Communicating hydrocephalus

303

0.62

1.27

4.8

2.9

44.61

66.83

u/ml

0.47

288

Cervicalgia

544

4993

1.09

1.26

2.9

3.7

40.29

63.76

u/ml

1.51

524

4805

Car occupant injured in other and unspecified transport accidents

410

3713

1.11

1.26

2.8

3.0

29.38

46.58

u/ml

3.17

394

3586

Other congenital malformations of skull and face bones

2.47

1.26

2.0

2.6

52.17

74.52

u/ml

—

Hyperprolactinaemia, drug-induced

145

0.46

1.26

1.4

2.7

19.71

54.80

u/ml

—

138

Other complications of labour and delivery, not elsewhere classified

317

3249

0.89

1.26

1.8

2.2

25.74

31.30

u/ml

1.37

309

3147

Other benign neoplasms of connective and other soft tissue

216

1884

1.15

1.25

3.3

3.2

112.67

56.35

u/ml

0.43

204

1819

Nonhereditary hypogammaglobulinemia

213

1.49

1.25

2.1

2.8

59.16

44.80

u/ml

0.29

207

Rosacea

301

2685

1.13

1.24

2.1

3.4

38.53

49.70

u/ml

0.70

287

2591

Hyperlipidaemia, other/unspecified

708

6045

1.08

1.24

3.2

3.8

58.13

71.20

u/ml

0.62

675

5815

Metabolic disorder, other/unspecified

2.25

1.24

1.8

3.4

20.19

23.33

u/ml

—

Malignant neoplasm of tongue, including Hilmo

171

1.53

1.24

3.1

1.4

26.62

24.61

u/ml

0.07

164

Ectopic pregnancy

668

6198

1.08

1.23

2.3

3.4

34.01

47.46

u/ml

1.09

645

5997

Other hearing loss

445

4779

0.91

1.23

3.1

3.8

72.42

77.90

u/ml

0.10

424

4580

Diseases of the musculoskeletal system and connective tissue

1507

7167

1.06

1.23

2.7

3.3

44.85

49.84

u/ml

0.40

1442

6961

Diabetic maculopathy

129

1446

0.84

1.23

2.1

2.7

132.74

61.19

u/ml

0.32

122

1374

Coxarthrosis, primary

1188

10644

0.94

1.23

3.1

3.9

55.16

66.39

u/ml

0.42

1140

10248

Acute appendicitis

1765

15743

1.05

1.22

2.8

3.1

39.64

47.36

u/ml

0.72

1708

15226

Asthma/COPD (KELA code 203)

2600

17141

1.04

1.22

2.7

3.2

36.61

50.83

u/ml

2.95

2499

16571

Other sleep disorders

205

1785

1.15

1.21

2.6

3.4

64.17

53.64

u/ml

0.17

199

1723

Twin gestation

332

2987

1.12

1.21

2.3

2.6

33.72

34.54

u/ml

0.03

320

2893

Intermittent heterotropia

113

936

1.22

1.20

1.9

2.6

33.94

43.33

u/ml

0.45

107

900

Hypothermia

168

0.53

1.20

1.8

2.6

65.56

49.56

u/ml

—

160

Other and unspecified degenerative diseases of nervous system

286

0.62

1.19

1.4

3.1

42.00

77.10

u/ml

0.59

278

Hyperkinetic disorders (excl. ADHD)

169

0.52

1.19

1.4

1.7

43.00

33.61

u/ml

—

161

Thyrotoxicosis

767

7160

1.08

1.19

3.2

3.5

73.17

58.33

u/ml

0.31

737

6913

Injuries to the neck

470

4299

1.10

1.19

2.3

3.0

30.45

45.40

u/ml

2.78

454

4158

Sulfasalazine

644

6942

0.92

1.19

2.7

3.5

40.97

52.99

u/ml

0.96

615

6704

Plantar fascial fibromatosis

282

2515

1.13

1.19

2.8

3.6

84.82

53.05

u/ml

0.30

271

2436

Excessive vomiting in pregnancy

280

2498

1.13

1.19

2.2

2.8

24.50

40.88

u/ml

3.36

272

2418

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

659

6115

1.08

1.18

2.4

3.1

43.45

43.33

u/ml

0.00

634

5913

Influenza and pneumonia

2890

17712

1.04

1.18

3.8

3.1

58.51

47.86

u/ml

0.82

2795

17102

Thyroiditis

203

1775

1.15

1.17

2.6

3.3

56.20

51.60

u/ml

0.09

195

1708

Congenital obstruction of the pelviureteric junction

155

0.50

1.17

6.1

2.7

31.88

51.76

u/ml

—

150

Brachial plexus disorders

253

2244

1.14

1.17

2.5

3.3

25.60

43.81

u/ml

3.62

239

2180

Sudden idiopathic hearing loss

146

1709

0.85

1.17

2.6

3.8

27.95

62.70

u/ml

4.71

137

1648

Superficial injury of head

500

4590

1.09

1.16

2.5

3.5

55.12

66.12

u/ml

0.44

481

4405

Postpartum care and examination

494

2867

1.10

1.16

2.2

2.3

23.63

36.87

u/ml

3.23

480

2779

Coxarthrosis

1039

7281

0.94

1.16

3.1

4.0

54.68

64.21

u/ml

0.29

1002

7042

Other and unspecified dermatitis

1379

13110

1.05

1.15

3.3

46.56

54.27

u/ml

0.62

1327

12658

Malignant neoplasm of hypopharynx, including Hilmo

2.53

1.15

1.6

1.3

21.20

18.08

u/ml

—

Allergic urticaria

199

1739

1.15

3.4

3.0

41.13

46.54

u/ml

0.18

189

1674

Fibroblastic disorders

444

4059

1.10

1.14

2.8

3.8

78.99

60.24

u/ml

0.26

427

3916

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

288

2494

1.12

1.14

2.4

3.1

37.94

51.00

u/ml

0.86

282

2403

Psoriasis

524

5684

0.92

1.14

2.6

3.4

32.02

55.94

u/ml

2.86

504

5478

Mantle cell lymphoma, including Hilmo

1.87

1.14

3.5

1.6

20.57

30.04

u/ml

0.28

Asthma-related infections

1469

13699

1.05

1.14

2.7

3.3

42.70

54.06

u/ml

0.62

1406

13214

Asthma, hospital admission 2, infections

1469

13699

1.05

1.14

2.7

3.3

42.70

54.06

u/ml

0.62

1406

13214

Patellar tendinitis

200

1.47

1.14

2.3

1.9

18.12

38.68

u/ml

1.10

195

Overexertion and strenuous or repetitive movements

179

1553

1.16

1.14

3.8

3.1

28.05

54.28

u/ml

3.47

168

1498

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1804

16785

1.05

1.14

2.8

3.2

51.21

48.08

u/ml

0.07

1751

16216

Perineal laceration during delivery

511

4636

0.92

1.13

2.2

2.5

27.66

34.83

u/ml

1.94

495

4495

KRA_PSY_EATING, excluding more controls

227

1994

1.14

1.13

1.6

2.2

20.94

34.58

u/ml

3.63

220

1929

Other disorders of patella

484

4449

1.09

1.13

2.6

3.4

37.38

52.86

u/ml

0.85

459

4307

Convulsions, not elsewhere classified

388

3482

1.10

1.12

2.8

2.9

119.09

47.98

u/ml

0.45

378

3357

Disorder of mineral metabolism, other/unspecified

2.05

1.12

1.3

1.8

23.02

62.87

u/ml

—

Vitamin B12 deficiency anaemia

187

1630

1.15

1.11

4.1

3.7

50.85

71.12

u/ml

0.70

182

1566

Recurrent and persistent haematuria

120

1.62

1.11

1.4

2.4

37.00

50.31

u/ml

0.20

115

Superficial injury of abdomen, lower back and pelvis

296

2657

1.12

1.11

1.8

3.0

25.86

53.27

u/ml

6.41

282

2569

Early onset COPD, excluding more controls

260

2913

0.89

1.11

2.3

3.5

49.13

48.95

u/ml

0.01

246

2810

Hypopituitarism

727

1.23

1.11

3.1

2.6

34.98

53.50

u/ml

1.03

702

Other obstructed labour

270

2417

1.13

1.11

3.2

3.3

46.76

43.55

u/ml

0.08

260

2339

Other disorders of binocular vision

267

0.62

1.11

1.9

2.3

32.64

40.74

u/ml

0.17

253

Chronic laryngitis and laryngotracheitis

328

2963

1.11

1.10

2.5

3.7

39.61

57.85

u/ml

1.34

309

2867

Pilonidal cyst

124

1047

1.19

1.10

3.6

2.3

24.27

41.60

u/ml

1.76

117

1005

Pyogenic arthritis

107

892

1.21

1.10

3.7

123.74

67.23

u/ml

0.57

102

857

Acute alcohol intoxication, ICD10

210

2383

0.88

1.09

2.3

2.9

27.17

47.64

u/ml

2.79

201

2297

Alcohol use disorder, ICD-based

490

5319

0.92

1.08

2.4

3.2

51.05

45.27

u/ml

0.26

472

5133

Astigmatism

110

920

1.20

1.08

2.5

2.9

37.96

51.85

u/ml

0.58

104

888

Sensorineural hearing loss

1652

11726

0.95

1.08

3.2

3.7

59.49

58.13

u/ml

0.05

1582

11321

Primary biliary cholangitis (PBC)

526

1.28

1.07

2.1

3.6

123.19

61.16

u/ml

0.36

512

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

649

6929

0.93

1.06

2.2

2.8

29.87

38.16

u/ml

1.29

622

6707

Type of accident

602

5597

1.08

1.06

2.6

3.4

53.20

55.62

u/ml

0.06

572

5397

Duodenal ulcer

132

1125

1.18

1.06

3.2

3.7

47.39

73.60

u/ml

1.51

126

1087

Effects of foreign body entering through natural orifice

334

3027

1.11

1.05

3.0

3.1

27.69

51.75

u/ml

4.85

321

2915

Superficial injury of wrist and hand

441

4052

1.09

1.05

2.3

3.1

37.19

45.79

u/ml

0.44

426

3914

Injury of unspecified body region

145

1248

1.17

1.05

2.6

3.2

43.26

57.68

u/ml

0.32

137

1204

Fitting and adjustment of other devices

636

5347

1.08

1.05

3.0

2.7

71.19

39.74

u/ml

1.72

611

5128

Other and unspecified syphilis

2.33

1.04

1.0

4.1

24.80

33.18

u/ml

—

Shoulder region

213

1.43

1.04

3.8

2.8

46.07

42.90

u/ml

0.05

207

Use of disulfiram, acamprosate or naltrexone

922

0.81

1.04

3.1

2.8

57.09

48.26

u/ml

0.11

889

Malignant neoplasm of nasopharynx, including Hilmo

2.31

1.04

2.0

1.2

48.60

13.27

u/ml

—

Diseases of the ear and mastoid process

3285

15971

1.03

1.04

2.9

3.2

45.51

47.85

u/ml

0.16

3156

15452

Allergic conjunctivitis

1860

17405

1.04

1.03

2.8

3.2

50.53

47.70

u/ml

0.06

1803

16812

Mental and behavioural disorders due to alcohol, excluding acute intoxication

530

5692

0.92

1.03

2.4

3.2

50.99

44.37

u/ml

0.33

510

5500

Conduction disorders

465

4090

0.92

1.03

2.9

4.0

48.72

74.14

u/ml

1.30

442

3941

385

3307

1.10

1.03

3.7

3.9

106.86

95.34

u/ml

0.12

369

3155

Multiple delivery

273

3026

0.89

1.03

2.3

3.4

34.12

42.36

u/ml

0.33

266

2931

Injury of cranial nerves

110

0.44

1.03

1.4

2.4

13.40

63.30

u/ml

—

105

Transient global amnesia

164

1878

0.87

1.02

3.9

4.3

25.36

76.65

u/ml

5.02

156

1807

Supplementary factors related to causes of morbidity and mortality classified elsewhere

648

6051

1.07

1.02

2.7

3.3

56.87

54.22

u/ml

0.07

617

5835

Visual impairment including blindness (binocular or monocular)

125

1066

1.18

1.02

2.9

3.3

60.93

68.91

u/ml

0.13

118

1028

Alcohol abuse, main dg

161

1848

0.87

1.01

2.2

2.9

24.14

46.41

u/ml

3.65

154

1784

Osteoporosis with pathological fracture (FG)

222

1977

1.13

1.01

3.9

4.3

39.94

102.80

u/ml

3.06

213

1889

Malignant neoplasm of other and unspecified parts of tongue

107

1.61

1.01

3.5

1.5

31.94

25.45

u/ml

0.15

102

Tumor necrosis factor alpha inhibitors

286

3165

0.90

1.00

2.2

3.1

40.74

45.50

u/ml

0.20

276

3059

Congenital myopathies

0.00

1.00

0.0

4.0

—

30.84

—

Polyarthrosis

605

5239

1.08

1.00

3.1

4.3

55.54

74.83

u/ml

0.92

576

5064

Injury of muscle and tendon at forearm level

206

1.42

1.00

4.5

2.5

27.39

45.64

u/ml

0.71

196

Autoimmune diseases

2912

14327

1.03

1.00

2.9

3.2

45.23

48.69

u/ml

0.24

2806

13840

Polymorphous light eruption

186

0.58

1.00

2.5

2.3

20.27

26.87

u/ml

0.42

174

Acute suppurative otitis media

562

4876

1.08

0.99

2.1

2.5

32.44

38.02

u/ml

0.65

535

4716

Contact with other sharp object(s)

108

912

1.19

0.99

1.9

2.4

18.98

45.24

u/ml

3.33

879

Unknown and unspecified causes of morbidity

143

1237

1.16

0.98

3.9

3.0

41.54

58.00

u/ml

0.44

138

1195

Melanocytic naevi of trunk

243

2177

1.12

0.98

2.3

3.1

48.77

48.75

u/ml

0.00

237

2097

Lactose intolerance, other/unspecified

523

1.26

0.98

2.2

2.9

27.16

60.94

u/ml

1.99

503

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

140

1.51

0.98

3.2

1.5

28.86

25.73

u/ml

0.08

134

Hypoparathyroidism

813

0.80

0.98

2.5

3.5

38.45

64.11

u/ml

0.54

785

Other inflammation of eyelid

317

2882

1.11

0.98

2.7

3.7

33.38

60.58

u/ml

3.30

306

2774

Malignant neoplasm of lip, including Hilmo

1.96

0.97

2.6

1.4

25.00

42.79

u/ml

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

335

3052

1.10

0.97

2.8

3.4

51.81

53.69

u/ml

0.04

327

2937

Fracture of femur

482

4046

1.08

0.96

2.9

3.8

78.25

79.16

u/ml

0.02

462

3877

Cellulitis of external ear

197

0.60

0.96

5.8

2.3

27.19

33.01

u/ml

0.19

189

Nonalcoholic steatohepatitis

150

1.50

0.96

2.8

2.6

24.08

53.46

u/ml

0.99

144

Other and unspecified vascular occlusions

157

1371

1.15

0.95

3.1

3.9

56.34

89.48

u/ml

0.94

146

1313

Glaucoma suspect

769

8159

0.94

0.95

3.3

3.8

79.74

63.53

u/ml

0.17

734

7860

Injuries to the thorax

795

7490

1.06

0.95

2.9

3.4

42.96

62.88

u/ml

2.23

760

7202

Adhesive middle ear disease

233

0.64

0.95

1.5

2.7

21.15

35.26

u/ml

1.02

224

Congenital malformations of great veins

2.27

0.94

2.7

2.0

26.68

34.59

u/ml

—

Other and unspecified syphilis

2.27

0.94

1.0

3.6

26.67

30.44

u/ml

—

Haemangioma and lymphangioma, any site

203

1806

1.13

0.94

2.2

3.3

233.12

52.30

u/ml

0.59

197

1742

Psoas tendinitis

1.72

0.94

1.4

2.4

17.15

60.52

u/ml

0.82

Viral haemorrhagic fevers, not elsewhere classified/unspecified

303

2752

1.10

0.94

2.7

3.4

54.49

54.74

u/ml

0.00

295

2653

Asthma, hospital admissions , main diagnosis only

2194

18680

1.04

0.94

2.6

3.2

44.32

50.46

u/ml

0.39

2110

18040

Postviral fatigue syndrome

176

1.46

0.94

2.2

1.9

24.04

34.91

u/ml

0.46

168

1119

10569

1.05

0.94

2.6

3.2

31.60

54.26

u/ml

5.91

1067

10189

Diabetic retinopathy, strict definition

203

2012

0.89

0.93

2.5

2.7

32.97

57.32

u/ml

3.84

196

1914

Non-ischemic cardiomyopathy

583

4381

1.07

0.93

3.2

4.1

90.70

82.47

u/ml

0.23

555

4210

Leisure time condition

348

3187

1.10

0.92

2.8

3.4

38.80

56.07

u/ml

1.26

332

3060

Other and unspecified injuries of ankle and foot

736

1.21

0.92

1.4

2.7

95.24

44.42

u/ml

0.52

708

Other systemic involvement of connective tissue (FG)

764

7112

1.06

0.92

3.0

3.8

41.02

63.44

u/ml

2.16

739

6867

Disorders of refraction and accommodation

651

6085

1.07

0.92

3.0

3.1

81.46

43.69

u/ml

0.39

631

5879

Foreign body on external eye

123

1057

1.17

0.92

3.0

2.8

29.73

51.96

u/ml

1.50

118

1016

Calcific aortic valvular stenosis

333

3529

0.91

0.92

3.0

3.8

58.31

86.28

u/ml

1.83

311

3366

Calcific aortic valvular stenosis, operated

333

3529

0.91

0.92

3.0

3.8

58.31

86.28

u/ml

1.83

311

3366

Viral warts

199

1772

1.13

0.91

2.4

3.0

26.43

47.30

u/ml

2.81

189

1708

Lichen planus

307

2800

1.10

0.91

2.9

3.9

35.03

61.68

u/ml

2.83

294

2689

Traumatic subdural haemorrhage

136

1501

0.87

0.91

3.4

4.2

63.16

77.80

u/ml

0.37

129

1445

Alcohol abuse counselling and surveillance

170

0.58

0.91

2.5

2.3

33.70

49.35

u/ml

—

165

Mixed and other personality disorders

132

1519

0.86

0.91

2.2

2.8

29.36

42.88

u/ml

1.30

126

1465

Other abnormal immunological findings in serum

395

1.28

0.90

2.8

2.5

28.32

49.62

u/ml

0.91

378

1.92

0.89

1.8

3.4

14.62

39.59

u/ml

—

Antepartum haemorrhage, not elsewhere classified

310

2835

1.10

0.89

1.6

2.5

28.75

34.07

u/ml

0.74

297

2743

Spondylopathies (FG)

297

2707

1.10

0.89

2.6

3.4

34.71

47.91

u/ml

1.11

283

2617

Injuries to the ankle and foot

1726

15927

0.96

0.89

2.6

3.1

49.24

45.77

u/ml

0.15

1644

15405

Disorders of choroid and retina

1736

12814

0.96

0.89

3.3

3.6

60.61

57.53

u/ml

0.12

1669

12360

Gestational [pregnancy-induced] hypertension

889

9340

0.95

0.88

2.4

2.8

33.29

38.62

u/ml

0.51

857

9039

Bronchitis

2942

17982

1.03

0.88

3.1

3.2

46.39

50.45

u/ml

0.32

2829

17370

Malignant neoplasm of gum

2.04

0.88

5.0

1.4

41.17

48.71

u/ml

—

Finngen Rheumatological endpoints

2664

14683

1.03

0.88

2.8

3.2

39.14

50.29

u/ml

1.81

2567

14208

Operations 2 for CAVS

333

3519

0.92

0.88

3.0

3.8

58.31

86.48

u/ml

1.85

311

3356

Calcific aortic valvular stenosis, diagnosis (helper)

333

3519

0.92

0.88

3.0

3.8

58.31

86.48

u/ml

1.85

311

3356

Missing teeth due to accident, extraction or parodontitis

1375

12416

1.05

0.87

3.1

3.7

39.30

62.29

u/ml

4.68

1305

11986

Acute sinusitis

1418

12591

1.04

0.87

2.5

3.1

31.73

46.84

u/ml

3.74

1350

12190

Diseases of the eye and adnexa

2212

10701

1.04

0.87

2.8

3.1

35.15

48.16

u/ml

3.06

2142

10351

Conductive and sensorineural hearing loss

1781

12472

0.96

0.87

3.2

3.7

61.53

56.07

u/ml

0.23

1703

12046

Budesonide

325

2979

1.10

0.87

2.2

3.3

49.78

48.98

u/ml

0.02

313

2873

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

806

1.19

0.87

3.0

3.2

215.38

48.73

u/ml

0.61

780

Other retinal disorders

1253

10196

0.96

0.86

3.3

3.7

70.59

62.45

u/ml

0.26

1201

9823

Crossbite

117

933

1.17

0.86

2.8

2.7

26.39

44.96

u/ml

1.49

111

900

Complications of anaesthesia during the puerperium

1.62

0.85

4.3

2.4

11.35

27.19

u/ml

4.49

Labour and delivery complicated by umbilical cord complications

169

1501

1.14

0.85

2.6

3.0

33.78

41.64

u/ml

0.44

162

1454

Deforming dorsopathies

750

7092

1.06

0.85

2.8

3.7

39.86

59.27

u/ml

1.77

716

6843

Lichen planus, including avohilmo

464

4321

1.08

0.85

2.8

3.8

39.33

64.31

u/ml

1.75

442

4153

Cervical disc disorders

851

8076

1.06

0.85

3.1

3.8

36.66

59.97

u/ml

3.49

817

7807

Asthma, hospital admissions 3, pneumonia

773

7300

1.06

0.85

2.9

3.5

55.48

65.84

u/ml

0.25

746

7030

Asthma-related pneumonia or sepsis

773

7300

1.06

0.85

2.9

3.5

55.48

65.84

u/ml

0.25

746

7030

Benign neoplasm of meninges

264

2403

1.11

0.84

2.9

3.9

41.74

63.89

u/ml

1.00

254

2309

Allergic asthma (mode), excluding more controls

628

5782

1.07

0.84

2.3

2.9

39.56

41.08

u/ml

0.07

608

5590

Wegener granulomatosis

237

0.67

0.83

2.4

3.0

37.19

54.12

u/ml

0.43

227

Extrapyramidal and movement disorders

728

7697

0.94

0.83

2.7

3.6

54.79

65.54

u/ml

0.41

691

7413

Macular pucker

227

2510

0.90

0.83

4.1

4.3

41.65

82.42

u/ml

1.73

218

2405

Atypical facial pain

140

1231

1.15

0.82

1.9

3.6

20.99

54.73

u/ml

4.79

130

1191

Open wound of head

886

8979

0.95

0.82

3.0

3.4

46.84

63.96

u/ml

1.31

853

8650

Kela reimbursement Agammaglobulinemia (D80-84)

164

1.43

0.82

2.0

2.4

47.48

48.91

u/ml

0.02

157

Achilles tendinitis

173

1940

0.89

0.82

3.5

3.8

31.72

53.40

u/ml

1.83

164

1877

Arthrosis

1753

9978

0.96

0.82

2.9

3.5

41.10

54.99

u/ml

1.52

1689

9670

Other and unspecified rosacea

212

1911

1.12

0.82

2.3

3.3

40.62

53.24

u/ml

0.55

202

1844

Other/unspecified enthesopathies, not elsewhere classified

186

1664

1.12

0.82

4.1

3.7

21.97

62.69

u/ml

7.40

179

1608

General autosomal fish scale disease

0.00

0.82

0.0

4.5

—

88.54

—

Asthma-related pneumonia

770

7281

1.06

0.82

2.9

3.5

55.66

65.98

u/ml

0.25

743

7011

Benign neoplasm: Short bones of lower limb

173

1.41

0.81

2.4

2.7

25.80

46.91

u/ml

0.63

167

Diseases of middle ear and mastoid

1305

11118

0.96

0.81

2.5

2.9

49.80

48.24

u/ml

0.05

1251

10730

Other specified/unspecified soft tissue disorders

119

1036

1.16

0.81

2.1

3.6

30.06

61.08

u/ml

2.16

114

1005

Tinnitus

526

4932

1.07

0.80

3.2

3.7

60.12

57.77

u/ml

0.03

506

4754

False labour

1158

6911

1.05

0.80

2.1

2.6

24.45

33.90

u/ml

3.74

1115

6708

Postprocedural disorders of nervous system

186

1668

1.12

0.80

2.0

2.6

18.23

40.87

u/ml

6.01

177

1617

Injuries to unspecified part of trunk, limb or body region

184

1648

1.12

0.79

2.5

3.3

38.55

61.00

u/ml

0.78

176

1590

Calcific aortic valvular stenosis, including rheumatic fever

337

3536

0.92

0.79

3.0

3.8

57.91

86.16

u/ml

1.88

314

3374

Adhesive capsulitis of shoulder

408

3796

1.08

0.79

3.2

3.8

41.75

59.20

u/ml

0.88

398

3660

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1195

11132

1.04

0.78

2.7

3.4

33.51

54.15

u/ml

3.24

1151

10762

Other rupture of muscle

1.55

0.77

4.3

2.2

19.79

74.01

u/ml

1.35

conjunctival haemorrhage

146

1293

1.14

0.77

2.3

3.7

51.68

69.23

u/ml

0.45

137

1246

Psychiatric diseases

2718

13225

1.03

0.77

2.9

3.4

59.21

49.29

u/ml

0.39

2605

12801

Choroidal detachment

2.24

0.77

5.4

2.9

28.00

78.89

u/ml

—

Internal derangement of knee

868

8227

1.05

0.77

2.7

3.6

57.40

54.20

u/ml

0.07

827

7971

Allergic asthma (mode)

628

5804

1.06

0.77

2.3

2.9

39.56

40.83

u/ml

0.06

608

5606

Other congenital malformations of female genitalia

201

1.37

0.77

2.7

1.9

27.12

42.87

u/ml

0.59

191

Peripheral arterial reconstruction

144

1625

0.88

0.76

2.6

3.7

42.04

93.91

u/ml

4.23

139

1553

Lesion of ulnar nerve

248

2262

1.10

0.76

2.3

3.5

40.85

55.11

u/ml

0.38

235

2185

Mucosal proctocolitis

229

2081

1.10

0.76

2.0

3.0

52.72

48.34

u/ml

0.08

221

2002

L04AA Selective immunosuppressants

465

4965

0.93

0.76

2.6

3.4

43.34

56.39

u/ml

0.75

446

4783

Fracture of spine, level unspecified

2.16

0.76

3.4

2.8

82.40

108.97

u/ml

—

Iodine-deficiency-related thyroid disorders and allied conditions

2.16

0.76

1.4

4.1

20.60

71.53

u/ml

—

Migraine with aura, drug-induced

254

0.70

0.76

3.2

2.5

16.03

53.30

u/ml

1.36

241

Other mosquito-borne viral fevers

134

0.58

0.75

6.8

2.5

63.50

54.52

u/ml

—

128

Embedded teeth, including avohilmo

187

1684

1.12

0.75

2.3

38.36

35.51

u/ml

0.12

181

1626

Ovarian dysfunction: estrogen excess

2.11

0.75

1.8

1.9

23.66

61.88

u/ml

—

Synovial cyst of popliteal space [Baker]

168

1505

1.12

0.75

2.8

3.9

29.69

65.40

u/ml

3.32

161

1450

Malignant neoplasm of lip

2.10

0.75

3.0

1.4

31.80

53.13

u/ml

—

Alcohol abuse, main dg, excluding more controls

161

1801

0.89

0.74

2.2

3.0

24.14

44.78

u/ml

3.31

154

1745

Chalazion

236

2152

1.10

0.74

3.5

3.4

28.59

55.89

u/ml

3.80

231

2070

Diabetic nephropathy, excluding more controls

170

1560

0.89

0.74

2.6

2.9

51.82

61.19

u/ml

0.27

159

1485

Peritonsillar abscess

455

4260

1.07

0.74

2.4

3.0

27.45

44.67

u/ml

4.32

441

4121

Other diseases of stomach and duodenum

125

1100

1.14

0.74

2.9

3.6

60.44

66.02

u/ml

0.10

117

1066

Radiodermatitis

1.65

0.74

3.3

2.9

15.00

33.68

u/ml

—

Senile cataract

1270

8095

0.96

0.74

3.6

4.0

53.07

63.08

u/ml

0.59

1225

7823

Contact with other hot fluids

446

0.78

0.74

1.7

2.4

70.35

42.93

u/ml

0.22

427

Retinal vascular disorders

189

1705

1.11

0.73

3.0

4.0

51.81

89.29

u/ml

1.45

177

1630

Maternal care for known or suspected fetal abnormality and damage

511

4668

0.94

0.73

1.9

2.5

26.01

34.56

u/ml

2.07

487

4528

Trigeminal neuralgia

145

1291

1.13

0.73

2.0

3.5

34.61

57.05

u/ml

1.33

136

1246

Herpesviral [herpes simplex] infections

696

6609

1.06

0.72

2.5

3.1

39.85

44.43

u/ml

0.27

667

6387

Complications following abortion and ectopic and molar pregnancy

113

992

1.15

0.72

4.2

3.8

45.41

52.55

u/ml

0.19

102

959

Chronic ulcer of skin, not elsewhere classified

107

933

1.15

0.72

3.6

53.95

66.35

u/ml

0.35

100

898

Fracture of lower leg, including ankle

1297

13328

0.96

0.72

3.4

3.5

52.46

57.70

u/ml

0.28

1244

12863

Other deformities of toe(s)

823

1.17

0.72

3.5

4.0

18.32

71.05

u/ml

5.23

796

Benign neoplasm: Cerebral meninges

237

2168

1.10

0.72

3.1

3.9

31.76

65.18

u/ml

2.80

228

2085

Superficial injury of lower leg

595

5628

1.06

0.71

2.3

3.3

40.31

56.76

u/ml

1.29

569

5421

Cardiomyopathy

224

2042

1.10

0.71

2.8

4.0

80.75

67.88

u/ml

0.36

216

1972

Diabetic retinopathy, excluding more controls

418

2506

0.93

0.70

2.9

3.0

90.54

53.93

u/ml

0.54

403

2393

Lymphoid leukaemia

592

1.19

0.70

2.7

3.6

512.46

61.05

u/ml

0.55

573

Orchitis and epididymitis

1.71

0.70

1.4

1.2

21.00

156.78

u/ml

—

Lumbar disc prolapse

1659

12308

1.04

0.69

2.7

3.5

40.88

53.60

u/ml

1.73

1585

11913

Other and unspecified injuries of head

125

1106

1.14

0.69

3.4

23.30

72.22

u/ml

6.54

117

1067

Injury of muscle and tendon at shoulder and upper arm level

488

5183

0.94

0.69

3.1

3.8

69.24

62.93

u/ml

0.08

468

4992

Other condition

265

2440

1.09

0.69

2.3

3.1

70.99

52.63

u/ml

0.24

250

2355

Atopic dermatitis, strict definition with reimbursement

747

7566

0.95

0.69

2.6

2.8

28.39

39.26

u/ml

3.08

721

7299

Diabetic maculopathy, excluding more controls

129

1452

0.89

0.69

2.1

3.3

132.74

67.17

u/ml

0.28

122

1402

Vitreous haemorrhage

164

1476

1.12

0.68

3.2

3.7

52.29

70.23

u/ml

0.43

155

1419

Chondropathies

311

2884

1.08

0.68

2.3

3.2

31.96

50.86

u/ml

1.55

304

2781

Haemorrhage in early pregnancy

1093

10231

1.04

0.68

2.5

3.1

33.50

44.15

u/ml

1.51

1060

9913

Benign neoplasm of mouth and pharynx

206

1877

1.10

0.68

3.0

3.6

36.68

63.43

u/ml

1.10

200

1810

Panniculitis, unspecified

188

1.35

0.68

2.2

2.7

150.28

54.41

u/ml

0.49

181

Eating disorders

262

2411

1.09

0.68

1.8

2.4

24.96

36.56

u/ml

1.72

254

2328

Other disorders of amniotic fluid and membranes

430

4466

0.94

0.67

2.1

2.5

26.73

35.80

u/ml

1.33

420

4329

Other disorders of choroid

188

1.35

0.67

2.4

3.0

59.84

70.19

u/ml

0.09

181

Psoriatic and enteropathic arthropathies

217

2371

0.91

0.67

2.5

3.7

29.41

53.99

u/ml

2.04

212

2284

Central nervous system disorder causing precocious puberty

1.83

0.67

1.2

1.4

25.00

21.54

u/ml

—

Foreign body in ear

305

0.75

0.67

2.2

2.7

16.46

49.40

u/ml

1.53

294

Iron deficiency

615

1.18

0.66

1.8

2.1

24.13

39.20

u/ml

1.14

597

Orthopaedic devices associated with adverse incidents

282

0.74

0.66

2.0

3.8

25.19

75.63

u/ml

1.88

272

Pigmented purpuric dermatosis

154

1.39

0.66

6.2

2.6

27.33

49.71

u/ml

0.67

148

Primary hyperparathyroidism

287

2660

1.08

0.66

2.5

4.1

88.81

64.91

u/ml

0.21

277

2559

Non-selective monoamine reuptake inhibitors

936

9402

0.96

0.66

3.0

3.7

97.46

57.38

u/ml

0.59

898

9104

Benign neoplasm of brain and other parts of central nervous system

124

1102

1.13

0.66

2.3

3.5

34.13

55.61

u/ml

1.12

119

1060

Neuromuscular dysfunction of bladder

151

1358

1.12

0.65

2.5

3.4

34.53

58.60

u/ml

2.20

144

1315

Disorders of tooth development and eruption

363

3142

0.93

0.65

2.9

3.2

29.04

62.97

u/ml

2.87

345

3055

Ulcerative enterocolitis

478

1.20

0.64

1.8

2.6

21.39

46.17

u/ml

2.04

460

Bitten or struck by other mammals

264

2441

1.09

0.64

2.6

2.9

24.28

43.02

u/ml

4.42

249

2359

Disorders of vestibular function (Vertigo)

1225

11623

1.04

0.64

3.2

3.6

55.29

60.24

u/ml

0.15

1191

11202

Other symptoms and signs involving general sensations and perceptions

635

1.17

0.64

2.1

3.5

39.48

79.29

u/ml

1.37

616

Embedded and impacted teeth

563

4401

1.06

0.64

2.0

2.3

28.53

34.99

u/ml

1.06

543

4246

Tooth eruption problems

287

2595

1.08

0.64

2.2

2.3

36.30

32.30

u/ml

0.26

275

2497

Vascular dementia (subcortical)

337

0.77

0.64

1.2

3.1

185.06

97.42

u/ml

0.23

328

Nail disorders

161

1455

1.11

0.64

2.4

3.5

50.40

49.40

u/ml

0.02

154

1408

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

270

1.28

0.64

5.4

2.8

21.96

45.63

u/ml

1.55

260

Persistent delusional disorders

115

1295

0.88

0.64

2.5

3.3

80.18

61.21

u/ml

0.20

108

1248

Supervision of normal pregnancy

718

4299

0.95

0.63

2.2

2.6

23.02

35.74

u/ml

5.28

701

4175

Eating disorder

227

2084

1.09

0.63

1.6

2.2

20.94

31.87

u/ml

3.15

220

2008

Striae atrophicae

235

1.30

0.63

2.2

2.3

21.18

41.68

u/ml

1.05

226

Periapical abscess

988

9497

1.04

0.63

3.1

3.4

49.96

50.12

u/ml

0.01

947

9177

Burn and corrosion of wrist and hand

488

1.20

0.63

2.7

2.3

53.25

39.22

u/ml

0.18

470

Other autoimmune haemolytic anaemias

173

1.35

0.63

2.9

19.53

58.86

u/ml

1.04

167

Other/unspecified rheumatoid arthritis

247

2672

0.92

0.62

2.7

3.8

30.85

69.46

u/ml

5.48

238

2568

Gonarthrosis

1547

9098

0.97

0.62

3.0

3.6

37.84

57.13

u/ml

2.73

1481

8810

Other and unspecified haemorrhagic conditions

271

1.27

0.62

4.3

2.6

33.24

48.79

u/ml

0.47

257

Accidents

2452

11968

1.03

0.62

3.0

3.3

38.37

52.95

u/ml

2.52

2368

11609

Other disorders of skin and subcutaneous tissue, not elsewhere classified

280

2599

1.08

0.62

3.1

3.7

63.53

64.69

u/ml

0.02

265

2502

Glomerular disorders in diseases classified elsewhere

149

1343

1.11

0.62

2.2

3.3

41.98

59.68

u/ml

1.27

141

1294

Seronegative rheumatoid arthritis

268

2888

0.92

0.62

3.4

4.0

48.55

74.14

u/ml

1.00

254

2775

Status epilepticus

480

1.19

0.62

1.7

3.4

43.48

79.01

u/ml

1.20

468

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

139

0.64

0.62

6.8

2.9

31.82

33.57

u/ml

—

133

Profound mental retardation

0.00

0.62

0.0

4.6

—

35.16

—

Hypotony of eye

0.00

0.62

0.0

3.5

—

54.20

—

Yaws

0.00

0.62

0.0

2.4

—

19.63

—

Benign neoplasm: Short bones of upper limb

289

0.75

0.61

2.5

2.3

21.02

40.84

u/ml

1.24

275

Scleritis and episcleritis

142

1279

1.12

0.61

1.7

3.1

21.40

48.14

u/ml

3.82

135

1234

Traumatic secondary and recurrent haemorrhage

0.00

0.61

0.0

4.2

—

109.16

—

Melanoma in situ of lower limb, including hip

157

1.37

0.61

3.9

3.0

18.48

39.52

u/ml

1.35

150

Superficial injury of hip and thigh

261

2416

1.08

0.61

2.9

3.4

38.05

73.82

u/ml

3.82

244

2324

Other diseases of hard tissues of teeth

1469

7351

1.03

0.61

3.2

3.6

49.94

66.63

u/ml

1.25

1394

7147

Calcific tendinitis

163

0.66

0.61

1.7

2.6

28.69

49.74

u/ml

0.49

158

Dengue fever [classical dengue]

0.00

0.61

0.0

1.8

—

70.47

—

Injuries to the elbow and forearm

1906

16290

1.03

0.61

3.4

3.3

47.36

52.78

u/ml

0.47

1838

15716

Other disorders of nervous system

115

1023

1.13

0.61

2.7

3.7

51.29

65.21

u/ml

0.36

110

988

Injuries to the hip and thigh

945

8223

1.04

0.61

2.7

3.6

58.93

65.29

u/ml

0.34

902

7919

Traumatic amputation of ankle and foot

0.00

0.61

0.0

2.3

—

69.64

—

Pedal cyclist injured in collision with motor vehicle

466

0.81

0.61

2.0

2.5

42.24

44.45

u/ml

0.03

449

Ulcerative colitis, NAS

267

2477

1.08

0.60

2.2

3.1

58.94

49.83

u/ml

0.19

258

2388

Childhood asthma (age<16), excluding more controls

256

1865

1.08

0.60

1.7

2.1

24.87

29.66

u/ml

0.73

244

1798

Haemangioma, any site

186

1700

1.10

0.60

2.1

3.3

253.28

49.14

u/ml

0.62

180

1640

Lichen ruber planus, wide definition including periferal and oral lichen planus

549

5216

1.06

0.60

2.9

3.8

41.47

61.60

u/ml

1.44

523

5023

Other acquired deformities of musculoskeletal system and connective tissue

677

1.16

0.60

2.5

3.1

208.17

60.37

u/ml

0.43

651

Preparatory care for dialysis

436

1.20

0.59

3.9

3.4

39.92

61.19

u/ml

0.80

416

Single delivery by caesarean section

648

3898

0.95

0.59

2.2

2.8

24.54

37.59

u/ml

4.23

627

3788

Pre-eclampsia

688

7192

0.95

0.59

3.0

3.1

40.91

40.10

u/ml

0.04

665

6941

Other strabismus

503

4752

1.06

0.59

2.5

3.1

47.40

44.98

u/ml

0.11

488

4585

Polymyalgia rheumatica

249

2307

1.08

0.59

3.4

4.2

62.48

85.17

u/ml

0.61

241

2211

Childhood asthma (age<16)

256

1869

1.08

0.59

1.7

2.0

24.87

29.90

u/ml

0.78

244

1802

Schizoaffective disorder

126

1402

0.89

0.59

2.2

2.9

31.32

46.20

u/ml

0.84

111

1358

Heart failure and bmi 25plus

500

3562

0.95

0.58

3.0

3.9

97.22

69.35

u/ml

0.47

477

3406

Diseases of pulp and periapical tissues and dental caries

1737

8641

1.03

0.58

3.3

3.6

55.07

63.36

u/ml

0.37

1651

8395

519

4289

1.06

0.58

3.6

4.0

110.49

86.55

u/ml

0.37

493

4111

Olecranon bursitis

382

1.21

0.58

2.3

3.5

35.43

61.43

u/ml

0.80

367

Other Crohn's disease

128

1151

1.12

0.58

2.0

2.9

32.76

45.76

u/ml

0.85

122

1111

Other puerperal infections

244

2264

1.08

0.58

1.9

2.3

48.17

33.79

u/ml

0.44

234

2186

Carcinoma in situ of skin of trunk

328

1.23

0.58

3.1

4.0

31.00

70.80

u/ml

1.29

316

Amputation of thigh

230

0.73

0.57

1.4

2.9

34.99

64.45

u/ml

1.21

222

Respiratory insufficiency

109

968

1.13

0.57

3.1

3.8

50.00

62.87

u/ml

0.48

102

928

Other fall from one level to another

299

3198

0.93

0.57

2.4

3.0

34.36

51.13

u/ml

1.71

289

3087

Bronchiectasis

126

1399

0.90

0.57

2.6

4.0

55.79

82.54

u/ml

0.81

120

1345

Other and unspecified visual disturbances

223

2062

1.09

0.57

3.5

3.4

54.84

59.67

u/ml

0.07

217

1987

Pneumonias (Asthma/COPD co-morbidities)

2677

17564

1.02

0.57

3.7

3.1

56.89

49.12

u/ml

0.63

2587

16962

Crohn disease (strict definition, require KELA, min 2 HDR)

118

1058

1.12

0.56

2.1

2.8

65.10

44.30

u/ml

0.42

111

1022

Ganglion

556

5835

0.95

0.56

2.5

3.3

40.36

49.86

u/ml

0.58

534

5647

Myopia

286

2671

1.07

0.56

2.5

2.8

135.93

41.26

u/ml

0.44

278

2587

Other degenerative diseases of the basal ganglia

183

0.70

0.56

1.6

3.1

176.15

70.66

u/ml

0.32

176

Benign paroxysmal vertigo

759

7285

1.04

0.56

3.2

3.6

57.75

66.57

u/ml

0.18

732

7004

Increased muscle tone

116

1.40

0.56

4.6

2.3

33.19

42.69

u/ml

0.19

110

Other enthesopathies

828

7962

1.04

0.55

3.1

3.6

50.83

52.52

u/ml

0.04

791

7698

Ptosis of eyelid

225

2084

1.08

0.55

3.5

4.0

34.53

71.51

u/ml

4.65

218

2002

Other bacterial agents as the cause of diseases classified to other chapters

186

1.31

0.55

1.8

3.0

71.68

35.70

u/ml

0.58

179

Other superficial mycoses

321

1.23

0.55

2.8

2.5

38.18

39.53

u/ml

0.03

309

Intracranial injury

1191

11633

0.97

0.55

2.7

3.3

41.82

57.42

u/ml

1.79

1143

11209

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

185

1426

0.92

0.55

3.2

4.8

42.01

67.98

u/ml

1.55

180

1397

Statin medication

1932

11148

0.97

0.55

2.7

3.3

44.76

50.92

u/ml

0.52

1859

10803

Other sexually transmitted chlamydial diseases

125

1127

1.11

0.55

1.7

2.1

30.30

30.61

u/ml

0.01

120

1094

Other predominantly sexually transmitted diseases, not elsewhere classified

452

4290

1.06

0.54

2.0

2.8

28.64

39.60

u/ml

1.80

436

4151

Ventricular septal defect, a heart condition

285

1.23

0.53

2.3

2.5

22.08

31.43

u/ml

0.81

272

Anterior Iridocyclitis

421

3989

1.06

0.53

3.2

3.5

32.88

54.92

u/ml

4.19

401

3846

Contusion of other and unspecified parts of foot

864

1.13

0.53

2.0

2.4

31.56

39.56

u/ml

0.35

833

Episcleritis

122

1102

1.11

0.53

1.7

3.1

18.82

49.09

u/ml

4.36

115

1067

Corns and callosities

130

1178

1.11

0.53

4.3

3.5

46.76

65.08

u/ml

0.63

120

1139

Preterm labour and delivery

899

9312

0.96

0.53

2.9

3.3

46.41

45.17

u/ml

0.05

864

9021

Fall on same level involving ice and snow

1443

14024

1.03

0.53

3.2

3.4

53.42

55.15

u/ml

0.10

1391

13518

Familial benign pemphigus (Hailey-Hailey disease)

1.54

0.53

4.7

3.7

20.50

73.14

u/ml

—

Striking against or struck by other objects

534

5087

1.05

0.52

2.8

3.0

53.77

45.00

u/ml

0.14

508

4908

Pre-eclampsia or poor fetal growth

1080

11114

0.97

0.52

2.7

2.9

35.12

40.54

u/ml

0.46

1050

10749

Disorders of ocular muscles, binocular movement, accommodation and refraction

1187

11402

1.03

0.52

2.8

3.1

66.06

45.78

u/ml

0.37

1145

11006

Use of teriflunomide

225

0.74

0.52

1.6

2.1

15.21

38.15

u/ml

1.39

214

Other diseases of spinal cord

434

1.18

0.52

3.1

2.7

32.98

62.83

u/ml

1.11

419

Crowding of teeth, including avohilmo

161

1218

1.10

0.52

1.8

2.2

27.00

34.02

u/ml

0.80

153

1166

Elevated blood glucose level

136

1236

1.10

0.52

2.4

3.2

25.81

59.86

u/ml

3.19

130

1194

Non-rheumatic valve diseases

879

6579

0.96

0.52

3.1

4.1

44.31

64.86

u/ml

2.05

831

6360

Postpartum haemorrhage due to retained placenta

412

3908

1.06

0.52

2.2

2.4

28.94

30.31

u/ml

0.17

398

3782

Other sexually transmitted chlamydial diseases

187

1725

1.09

0.52

1.6

2.0

27.39

29.73

u/ml

0.14

177

1669

Poisoning by medicine, drug-induced

236

0.75

0.52

5.8

2.6

29.38

36.68

u/ml

0.24

227

Personal history of medical treatment

168

0.71

0.51

2.7

2.9

83.25

50.24

u/ml

0.31

162

Dissection of aorta

259

0.77

0.51

1.8

3.4

43.32

62.63

u/ml

0.32

251

Cerebrovascular diseases (FINNGEN)

759

5160

1.04

0.51

2.8

3.2

93.18

41.88

u/ml

0.69

728

5000

Crohn disease (strict definition, require KELA)

118

1066

1.11

0.51

2.1

2.8

65.10

45.35

u/ml

0.39

111

1030

Contracture of muscle

1.46

0.51

5.8

2.0

40.25

53.73

u/ml

0.20

Other bursopathies

269

2519

1.07

0.51

3.1

3.9

37.56

63.01

u/ml

2.36

261

2430

Toxic effect of ethanol

491

1.17

0.50

1.7

2.3

38.01

40.68

u/ml

0.05

469

Insulin, intermediate and long-acting

908

9135

0.96

0.50

2.7

3.4

68.01

58.64

u/ml

0.25

867

8798

Substance use, excluding alcohol

352

3325

1.06

0.50

2.9

3.2

34.00

46.40

u/ml

1.09

341

3207

Otitis externa, unspecified

220

2047

1.08

0.50

2.6

3.0

68.90

43.88

u/ml

0.50

207

1971

Graves disease, strict definition

284

2668

1.07

0.50

3.2

52.61

47.06

u/ml

0.14

273

2582

Unspecified threat to breathing

178

0.72

0.50

2.2

2.3

46.92

48.43

u/ml

0.02

171

Ankylosing spondylitis

147

1345

1.10

0.50

2.8

3.3

52.40

52.89

u/ml

0.01

141

1303

Ulcerative colitis

491

4683

1.05

0.49

2.2

3.2

50.54

47.81

u/ml

0.09

478

4521

Unspecified parasitic disease

106

0.65

0.49

2.3

2.2

147.29

35.42

u/ml

—

101

Memory loss

136

1489

0.91

0.49

3.2

3.8

68.70

82.81

u/ml

0.23

125

1424

Asymmetry of jaw

278

0.78

0.49

1.7

2.2

25.40

37.39

u/ml

0.50

266

Keratitis

743

7715

0.96

0.49

2.4

3.3

47.48

55.06

u/ml

0.18

712

7447

Cleft lip, lip and palate or palate

267

0.78

0.49

5.8

2.0

43.07

37.84

u/ml

0.09

252

Donors of organs and tissues

217

1.26

0.49

3.8

2.2

66.09

34.27

u/ml

0.26

212

Horner syndrome

211

0.75

0.48

6.2

2.9

25.63

45.87

u/ml

0.65

202

Gingival hyperplasia

475

1.16

0.48

2.3

3.0

26.38

47.54

u/ml

0.90

456

Spinal enthesopathy

280

1.22

0.48

1.7

2.6

268.03

98.49

u/ml

0.52

270

Congenital malformations of great arteries

229

0.77

0.48

3.8

2.4

29.41

35.18

u/ml

0.19

218

Insulin, fast-acting or short human

582

6067

0.96

0.48

2.6

3.3

70.98

56.65

u/ml

0.27

561

5836

Poisoning by drugs, medicaments and biological substances

494

5171

0.95

0.48

2.6

3.0

38.56

42.60

u/ml

0.27

472

5005

Bronchitis, not specified as acute or chronic

140

1281

1.10

0.48

3.0

3.3

75.87

66.83

u/ml

0.11

130

1241

Retinal vascular occlusion

181

1675

1.08

0.48

3.0

4.0

43.16

90.49

u/ml

2.60

169

1601

Other predominantly sexually transmitted diseases, not elsewhere classified

529

5062

1.05

0.48

1.9

2.7

30.20

38.07

u/ml

0.98

510

4899

Congenital malformations of the respiratory system

263

1.23

0.48

4.2

2.8

19.79

52.17

u/ml

1.61

253

Other disorders of pigmentation

853

1.12

0.47

3.3

3.5

25.18

54.12

u/ml

2.90

824

Complications specific to multiple gestation

120

0.65

0.47

1.3

2.2

35.13

52.84

u/ml

—

114

Contracture of joint

191

1.27

0.47

2.5

2.7

52.21

38.87

u/ml

0.15

184

Eccrine sweat disorders

1.46

0.47

1.3

2.5

14.01

22.63

u/ml

—

Anomalies of dental arch relationship, including avohilmo

439

3770

1.05

0.47

2.2

3.1

35.28

42.62

u/ml

0.35

417

3645

Diseases of inner ear

1357

12771

1.03

0.47

3.3

3.6

58.90

58.67

u/ml

0.01

1316

12311

Calcific tendinitis of shoulder

148

1361

1.09

0.47

2.6

3.7

26.83

42.33

u/ml

1.67

141

1318

Respiratory tuberculosis, bacteriologically and histologically confirmed

191

1.26

0.47

2.7

142.73

50.22

u/ml

0.44

183

Pre-eclampsia or eclampsia

754

7812

0.96

0.46

3.0

3.1

41.18

44.76

u/ml

0.18

730

7541

Other external causes of accidental injury

2440

11968

1.02

0.46

3.0

3.3

37.68

52.95

u/ml

2.72

2358

11609

Foreign body in genitourinary tract

210

1.26

0.46

2.0

2.7

29.12

43.81

u/ml

0.40

203

Other deformity of hallux (acquired)

174

1.29

0.46

3.1

3.4

17.24

78.06

u/ml

1.67

168

Other disorders of electrolyte and fluid balance, not elsewhere classified

147

1.31

0.46

6.9

3.3

109.74

69.73

u/ml

0.31

141

Type 2 diabetes, wide definition

1931

12076

1.02

0.46

3.3

3.7

69.19

54.55

u/ml

0.89

1850

11677

Coeliac disease

268

2521

1.07

0.46

3.6

3.3

47.47

51.83

u/ml

0.11

261

2433

severe traumatic brain injury, does not include concussion

245

2612

0.94

0.46

3.2

3.6

49.06

74.40

u/ml

1.40

231

2507

Iridocyclitis

476

4549

1.05

0.46

3.1

3.5

33.46

55.15

u/ml

4.68

453

4389

Valvular heart disease excluding rheumatic fever

884

6598

0.97

0.46

3.1

4.0

44.58

64.76

u/ml

2.00

836

6377

Poisoning by medicine

446

4672

0.95

0.45

2.7

2.9

31.99

40.52

u/ml

0.92

426

4521

Cerebral palsy and other paralytic syndromes

203

1892

1.08

0.45

3.1

35.58

54.32

u/ml

1.38

197

1822

Vasomotor and allergic rhinitis

962

9740

0.97

0.45

2.7

3.2

48.96

48.83

u/ml

0.00

929

9409

Typhoid and paratyphoid fevers

121

1.34

0.45

3.0

2.8

83.06

61.40

u/ml

0.18

115

Other arterial embolism and thrombosis

283

1.21

0.45

2.4

3.4

50.45

67.38

u/ml

0.34

272

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

264

2487

1.07

0.45

3.1

2.6

26.59

31.77

u/ml

0.47

255

2416

Postdysenteric arthropathy

152

0.71

0.45

4.0

2.4

39.55

56.02

u/ml

0.32

144

Abrasion of teeth

937

9081

1.03

0.45

3.1

3.4

36.12

50.36

u/ml

1.32

899

8783

Vocal cord dysfunction

377

3216

1.05

0.45

2.5

3.8

33.42

44.66

u/ml

1.15

362

3130

Habit and impulse disorders

197

0.76

0.44

2.3

2.2

22.42

35.44

u/ml

0.69

188

Degeneration of macula and posterior pole

893

7338

0.97

0.44

3.6

4.1

88.06

72.35

u/ml

0.39

853

7052

Idiopathic pulmonary fibrosis

768

0.88

0.44

3.5

3.6

89.42

79.66

u/ml

0.09

741

Bacterial pneumoniae

727

6641

0.96

0.44

3.3

3.4

40.88

60.88

u/ml

2.45

701

6389

Other diseases of lip and oral mucosa

1026

9960

1.03

0.44

2.9

3.5

35.73

56.29

u/ml

3.14

984

9630

Benign neoplasm: Oesophagus

184

1.26

0.44

5.8

2.9

21.15

36.09

u/ml

1.11

178

Pregnancy hypertension

1559

14296

0.97

0.44

2.8

3.1

36.53

44.70

u/ml

1.02

1506

13832

Fracture of lumbar spine and pelvis

374

3923

0.95

0.44

3.2

3.6

55.22

75.97

u/ml

0.44

357

3752

Pregnancy with abortive outcome

2753

14100

1.02

0.44

3.0

3.3

45.05

54.15

u/ml

1.05

2657

13633

Disorders of adult personality and behaviour

632

6563

0.96

0.44

2.3

2.8

75.11

38.99

u/ml

0.35

605

6337

Spontaneous abortion

1792

12350

0.98

0.44

2.9

3.3

36.31

48.16

u/ml

1.63

1725

11960

Pneumonia, organism unspecified

2340

16076

1.02

0.43

3.7

3.2

54.96

50.21

u/ml

0.48

2263

15518

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

126

1155

1.09

0.43

2.1

2.8

62.25

44.61

u/ml

0.37

118

1116

Other specified/unspecified disorders of bone/cartilage

368

1.18

0.43

1.6

2.7

40.10

54.71

u/ml

0.32

354

Secondary polycythaemia

248

1.22

0.43

2.5

2.7

22.20

47.64

u/ml

1.26

236

Contusion of toe(s) without damage to nail

462

1.16

0.43

1.6

2.3

87.72

39.91

u/ml

0.30

445

Focal brain injury

678

1.12

0.43

3.2

3.7

56.82

77.64

u/ml

0.35

660

Other abnormal products of conception

1279

8246

1.03

0.43

2.5

2.7

33.44

34.69

u/ml

0.09

1240

7998

Anetoderma (of Jadassohn-Pellizzari/Pasini and pierini)

0.00

0.43

0.0

2.3

—

93.93

—

Agoraphobia

594

1.13

0.43

1.9

2.1

33.55

37.48

u/ml

0.10

572

Other and unspecified disorders of vitreous body

1079

10345

1.03

0.42

3.4

3.9

41.88

61.26

u/ml

2.52

1052

9977

Disease of hard tissues of teeth, NOS

1426

7272

1.03

0.42

2.8

3.7

35.51

66.08

u/ml

4.41

1363

7076

Disorders in reading

173

0.75

0.42

1.4

2.1

19.69

28.11

u/ml

0.76

164

Exclusion endpoint for supernumerary teeth

176

1.26

0.42

4.5

2.2

24.59

43.26

u/ml

0.66

169

Gingivitis and periodontal diseases

2755

13956

1.02

0.42

2.9

3.3

45.71

55.68

u/ml

1.00

2641

13502

Inflammatory diseases of the central nervous system

152

1407

1.08

0.42

2.7

3.2

36.03

49.29

u/ml

0.86

147

1360

Acute epiglottitis

206

0.77

0.42

2.4

2.6

22.00

39.02

u/ml

0.71

198

All pneumoniae

2688

17637

1.02

0.42

3.8

3.1

56.89

48.99

u/ml

0.65

2599

17032

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2589

17330

1.02

0.42

3.8

3.1

52.96

50.24

u/ml

0.26

2503

16733

Need for immunization against other single viral diseases

231

1.22

0.41

2.5

2.9

20.77

41.94

u/ml

1.16

222

Toxic effect of alcohol

228

0.78

0.41

1.7

2.4

17.07

44.72

u/ml

1.46

215

Intentional self-harm by jumping or lying before moving object

0.00

0.41

0.0

1.4

—

35.81

—

Other eating disorders

118

1081

1.10

0.41

1.7

2.3

22.80

34.81

u/ml

1.65

113

1045

Spondylolisthesis/Spondylolysis

457

4379

1.05

0.41

2.9

3.9

32.49

66.36

u/ml

3.34

433

4218

Lymphangioma, anys site

123

1.32

0.41

2.5

2.6

21.06

37.30

u/ml

0.75

118

Sequelae of poisoning by drugs, medicaments and biological substances

0.00

0.41

0.0

4.9

—

31.82

—

Other (seronegative) rheumatoid arthritis, wide

423

4420

0.95

0.41

3.3

3.7

47.91

70.47

u/ml

1.33

406

4253

Congenital malformations of the respiratory system

296

1.19

0.41

3.9

2.8

19.09

57.41

u/ml

2.12

284

Choroidal haemorrhage and rupture

1.49

0.41

1.4

2.1

32.28

80.51

u/ml

—

Other diseases of arteries and capillaries

156

1449

1.08

0.40

3.2

3.6

43.11

64.37

u/ml

1.24

150

1397

Dislocation, sprain and strain of joints and ligaments of elbow

108

1179

0.91

0.40

3.3

2.9

24.40

48.01

u/ml

2.96

102

1140

Benign neoplasm: Lip

297

1.19

0.40

3.5

3.4

14.46

66.13

u/ml

2.41

283

Viral pneumonia

203

1905

1.07

0.39

3.9

3.3

37.42

61.47

u/ml

1.87

192

1836

Retinal breaks without detachment

331

3152

1.05

0.39

2.9

3.8

45.15

54.58

u/ml

0.30

316

3030

Lesion of plantar nerve

142

1530

0.92

0.39

3.8

4.0

36.55

60.77

u/ml

1.23

133

1475

Tarsal tunnel syndrome

224

1.22

0.39

1.4

3.0

32.83

58.16

u/ml

0.56

218

Disorders of lens

1450

9263

0.98

0.39

3.5

3.8

45.79

58.50

u/ml

1.17

1403

8953

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

302

0.82

0.39

3.6

2.4

24.80

44.83

u/ml

1.12

290

Diseases of oral cavity, salivary glands and jaws

1466

7363

1.02

0.39

3.3

3.6

57.21

66.59

u/ml

0.36

1393

7158

COPD-related respiratory insufficiency

130

1200

1.09

0.39

2.1

3.7

57.55

73.66

u/ml

0.51

123

1157

Exophthalmic conditions

215

1.22

0.39

3.5

2.6

78.82

69.21

u/ml

0.08

209

Sequelae of injuries of lower limb

174

1626

1.07

0.39

2.5

3.2

36.99

49.05

u/ml

0.56

166

1567

Diabetes medication

2795

16847

0.98

0.39

2.8

3.3

58.70

48.60

u/ml

0.83

2672

16305

Meniscus derangement

1270

8767

0.97

0.39

3.1

3.7

53.50

58.54

u/ml

0.17

1224

8486

Deep bite

181

1695

0.93

0.39

2.1

2.9

48.45

47.88

u/ml

0.01

167

1642

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

904

1.10

0.39

2.2

3.2

337.77

40.37

u/ml

0.48

876

Other disorders of ear

2284

15226

0.98

0.39

3.1

3.4

59.57

51.42

u/ml

0.40

2199

14710

Other extrapyramidal and movement disorders in other diseases

508

4888

1.04

0.39

2.6

3.7

47.65

68.94

u/ml

0.88

477

4710

Strabismus

585

5630

1.04

0.38

2.6

3.2

46.18

47.91

u/ml

0.08

563

5431

Congenital hypothyroidism without goiter

114

0.69

0.38

1.8

3.0

11.41

41.19

u/ml

—

108

Maternal care for known or suspected disproportion

158

1475

1.08

0.38

2.6

2.4

27.18

34.37

u/ml

0.89

152

1429

Complications predominantly related to the puerperium

902

9275

0.97

0.38

2.7

3.1

35.07

43.93

u/ml

0.81

873

8986

Erosion of teeth , including avohilmo

564

5440

1.04

0.38

2.6

2.9

34.66

42.16

u/ml

0.41

540

5249

243

1.20

0.38

1.6

1.9

19.85

40.54

u/ml

1.12

234

Atopic dermatitis, strict definition

718

7256

0.97

0.38

2.6

2.7

27.91

38.13

u/ml

2.78

694

7000

Chronic periodontitis, including avohilmo

2417

16476

0.98

0.38

3.1

3.3

39.26

53.65

u/ml

2.79

2317

15932

Protein-energy malnutrition of moderate and mild degree

125

1.29

0.37

1.6

2.7

25.25

45.15

u/ml

0.99

120

Eosinophilia

235

0.80

0.37

1.7

2.7

18.63

39.96

u/ml

1.22

224

Other and unspecified injuries of lower leg

154

1436

1.08

0.37

2.9

23.65

49.60

u/ml

4.11

149

1381

Biological medicines for asthma

343

0.84

0.37

1.3

2.6

16.31

38.84

u/ml

2.21

333

Metatarsalgia

260

2467

1.06

0.37

3.1

3.7

86.92

52.96

u/ml

0.30

242

2388

Bacterial pneumonia, not elsewhere classified

687

6246

0.97

0.37

3.3

3.4

41.87

62.60

u/ml

2.37

662

6009

Continuous positive airway pressure

349

2807

1.05

0.37

3.3

4.2

35.39

48.73

u/ml

1.58

333

2728

Other blood glucose lowering drugs, excl. Insulins

256

2699

0.95

0.37

2.7

4.2

74.64

73.18

u/ml

0.03

248

2593

Other disorders of breast and lactation associated with childbirth

449

0.86

0.37

1.4

2.1

26.89

37.57

u/ml

0.62

429

Glaucoma secondary to eye inflammation

135

0.73

0.37

3.6

3.0

19.40

37.01

u/ml

—

130

Sleep apnoea, including avohilmo

2553

16071

0.98

0.37

2.6

3.4

36.57

51.53

u/ml

2.91

2447

15545

Spinal osteochondrosis

135

0.73

0.37

2.0

2.4

208.50

58.25

u/ml

—

128

Maternal care related to the fetus and amniotic cavity and possible delivery problems

1675

10029

0.98

0.37

2.5

3.1

28.58

39.78

u/ml

3.45

1626

9717

Actinic keratosis

684

6132

1.03

0.36

3.6

4.0

95.83

79.54

u/ml

0.29

656

5880

Meningitis, viral

1.34

0.36

3.2

2.4

19.77

61.13

u/ml

0.96

Viral pneumonia (unknown virus, not influenza)

907

1.09

0.36

2.9

29.38

57.43

u/ml

2.34

874

Non-allergic asthma

141

1513

0.93

0.36

2.6

3.5

19.88

64.75

u/ml

6.80

134

1455

Other specified/unspecified dorsopathies

669

1.11

0.36

2.1

3.8

40.89

54.83

u/ml

0.34

648

Sequelae of injuries of upper limb

148

1586

0.93

0.36

2.4

3.4

30.28

51.68

u/ml

1.84

140

1530

Cardiodefibrillation

456

4375

1.04

0.36

3.0

4.0

101.32

82.03

u/ml

0.25

440

4191

Lyme disease

721

6994

1.03

0.36

3.1

3.6

59.83

54.98

u/ml

0.10

693

6750

Discitis, unspecified

171

1.24

0.36

2.5

3.0

37.52

78.14

u/ml

0.68

165

Personality disorders

603

6233

0.97

0.36

2.4

2.9

78.22

39.46

u/ml

0.36

578

6026

Hypermetropia

127

1177

1.08

0.36

3.4

3.2

64.15

56.12

u/ml

0.10

122

1136

Gonarthrosis,primary

2112

13241

0.98

0.36

3.0

3.6

49.09

57.58

u/ml

0.54

2029

12792

Azathioprine

305

2910

1.05

0.35

2.0

3.4

38.94

47.51

u/ml

0.67

289

2811

ILD medications: azathioprine

305

2910

1.05

0.35

2.0

3.5

38.94

46.73

u/ml

0.59

289

2810

Heart failure,strict

909

6239

1.03

0.35

3.2

4.1

95.67

70.54

u/ml

0.79

877

5996

Cerebral atherosclerosis

125

0.71

0.35

1.3

2.6

34.88

39.53

u/ml

—

119

Other disorders of conjunctiva

270

2569

1.05

0.35

2.7

3.8

52.92

65.38

u/ml

0.35

255

2466

Excessive attrition of teeth

1456

14261

1.02

0.35

2.6

3.1

33.20

46.15

u/ml

2.31

1392

13789

Caries of dentine, including avohilmo

2087

10470

1.02

0.35

3.1

3.5

58.11

58.71

u/ml

0.02

1978

10171

Periodontitis

2427

16490

0.98

0.35

3.1

3.3

39.45

53.58

u/ml

2.72

2328

15946

Decubitus ulcer and pressure area

680

1.11

0.35

3.3

3.5

95.28

81.85

u/ml

0.17

659

Injury of nerves at shoulder and upper arm level

163

1.24

0.34

3.4

2.8

34.03

44.86

u/ml

0.22

155

Cysts of oral region, not elsewhere classified

824

1.10

0.34

2.8

3.0

73.05

54.89

u/ml

0.16

795

Wet age-related macular degeneration

264

2690

0.95

0.34

3.5

4.1

83.21

92.31

u/ml

0.15

247

2554

Insulin, fast-acting

579

5980

0.97

0.34

2.6

3.4

71.25

56.69

u/ml

0.27

558

5765

Pleural plaque without asbestos

255

1.18

0.34

3.8

3.7

27.91

71.71

u/ml

1.26

245

Other and unspecified hypertrophic disorders of skin

118

1.29

0.34

2.9

2.5

50.20

59.47

u/ml

0.08

113

Allergic contact dermatitis due to drugs in contact with skin

425

1.14

0.34

3.5

2.8

48.60

50.24

u/ml

0.03

409

Postpartum hemorraghe, parous women as controls

906

7516

1.03

0.34

2.3

2.5

28.74

31.88

u/ml

0.64

877

7264

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1759

15571

0.98

0.34

2.9

3.2

36.67

45.52

u/ml

1.24

1700

15062

Complications of labour and delivery

2482

14016

0.98

0.34

3.2

3.3

46.65

47.01

u/ml

0.02

2402

13556

Other specified and unspecified personality disorders

184

1735

1.06

0.33

2.1

2.8

195.07

43.61

u/ml

0.46

178

1673

Disorders of puberty, other/unspecified

1.32

0.33

2.0

1.8

18.00

65.00

u/ml

—

Chronic lower respiratory diseases

3266

17148

1.01

0.33

2.7

3.2

43.87

50.81

u/ml

0.64

3141

16578

Abnormalities of forces of labour

344

3584

0.96

0.33

2.7

2.9

28.12

33.95

u/ml

0.68

328

3481

Acute appendicitis, with complications

356

3416

1.04

0.33

3.6

3.4

45.74

52.10

u/ml

0.21

348

3289

Other disorders of cornea

168

1784

0.94

0.33

2.1

3.7

27.45

60.10

u/ml

4.05

157

1722

Superficial injury of shoulder and upper arm

197

1863

1.06

0.33

2.6

3.2

48.07

57.20

u/ml

0.23

191

1795

Pre-eclampsia superimposed on chronic hypertension

165

1.23

0.32

1.8

2.0

25.57

38.33

u/ml

0.33

158

Inflammatory disorders of breast

196

1856

1.06

0.32

2.8

2.9

27.26

45.50

u/ml

2.71

189

1789

Carcinoma in situ of vulva

230

1.19

0.32

2.0

2.9

63.78

70.60

u/ml

0.05

220

Unspecified visual impairment (binocular)

241

0.82

0.32

2.9

14.09

69.46

u/ml

1.99

233

Other otitis externa (chronic)

121

1127

1.08

0.32

2.9

3.3

65.61

48.85

u/ml

0.24

112

1088

Spirochaetal infections, other/unspecified

725

7052

1.03

0.32

3.1

3.6

59.62

54.74

u/ml

0.10

697

6804

Disorders of optic nerve and visual pathways

202

1914

1.06

0.32

2.7

3.1

56.01

47.31

u/ml

0.14

196

1845

Peroneal tendinitis

342

1.15

0.32

3.3

2.8

49.76

47.02

u/ml

0.04

332

Respiratory disorders in diseases classified elsewhere

230

0.82

0.32

2.6

2.9

56.84

58.19

u/ml

0.01

222

Other arthritis (FG)

757

7368

1.03

0.32

3.1

3.6

54.95

56.25

u/ml

0.04

727

7122

Vasculitis limited to skin, not elsewhere classified

408

1.13

0.32

3.3

3.4

48.61

59.39

u/ml

0.23

393

Erythema nodosum

647

1.10

0.31

2.1

3.0

54.78

59.37

u/ml

0.06

624

Mandibular retrognathia

129

1202

1.07

0.31

2.4

2.5

26.03

39.43

u/ml

1.21

122

1166

Unspecified fall

1026

10341

0.98

0.31

3.1

3.3

36.48

60.67

u/ml

4.91

987

9961

Autonomic disorders

358

0.86

0.31

4.0

3.0

17.93

58.78

u/ml

2.05

344

Other and unspecified injuries of neck

131

0.76

0.31

1.0

2.4

14.00

45.13

u/ml

—

126

Other and unspecified bullous disorders

184

1.21

0.31

6.9

2.9

39.61

48.83

u/ml

0.15

178

Dyshidrosis [pompholyx]

304

0.85

0.31

2.6

22.95

51.36

u/ml

1.06

288

Burns and corrosions of external body surface, specified by site

154

1449

1.06

0.31

2.3

3.0

41.00

52.11

u/ml

0.36

149

1404

Other specified/unspecified arthritis

659

6407

1.03

0.31

3.1

3.7

58.75

61.11

u/ml

0.07

631

6205

Other and unspecified erythematous conditions

562

1.11

0.30

2.9

3.2

45.86

61.48

u/ml

0.32

542

Open bite that required surgery (Lefort1 or BSSO)

196

0.81

0.30

1.5

2.1

20.26

37.48

u/ml

0.77

187

Primary open-angle glaucoma

580

5776

0.97

0.30

3.4

4.0

82.03

75.40

u/ml

0.09

552

5544

Impacted teeth

376

3220

1.04

0.30

1.8

2.1

23.41

32.37

u/ml

3.23

365

3094

Other spirochaetal diseases

725

7060

1.03

0.30

3.1

3.6

59.64

54.70

u/ml

0.10

697

6814

Localized scleroderma [morphea]

325

1.15

0.30

2.2

3.2

23.56

55.98

u/ml

1.63

316

Shock, not elsewhere classified

102

1.28

0.30

1.3

2.6

89.46

44.57

u/ml

0.28

Mouth breathing

688

6686

1.03

0.30

2.7

3.4

56.04

52.45

u/ml

0.07

662

6442

Pemphigoid

346

0.86

0.30

2.8

3.5

141.97

69.02

u/ml

0.25

333

AV-block

213

1962

0.95

0.30

2.4

4.0

52.68

80.70

u/ml

0.78

202

1883

Dental caries, including avohilmo

1913

9622

1.02

0.30

3.2

3.5

55.23

61.17

u/ml

0.27

1816

9352

Complications of internal orthopaedic prosthetic devices, implants and grafts

434

4194

1.04

0.30

2.6

3.7

66.87

73.13

u/ml

0.16

417

4011

Other abnormal findings in urine

194

1.19

0.30

4.3

3.0

36.39

35.84

u/ml

0.01

187

Postpartum haemorrhage

906

7801

0.98

0.29

2.3

2.7

28.74

35.31

u/ml

1.84

877

7558

Crushed, pushed or stepped on by crowd or human stampede

104

968

1.08

0.29

2.1

2.4

20.72

44.35

u/ml

2.90

931

Other and unspecified vaccines and biological substances

140

0.78

0.29

1.5

2.5

27.04

38.72

u/ml

0.44

134

Toxic effects of substances chiefly nonmedicinal as to source

185

1756

1.06

0.29

2.5

3.0

31.19

50.27

u/ml

1.32

178

1690

Maternal care for cervical incompetence

117

1096

1.07

0.29

3.0

3.3

33.23

52.05

u/ml

1.22

110

1053

Injury of muscle and tendon at wrist and hand level

189

1795

1.05

0.28

3.8

3.2

41.57

47.83

u/ml

0.24

180

1733

Other bursitis, not elsewhere classified

158

1.21

0.28

1.5

2.8

14.27

67.84

u/ml

1.82

150

Chronic periodontitis, complicated

1109

11214

0.98

0.28

3.2

3.7

46.39

58.25

u/ml

1.13

1064

10836

Juvenile cataract

1.26

0.28

1.9

2.6

19.50

41.06

u/ml

—

Unequal limb length (acquired)

116

0.77

0.28

1.9

2.6

28.89

44.13

u/ml

—

109

Urethritis and urethral syndrome

394

1.12

0.27

1.6

3.3

28.02

54.57

u/ml

1.57

382

Thyrotoxicosis with diffuse goitre

422

4086

1.04

0.27

3.1

3.4

49.12

50.28

u/ml

0.04

405

3955

Mental retardation, excluding more controls

466

1.11

0.27

2.4

2.9

37.93

49.77

u/ml

0.33

455

Ankyloglossia

139

0.79

0.27

1.5

2.0

18.88

32.51

u/ml

0.83

133

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

143

1512

0.94

0.27

3.0

3.6

30.36

51.83

u/ml

1.66

138

1457

Atopic dermatitis

1668

13448

1.02

0.27

2.5

3.0

26.79

44.42

u/ml

7.63

1602

12998

Polyarthropathies

1703

10945

1.02

0.27

3.0

3.4

49.38

52.59

u/ml

0.21

1641

10610

Bullous pemphigoid

236

0.84

0.27

2.4

3.5

202.30

81.32

u/ml

0.28

226

Other maltreatment syndromes

347

1.13

0.27

2.4

2.2

71.50

37.66

u/ml

0.35

332

Premature separation of placenta [abruptio placentae]

676

0.91

0.27

2.8

2.6

22.36

40.74

u/ml

1.64

651

Dystonia

125

1177

1.07

0.27

3.0

3.4

66.29

58.28

u/ml

0.09

120

1137

Presbycusis

183

1904

0.95

0.27

3.2

4.1

105.02

89.58

u/ml

0.13

170

1808

Benign neoplasm of eye and adnexa

201

1919

1.05

0.26

2.9

3.6

28.49

63.50

u/ml

4.38

193

1844

Other spirochaetal diseases

733

7160

1.03

0.26

3.1

3.6

59.19

54.82

u/ml

0.09

704

6912

Bacterial pneumonia (organism specified)

772

7162

0.98

0.26

3.3

3.4

56.48

64.26

u/ml

0.18

746

6887

Arteriovenous malformation of cerebral vessels

169

1.19

0.26

4.0

2.8

31.35

36.93

u/ml

0.19

158

Puerperal sepsis

414

4270

0.97

0.26

3.4

3.7

34.96

47.23

u/ml

1.17

403

4125

Other congenital malformations of intestine

169

1.19

0.26

2.2

3.0

45.40

48.33

u/ml

0.03

162

Amputation of ankle bones

171

0.82

0.26

2.1

3.0

21.29

51.24

u/ml

1.18

161

Pollen allergy

405

4127

0.97

0.26

2.3

2.6

30.61

37.67

u/ml

0.62

394

3993

Other enthesopathy of foot (+metatarsalgia)

279

2685

1.04

0.26

3.2

3.6

82.54

51.39

u/ml

0.29

259

2600

Other disorders of optic disc

235

1.16

0.26

3.3

2.5

49.38

43.09

u/ml

0.10

224

Ankylosing spondylitis, ICD10

143

1354

1.06

0.25

2.7

3.0

53.18

46.32

u/ml

0.21

137

1309

Stenosis and insufficiency of lacrimal passages

222

2127

1.05

0.25

3.0

3.9

29.42

67.33

u/ml

6.43

215

2041

Impingement syndrome of shoulder

522

5079

1.03

0.25

3.0

3.9

39.77

55.17

u/ml

0.81

501

4913

Cardiomyopathy, other and unspecified

110

1033

1.07

0.25

3.2

3.6

81.59

61.12

u/ml

0.39

105

998

Other superficial mycoses

192

1833

1.05

0.25

1.8

2.8

24.31

45.46

u/ml

3.52

183

1768

Use of fingolimod

202

0.83

0.25

1.6

2.0

15.08

35.97

u/ml

1.16

192

Short stature, not elsewhere classified

157

1.18

0.25

2.3

2.2

56.30

33.83

u/ml

0.41

152

Early lumbar disc prolapse, operated

194

1854

1.05

0.25

2.1

2.6

44.39

34.00

u/ml

0.42

187

1805

Enteritis due to Yersinia enterocolitica

1.30

0.24

1.3

2.8

65.32

62.10

u/ml

—

Rheumatoid arthritis

830

7600

0.98

0.24

3.1

3.8

52.48

62.17

u/ml

0.52

799

7356

Viral infections of the central nervous system

149

1415

1.06

0.24

2.8

3.2

28.21

50.65

u/ml

2.41

144

1368

Other acute disseminated demyelination

227

1.16

0.24

1.9

2.1

34.12

42.69

u/ml

0.16

215

Respiratory tuberculosis, confirmed

189

1.17

0.24

2.7

154.30

50.68

u/ml

0.46

181

Premature rupture of membranes

791

5540

1.02

0.24

2.1

2.6

26.10

36.73

u/ml

4.28

768

5369

Contact with nonpowered hand tool

318

0.88

0.24

3.1

2.2

20.84

43.84

u/ml

1.35

300

Other forms of systemic lupus erythematosus

218

1.16

0.24

2.0

2.8

44.62

40.54

u/ml

0.08

207

Other and unspecified vasculitis limited to skin

360

1.12

0.24

2.3

2.9

47.97

60.52

u/ml

0.24

347

Accidental poisoning by and exposure to alcohol

201

0.84

0.24

1.5

2.1

22.41

43.80

u/ml

0.95

191

Pacemaker

430

4240

0.97

0.24

2.5

3.8

127.65

85.28

u/ml

0.46

408

4055

Impacted maxillary molar

109

1027

1.06

0.23

1.6

2.0

22.30

30.37

u/ml

1.30

104

992

Glaucoma secondary to drugs

1.33

0.23

1.0

5.3

15.40

75.96

u/ml

—

Other factor of the environment

190

1.17

0.23

4.2

2.6

142.02

42.72

u/ml

0.46

182

Vertical strabismus

553

1.09

0.23

2.4

3.1

64.58

54.19

u/ml

0.10

533

Tularaemia

285

0.87

0.23

1.8

2.7

31.60

51.56

u/ml

0.48

275

Disorders of parathyroid gland

496

5024

0.97

0.22

2.8

3.8

72.48

77.37

u/ml

0.06

471

4818

Primary open-angle glaucoma, strict

478

4893

0.97

0.22

3.4

4.0

81.87

78.92

u/ml

0.03

455

4693

Injury of nerves at lower leg level

146

0.82

0.22

4.1

2.3

37.13

42.22

u/ml

0.06

139

Diseases of arteries, arterioles and capillaries (FINNGEN)

456

3071

1.03

0.22

2.9

3.6

44.25

48.74

u/ml

0.23

445

2972

Oral lichen planus, including avohilmo , including avohilmo

161

1539

1.05

0.22

3.2

3.8

37.20

60.68

u/ml

0.94

152

1487

Sequelae of complication of pregnancy, childbirth and the puerperium

0.00

0.22

0.0

2.6

—

18.82

—

Niacin deficiency [pellagra]

0.00

0.22

0.0

2.8

—

107.65

—

Other accidental hanging and strangulation

0.00

0.22

0.0

2.4

—

139.50

—

Entropion and trichiasis of eyelid

119

1128

1.06

0.22

3.9

50.61

81.61

u/ml

0.80

114

1081

Macular pucker, drug-induced

0.00

0.22

0.0

2.3

—

102.20

—

Unspecified hairloss

0.00

0.21

0.0

3.7

—

16.40

—

Aortic hypoplasia

0.00

0.21

0.0

2.5

—

17.64

—

Amputation of ankle

0.00

0.21

0.0

2.1

—

91.73

—

Intracranial nontraumatic haemorrhage of fetus and newborn

0.00

0.21

0.0

2.4

—

36.40

—

Other and unspecified disorders of refraction

0.00

0.21

0.0

1.6

—

20.00

—

Discharge from other and unspecified firearms

0.00

0.21

0.0

1.8

—

15.34

—

ILD-related respiratory insufficiency

315

1.11

0.21

2.7

3.2

43.56

74.04

u/ml

0.83

301

MS-disease / Multiple Sclerosis

160

1672

0.95

0.21

1.8

2.8

26.17

43.63

u/ml

1.91

154

1618

Glaucoma

1242

10521

1.02

0.21

3.4

3.8

85.48

61.51

u/ml

0.42

1186

10137

Burns and corrosions confined to eye and internal organs

356

0.90

0.21

3.4

2.3

42.33

39.76

u/ml

0.04

342

Compression of brain

0.00

0.21

0.0

5.2

—

17.15

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

267

2584

1.04

0.21

3.1

2.8

34.32

40.21

u/ml

0.26

257

2497

Papulosquamous disorders

856

8715

0.98

0.21

2.9

3.6

33.08

57.54

u/ml

4.55

822

8415

Skin changes due to chronic exposure to nonionizing radiation

709

6408

1.02

0.21

3.5

3.9

93.92

77.54

u/ml

0.31

679

6141

Disorders of puberty

145

1.18

0.20

1.4

2.1

21.76

47.76

u/ml

1.14

140

Other papulosquamous disorders

183

1.16

0.20

4.6

2.7

19.46

34.29

u/ml

1.15

173

Osteolysis

0.00

0.20

0.0

2.1

—

160.57

—

Injury of blood vessels at ankle and foot level

0.00

0.20

0.0

5.4

—

34.89

—

Mental retardation

486

1.09

0.20

2.4

37.93

42.84

u/ml

0.13

466

Benign neoplasm: Pituitary gland, craniopharyngeal duct

888

1.06

0.20

2.9

3.0

348.92

52.49

u/ml

0.44

859

Other disorders of penis

1.25

0.20

1.0

1.6

41.67

136.93

u/ml

—

Simple and mucopurulent chronic bronchitis

500

0.92

0.20

1.9

3.5

20.85

70.99

u/ml

3.61

485

Chronic myeloid leukaemia [CML], BCR/ABL-positive

127

1.19

0.20

1.6

2.9

29.33

69.43

u/ml

0.66

122

Diabetic nephropathy

170

1611

1.04

0.19

2.6

2.8

51.82

65.04

u/ml

0.39

159

1531

Pregnancy, childbirth and the puerperium

1039

5512

0.98

0.19

3.2

3.5

58.37

65.35

u/ml

0.34

997

5316

Open wound of lower leg

248

2562

0.97

0.19

2.6

3.3

39.96

71.03

u/ml

2.71

237

2461

Transient synovitis

122

0.81

0.19

1.5

2.0

16.38

34.32

u/ml

—

117

Excessive earwax

1119

10757

1.02

0.19

3.2

3.6

37.49

62.46

u/ml

3.51

1076

10375

Injuries to the knee and lower leg

3213

17670

1.01

0.19

3.0

3.2

40.86

51.47

u/ml

1.79

3080

17081

Acute alcohol intoxication ICD-9

291

0.89

0.19

2.6

2.8

53.38

51.91

u/ml

0.02

279

Caries in Clefts patients

175

0.85

0.19

4.7

2.1

52.49

45.17

u/ml

0.09

166

Flat foot [pes planus] (acquired)

250

2580

0.97

0.19

2.4

4.1

30.06

70.04

u/ml

2.10

239

2489

Other congenital malformations of nervous system

196

0.86

0.19

2.1

16.25

47.28

u/ml

1.56

187

Heart failure, strict

960

6878

0.98

0.19

3.2

4.0

97.41

72.22

u/ml

0.84

922

6604

Antenatal screening

767

4383

0.98

0.19

2.3

2.6

25.31

37.20

u/ml

3.44

744

4255

Cardiac murmurs and other cardiac sounds

199

1898

1.04

0.19

2.6

3.2

68.26

55.57

u/ml

0.24

192

1824

Myocardial infarction, with ST-elevation

131

1370

0.96

0.19

3.8

3.5

38.71

78.02

u/ml

3.07

123

1310

Specific personality disorders

532

5432

0.98

0.18

2.3

2.8

83.24

38.18

u/ml

0.37

509

5250

Aphakia

156

1.16

0.18

6.5

3.1

58.17

89.94

u/ml

0.28

149

Pedal cyclist injured in transport accident

399

4088

0.98

0.18

2.9

3.3

35.79

48.53

u/ml

0.68

389

3947

Maternal care for other known or suspected fetal problems

843

5426

0.98

0.18

2.2

2.4

24.05

33.65

u/ml

3.76

818

5265

Occlusion and stenosis of arteries, not leading to stroke

132

0.83

0.18

1.8

2.8

14.24

41.64

u/ml

1.85

124

Meralgia paraesthetica

619

1.07

0.18

1.8

3.5

30.74

55.77

u/ml

1.15

597

Nonsuppurative otitis media

433

3660

1.02

0.18

2.2

2.8

65.09

44.45

u/ml

0.28

411

3522

Other peripheral vascular diseases

159

1653

0.96

0.18

2.7

3.4

32.57

59.31

u/ml

2.21

153

1599

Abnormalities of gait and mobility

180

1735

1.04

0.18

2.9

3.7

48.14

68.33

u/ml

0.68

171

1668

Enthesopathies of lower limb, excluding foot

528

5389

0.98

0.18

2.9

3.6

30.35

57.25

u/ml

3.47

513

5206

All-cause Heart Failure

945

6773

0.98

0.18

3.2

4.0

98.13

72.67

u/ml

0.84

907

6505

Pedestrian injured in transport accident

119

1137

1.05

0.18

2.4

3.2

71.82

53.23

u/ml

0.30

113

1098

Degenerative macular diseases

199

2059

0.97

0.18

4.0

4.1

79.76

77.73

u/ml

0.02

193

1964

Mandibular prognathia

216

0.88

0.18

2.0

2.4

16.04

42.81

u/ml

1.50

206

Complications of anaesthesia during labour and delivery

110

1.20

0.18

3.0

2.1

34.28

57.56

u/ml

0.46

102

285

2930

0.97

0.18

1.9

2.2

23.30

31.09

u/ml

1.27

276

2831

Fracture of forearm

1514

14027

0.99

0.18

3.5

50.89

56.60

u/ml

0.40

1456

13527

Retinal detachments and breaks

676

6641

1.02

0.17

3.0

3.8

45.79

65.69

u/ml

1.35

647

6388

Hereditary corneal dystrophies

630

0.93

0.17

1.8

3.8

18.09

71.26

u/ml

5.04

609

Combinations of oral blood glucose lowering drugs

396

4054

0.98

0.17

3.1

4.0

104.12

66.79

u/ml

0.53

380

3905

Other contact dermatitis

178

1718

1.04

0.17

2.0

3.1

23.78

47.60

u/ml

4.42

173

1657

Carcinoma in situ of skin

137

1315

1.04

0.17

3.0

3.9

99.96

69.84

u/ml

0.21

131

1259

Burn and corrosion confined to eye and adnexa

299

0.90

0.17

3.6

2.2

47.28

43.63

u/ml

0.05

289

Kyphosis

205

1.13

0.17

1.6

3.3

38.30

73.60

u/ml

0.62

197

Abdominal aortic aneurysm (AAA)

307

0.90

0.17

2.9

3.4

63.54

94.78

u/ml

0.41

293

Normotensive glaucoma

159

1650

0.96

0.17

3.4

4.3

134.94

86.35

u/ml

0.23

151

1579

Falls/tendency to fall

3007

15180

0.99

0.17

2.9

3.2

40.19

49.39

u/ml

1.48

2889

14704

Other symptoms and signs involving cognitive functions and awareness

902

8333

0.98

0.17

2.8

3.8

64.65

65.18

u/ml

0.01

851

8037

Carcinoma in situ of skin, other sites/unspecified

173

0.86

0.17

2.5

2.8

48.07

52.59

u/ml

0.05

167

Artrosis, including avohilmo

2114

11681

0.99

0.17

2.9

3.5

40.51

53.05

u/ml

1.60

2043

11322

Varicella [chickenpox]

504

1.07

0.16

2.4

30.92

41.67

u/ml

0.50

483

Scabies

243

2501

0.97

0.16

2.4

2.6

26.49

41.81

u/ml

2.22

234

2417

Biguanides

2530

15550

0.99

0.16

3.0

3.4

61.81

50.05

u/ml

0.91

2421

15032

Postpartum hemorraghe, all women as controls

906

8790

1.02

0.16

2.3

2.6

28.74

33.51

u/ml

1.20

877

8507

Open wound of forearm

120

1252

0.96

0.16

2.3

2.8

27.58

64.29

u/ml

4.55

120

1199

Cervicocranial syndrome

260

2529

1.03

0.16

2.3

3.8

24.18

61.58

u/ml

6.93

249

2444

Foreign body in respiratory tract

866

1.05

0.16

1.9

3.1

23.61

47.21

u/ml

2.38

837

Sixth [abducent] nerve palsy

453

0.92

0.16

3.3

3.2

37.24

59.93

u/ml

0.41

435

Other meningitis

287

0.90

0.16

1.8

2.5

31.23

54.30

u/ml

0.66

274

Other keratitis

213

2066

1.03

0.16

2.5

3.1

30.18

53.48

u/ml

2.71

206

1989

Other respiratory disorders and diseases

278

2707

1.03

0.16

2.9

3.9

54.90

75.73

u/ml

0.99

262

2600

Other diseases of the respiratory system

278

2707

1.03

0.16

2.9

3.9

54.90

75.73

u/ml

0.99

262

2600

Infective dermatitis

200

1938

1.03

0.16

3.1

3.4

70.69

57.54

u/ml

0.32

195

1868

Degenerative myopia

159

1.14

0.15

2.4

3.0

25.83

37.43

u/ml

0.56

153

Melanocytic naevi of lip

188

1.13

0.15

2.9

22.43

37.27

u/ml

0.97

180

Other/unspecified reactive arthropathies

117

1125

1.04

0.14

3.5

3.1

35.50

50.57

u/ml

0.69

112

1088

Other respiratory diseases principally affecting the interstitium

243

2367

1.03

0.14

3.3

3.8

54.39

69.08

u/ml

0.52

233

2268

Specific development disorders of speech and language

651

0.95

0.14

2.8

2.4

25.76

46.94

u/ml

1.67

619

Unspecified nephritic syndrome

285

0.91

0.14

1.7

2.7

53.13

57.83

u/ml

0.08

272

Other congenital malformations, not elsewhere classified

139

0.86

0.14

2.5

2.3

45.62

32.03

u/ml

0.43

133

Scleritis

264

0.90

0.14

1.5

2.7

29.67

45.25

u/ml

0.39

256

Radial styloid tenosynovitis [de Quervain]

142

1469

0.96

0.14

3.2

3.3

34.26

46.33

u/ml

0.62

137

1424

Benign neoplasm: Skin of scalp and neck

382

1.08

0.14

2.7

21.60

47.51

u/ml

1.35

366

Family history of other specific disorders

266

1.10

0.14

2.2

2.4

18.29

29.99

u/ml

1.25

255

Early lumbar disc prolapse operation

195

1895

1.03

0.14

2.0

2.3

44.34

30.68

u/ml

0.63

188

1837

Acute and transient psychotic disorders

210

2158

0.97

0.14

2.6

3.2

43.96

49.74

u/ml

0.20

199

2082

Defect, injury or illness of neck

103

1.17

0.14

1.7

1.9

25.08

44.74

u/ml

0.60

Other and unspecified disorders of adult personality and behaviour

0.82

0.14

5.1

2.5

21.62

43.38

u/ml

—

Human immunodeficiency virus [HIV] disease

141

1.14

0.14

1.5

2.2

22.88

33.20

u/ml

0.55

134

D07AA Corticosteroids, weak (group I)

311

3038

1.02

0.14

2.6

2.9

34.24

42.55

u/ml

0.71

300

2938

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

208

2025

1.03

0.14

2.6

2.3

23.96

30.88

u/ml

0.94

203

1961

Lifestyle-related condition

170

1.12

0.13

4.3

2.7

44.71

49.37

u/ml

0.05

161

Non-allergic asthma (mode)

404

4076

0.98

0.13

2.4

3.2

27.14

48.37

u/ml

5.21

393

3930

Other localized connective tissue disorders

422

1.07

0.13

2.0

3.5

28.48

50.22

u/ml

1.14

407

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

384

3351

1.02

0.13

1.9

2.0

26.93

30.31

u/ml

0.48

373

3224

Other/unspecified synovitis and tenosynovitis

262

2560

1.02

0.13

2.9

3.6

41.80

54.70

u/ml

0.74

252

2474

Scissor bite

283

1.09

0.13

2.7

2.1

25.10

38.68

u/ml

0.64

272

Other (not insulin) diabetes medications

2638

15756

0.99

0.13

2.9

3.4

60.42

49.74

u/ml

0.82

2524

15237

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

267

2611

1.02

0.13

3.1

2.9

34.32

39.24

u/ml

0.22

257

2527

Maternal care for known or suspected abnormality of pelvic organs

928

6390

0.99

0.13

2.1

2.7

23.58

35.89

u/ml

6.38

881

6189

Superficial injury of thorax

224

2296

0.97

0.13

3.0

3.2

37.19

58.25

u/ml

1.33

212

2214

Alopecia areata

560

0.94

0.13

2.5

2.6

110.54

51.02

u/ml

0.30

543

Other and unspecified pemphigoid

123

1.14

0.12

4.6

3.0

25.36

45.61

u/ml

0.89

118

Allergic contact dermatitis

361

3677

0.98

0.12

3.3

38.40

47.96

u/ml

0.59

347

3553

Atopic conjunctivitis

894

1.04

0.12

2.2

3.0

28.65

49.21

u/ml

1.34

863

Routine general health check-up of defined subpopulation

492

1.06

0.12

3.1

2.9

42.12

56.85

u/ml

0.32

475

Disorder of lipoprotein metabolism, unspecified

186

1811

1.03

0.12

3.4

3.9

55.20

86.82

u/ml

1.22

180

1740

Viral hepatitis

106

1022

1.04

0.12

2.4

2.8

53.41

43.65

u/ml

0.25

989

Other mycoses, not elsewhere classified/unspecified

268

1.09

0.12

4.6

2.7

47.34

49.63

u/ml

0.03

257

Restless leg syndrome

293

2871

1.02

0.12

3.0

3.5

33.60

56.22

u/ml

1.63

275

2763

Personal history of allergy to drugs, medicaments and biological substances

210

1.10

0.12

7.9

2.4

56.04

43.92

u/ml

0.13

203

Hypertensive heart and/or renal disease

368

2797

0.98

0.12

3.4

4.0

84.30

79.30

u/ml

0.10

351

2695

Retained placenta and membranes, without haemorrhage

414

4072

1.02

0.12

3.2

3.3

64.09

43.26

u/ml

0.70

400

3942

Persistent mood disorders

440

4329

1.02

0.12

2.5

3.5

54.13

49.66

u/ml

0.14

425

4187

Inflammatory bowel disease, strict (require KELA)

438

4309

1.02

0.12

2.1

3.1

47.32

42.10

u/ml

0.17

422

4167

Other and unspecified acne

210

1.10

0.12

1.4

2.4

19.34

45.35

u/ml

1.24

202

Emotionally unstable personality disorder

292

2862

1.02

0.12

2.1

2.5

27.98

36.37

u/ml

0.93

280

2770

Other disorders of the musculoskeletal system and connective tissue

284

2783

1.02

0.12

2.6

3.7

79.53

59.18

u/ml

0.19

272

2669

Pneumococcal septicemia

405

0.94

0.12

3.7

3.0

27.68

51.50

u/ml

1.18

387

Maxillary retrognathism

259

1.08

0.11

1.7

2.1

22.20

38.22

u/ml

0.86

246

Acute and subacute iridocyclitis

382

3756

1.02

0.11

3.2

3.5

33.37

54.53

u/ml

3.59

364

3624

Otitis media, unspecified

181

1709

0.97

0.11

2.1

2.7

27.35

41.31

u/ml

1.88

170

1655

Arnold-Chiari syndrome

178

0.89

0.11

2.2

2.1

16.14

48.19

u/ml

1.43

170

Conjunctivitis (acute, non atopic)

647

6366

1.01

0.11

2.5

3.2

45.20

49.11

u/ml

0.20

624

6140

Palmar fascial fibromatosis [Dupuytren]

148

1439

1.03

0.11

2.8

4.1

65.15

68.58

u/ml

0.04

140

1385

Other injuries of upper limb, level unspecified

157

0.89

0.11

1.7

2.6

9.71

38.34

u/ml

2.86

151

Necrosis of pulp, including avohilmo

1392

13992

0.99

0.11

2.6

3.1

32.20

45.31

u/ml

2.55

1319

13541

Non-allergic asthma (mode), excluding more controls

404

4063

0.98

0.11

2.4

3.2

27.14

49.21

u/ml

4.84

393

3920

759

6880

1.01

0.11

3.4

3.9

90.64

74.43

u/ml

0.33

727

6596

Obstructed labour due to maternal pelvic abnormality

539

5321

1.01

0.11

3.7

3.5

56.14

43.03

u/ml

0.21

515

5154

Benign neoplasm: Uterine tubes and ligaments

173

1.11

0.11

1.2

3.2

16.68

58.20

u/ml

1.11

167

ILD medications: immunosuppressive drugs

1609

15052

0.99

0.11

2.4

3.4

42.40

50.92

u/ml

1.07

1540

14553

Bleeding

1803

12909

0.99

0.10

3.3

3.6

71.15

56.13

u/ml

0.41

1730

12462

Lateral epicondylitis

328

3225

1.02

0.10

2.5

3.5

41.21

49.10

u/ml

0.36

320

3122

Fracture at wrist and hand level

593

5990

0.99

0.10

2.9

3.3

41.72

53.97

u/ml

0.58

563

5779

Thyroiditis, ILD-related definition

312

3067

1.02

0.10

2.8

3.4

66.08

51.05

u/ml

0.38

302

2960

Maternal care for known or suspected malpresentation of fetus

672

4814

1.01

0.10

2.0

2.4

22.99

35.11

u/ml

5.44

649

4670

Suppurative and unspecified otitis media

776

6804

1.01

0.10

2.2

2.8

35.19

40.23

u/ml

0.54

743

6567

Bell's palsy

223

2185

1.02

0.10

3.3

3.5

44.50

56.64

u/ml

0.58

210

2107

Exposure to unspecified factor

2575

18419

1.01

0.10

2.8

3.2

39.56

51.22

u/ml

2.12

2475

17790

Viral infections of the central nervous system

136

1324

1.03

0.10

3.0

3.2

24.75

52.76

u/ml

3.89

131

1281

Disorders of psychological development

165

1493

1.03

0.10

2.4

2.3

27.40

37.15

u/ml

1.29

156

1439

Ulcerative colitis (strict definition, require KELA)

277

2820

0.98

0.10

2.2

3.1

44.47

44.80

u/ml

0.01

270

2721

Pulmonary eosinophilia, not elsewhere classified

193

1.09

0.10

2.0

3.1

18.38

60.22

u/ml

1.60

187

Hydrocephalus in other diseases

106

1.14

0.10

5.8

3.1

42.75

43.34

u/ml

0.01

100

Paralytic strabismus

100

1032

0.97

0.10

3.2

3.5

34.20

64.08

u/ml

1.52

996

Erectile dysfunction

1.14

0.10

1.2

1.4

41.20

212.56

u/ml

—

IBD patients in KELA-register

438

4321

1.01

0.10

2.1

3.1

47.32

42.16

u/ml

0.16

422

4174

Postprocedural disorders of ear and mastoid process, not elsewhere classified

114

0.87

0.09

1.3

3.0

15.08

42.24

u/ml

—

109

Other congenital malformations of skin

166

1623

1.02

0.09

2.6

3.0

23.90

45.34

u/ml

3.59

161

1564

Polypectomy (DHB20)

686

0.96

0.09

2.7

3.1

27.44

64.74

u/ml

2.69

661

Corneal ulcer

340

3451

0.98

0.09

2.6

3.3

66.88

50.75

u/ml

0.18

325

3328

Fracture of foot, except ankle

524

5179

1.01

0.09

2.6

3.3

33.59

46.70

u/ml

1.90

501

4999

Use of pramipexole

462

4676

0.99

0.09

2.9

3.8

36.53

73.96

u/ml

3.20

443

4500

Dermatophytosis

184

1803

1.02

0.09

3.4

115.28

63.39

u/ml

0.30

177

1738

Other hammer toe(s) (acquired)

484

4515

0.99

0.08

3.3

4.4

61.84

76.89

u/ml

0.23

462

4362

Aortic valve malfunction, age under 60 years

108

1051

1.03

0.08

2.3

3.2

68.31

54.70

u/ml

0.24

103

1011

Benign neoplasm: Lymph nodes

1.04

0.08

2.0

3.3

18.33

59.12

u/ml

—

Other symptoms and signs involving the nervous and musculoskeletal systems

1008

10154

0.99

0.08

2.5

3.3

33.66

55.07

u/ml

4.30

969

9805

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

304

3084

0.99

0.08

2.1

3.1

42.39

44.12

u/ml

0.04

294

2975

Open wound of wrist and hand

741

7177

1.01

0.08

2.2

3.0

35.41

44.00

u/ml

0.80

716

6923

Pediculosis and phthiriasis

1.14

0.08

1.1

2.4

14.91

27.00

u/ml

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

311

3065

1.01

0.08

3.2

3.4

134.91

56.52

u/ml

0.38

300

2957

Adalimumab

182

1855

0.98

0.08

1.9

2.9

43.64

44.72

u/ml

0.03

175

1789

Necrotizing fasciitis

1.08

0.08

1.6

2.3

19.57

62.28

u/ml

—

Autoimmune diseases excluding thyroid diseases

2623

14246

1.00

0.08

2.8

3.2

46.53

48.83

u/ml

0.14

2522

13761

Retrobulbar neuritis in diseases classified elsewhere

0.81

0.08

3.0

2.7

34.67

24.85

u/ml

—

Infection due to other mycobacteria

215

0.93

0.07

6.2

3.0

37.75

50.79

u/ml

0.30

207

Speech and linguistic disorders, excluding more controls

107

1032

0.97

0.07

2.4

2.5

26.21

45.00

u/ml

2.27

100

999

Polyhydramnios

141

1381

1.02

0.07

1.9

2.3

21.41

35.28

u/ml

3.53

135

1334

Other protozoal intestinal diseases

388

0.95

0.07

2.8

2.4

23.68

44.03

u/ml

0.99

374

Use of antiglaucoma preparations and miotics

122

1248

0.98

0.07

3.0

3.9

227.14

74.83

u/ml

0.65

115

1199

Injury of muscle and tendon at hip and thigh level

154

1510

1.02

0.07

2.2

3.2

34.42

51.53

u/ml

0.55

147

1451

Hypertensive Heart Disease

326

2586

0.99

0.07

3.3

4.0

87.88

83.28

u/ml

0.08

311

2491

Hypersensitivity pneumonitis due to organic dust

235

0.93

0.07

3.7

3.0

36.36

59.51

u/ml

0.54

225

Residual foreign body in soft tissue

702

0.97

0.07

3.2

2.9

86.44

50.07

u/ml

0.24

678

Outcome of delivery

553

3451

0.99

0.07

2.2

2.5

22.34

35.53

u/ml

4.68

543

3351

Abnormal findings on antenatal screening of mother

251

2474

1.02

0.07

2.1

24.70

32.62

u/ml

1.81

238

2395

5-aminosalicylic acid

429

4244

1.01

0.07

1.9

3.2

41.21

47.11

u/ml

0.20

415

4098

Pneumonia derived septicemia

412

1.05

0.07

4.5

3.2

26.72

56.88

u/ml

1.61

392

Varicella [chickenpox]

412

1.04

0.07

2.4

27.09

43.59

u/ml

0.73

392

Other retinal artery occlusion

245

0.94

0.07

2.8

3.1

38.57

67.16

u/ml

0.74

237

Other viral hepatitis

837

1.03

0.07

2.1

2.4

42.19

42.67

u/ml

0.01

810

Other protozoal intestinal diseases

255

0.94

0.07

2.3

2.4

18.88

55.15

u/ml

1.31

243

Pediculosis, acariasis and other infestations

295

2988

0.99

0.07

2.5

2.8

31.00

40.30

u/ml

0.95

284

2888

Vasomotor rhinitis (mode)

141

1438

0.98

0.07

3.5

3.4

131.29

51.03

u/ml

0.41

136

1390

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

916

9055

1.01

0.07

2.6

2.9

39.47

44.67

u/ml

0.31

869

8749

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

498

4933

1.01

0.07

2.7

3.5

30.76

56.19

u/ml

5.33

487

4751

Burns and corrosions

194

1909

1.02

0.07

2.7

3.0

42.08

47.70

u/ml

0.20

188

1844

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

338

3419

0.99

0.07

2.2

3.0

32.28

41.53

u/ml

0.80

322

3305

Other erythematous conditions

650

1.03

0.07

2.9

3.2

64.91

56.98

u/ml

0.11

628

Trigger finger

352

3559

0.99

0.06

2.8

3.7

31.01

52.25

u/ml

1.43

340

3435

Dental operations

1490

7613

1.01

0.06

3.3

3.6

61.58

63.97

u/ml

0.08

1423

7411

Disorders of sclera, cornea, iris and ciliary body

1270

12768

0.99

0.06

2.6

3.3

40.42

53.00

u/ml

0.63

1210

12319

Myositis

366

0.95

0.06

4.7

3.4

28.39

53.16

u/ml

1.21

350

Neovascular glaucoma

518

0.96

0.06

3.4

3.1

22.02

68.60

u/ml

3.55

499

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1144

7223

1.01

0.06

1.8

2.2

23.21

30.85

u/ml

4.68

1099

7004

Eustachian salpingitis and obstruction

142

1446

0.98

0.06

1.9

2.6

62.77

36.49

u/ml

0.58

137

1399

Severe visual impairment, monocular

152

0.92

0.06

4.7

3.0

36.36

52.74

u/ml

0.26

145

Mixed conductive and sensorineural hearing loss

218

2150

1.01

0.06

2.9

4.0

78.61

65.11

u/ml

0.20

206

2067

Benign neoplasm: Parathyroid gland

207

1.07

0.06

1.7

2.9

13.28

45.75

u/ml

1.93

201

Medical abortion

2594

14018

1.00

0.06

3.1

3.3

43.64

54.24

u/ml

1.35

2492

13557

Symptoms and signs involving the nervous and musculoskeletal systems

1361

13667

1.00

0.06

2.6

3.4

37.92

56.57

u/ml

3.15

1305

13199

Diabetes, varying definitions

2802

16478

1.00

0.06

2.9

3.3

60.81

48.35

u/ml

1.10

2682

15948

Psoriasis vulgaris

314

3174

0.99

0.06

2.6

3.5

32.46

52.84

u/ml

2.00

299

3054

Mixed specific developmental disorders

140

0.92

0.06

1.6

2.2

28.71

37.32

u/ml

0.31

135

Congenital dislocation of hip, unilateral

129

1.09

0.05

2.7

2.3

14.69

40.80

u/ml

1.82

124

Amyloidosis

306

1.05

0.05

1.7

3.4

38.13

77.59

u/ml

1.09

294

Disorders of puberty, all

178

1.07

0.05

1.4

2.0

22.95

43.27

u/ml

1.04

171

Other and unspecified tonsillitis

633

5283

1.01

0.05

2.1

2.6

74.28

37.50

u/ml

0.36

603

5123

Left bundle-branch block

119

1168

1.02

0.05

3.2

3.7

46.29

71.18

u/ml

1.08

113

1129

Raynaud syndrome

190

1926

0.99

0.05

2.4

3.1

27.54

47.97

u/ml

2.48

182

1856

Glaucoma secondary to other eye disorders

516

0.97

0.05

3.4

3.1

22.02

66.87

u/ml

3.46

498

Type 2 diabetes, definitions combined, including avohilmo

2627

15341

1.00

0.05

2.9

3.4

53.46

49.23

u/ml

0.36

2514

14835

Other obstetric conditions, not elsewhere classified

1166

7451

0.99

0.05

1.8

2.3

23.37

31.17

u/ml

4.79

1121

7222

Impacted maxillary canine

100

1.10

0.05

1.9

2.3

28.91

45.03

u/ml

0.36

Dacryoadenitis

159

1.07

0.05

3.5

2.7

47.35

53.86

u/ml

0.08

154

Other diseases caused by chlamydiae

303

0.95

0.05

2.0

2.4

66.70

36.12

u/ml

0.39

288

Other bacterial agents as the cause of diseases classified to other chapters

159

1.07

0.05

1.9

3.0

97.29

38.07

u/ml

0.74

153

159

1.07

0.05

1.6

2.3

157.10

52.13

u/ml

0.33

153

Epilepsy

592

5864

1.01

0.05

3.0

3.5

102.09

57.91

u/ml

0.41

566

5662

Glaucoma, exfoliation

174

1762

0.99

0.04

3.3

4.2

60.79

93.29

u/ml

0.59

165

1678

Eosinophilic disease (BM)

201

0.94

0.04

1.7

2.6

18.63

47.66

u/ml

0.87

193

Deviated nasal septum

467

4633

1.01

0.04

2.9

3.5

26.96

53.69

u/ml

8.99

451

4466

Glaucoma-related operations

933

1.02

0.04

3.1

3.8

60.79

77.11

u/ml

0.19

897

Other cataract

923

6952

1.00

0.04

3.6

3.9

50.16

65.57

u/ml

0.89

888

6723

Lichen simplex chronicus and prurigo

111

1128

0.98

0.04

2.8

3.4

36.28

60.28

u/ml

1.41

105

1089

Cardiomyopathy, Hypertrophic obstructive

221

0.95

0.04

1.4

3.5

34.33

51.91

u/ml

0.49

216

Benign neoplasm: Tongue

423

0.97

0.04

4.4

3.5

18.81

53.65

u/ml

2.36

408

Other and unspecified disorders of skin and subcutaneous tissue

120

1218

0.98

0.04

2.4

3.6

83.25

62.57

u/ml

0.26

114

1177

Juvenile rheumatoid arthirtis

457

1.03

0.04

1.7

2.5

68.46

42.15

u/ml

0.32

444

Autoimmune diseases excluding thyroid diseases, strict definition

2514

13799

1.00

0.04

2.8

3.2

47.40

48.54

u/ml

0.06

2417

13331

Drug-induced hypoglycaemia without coma

170

1.06

0.04

1.9

2.6

36.54

50.50

u/ml

0.34

164

Postpartum haemorrhage due to anatomy

302

2996

1.01

0.04

1.9

2.1

28.12

28.47

u/ml

0.04

294

2894

Mental retardation, wide definition

514

1.03

0.03

2.4

2.5

37.93

44.66

u/ml

0.18

494

Abscess of external ear

220

0.95

0.03

1.6

2.4

23.07

31.99

u/ml

0.44

210

Corticotropin deficiency

159

0.94

0.03

3.9

2.3

19.63

51.47

u/ml

1.23

151

Diseases caused by chlamydiae

290

0.96

0.03

2.0

2.3

68.48

34.95

u/ml

0.42

275

Atypical mycobacterium lung infection

171

1.05

0.03

5.8

2.8

38.78

56.93

u/ml

0.35

166

ILD, hospital admissions

198

1963

1.01

0.03

3.3

3.8

55.85

72.73

u/ml

0.51

191

1884

Diseases caused by chlamydiae

350

1.03

0.03

1.9

2.3

57.73

32.41

u/ml

0.40

332

Focal epilepsy

356

3538

1.01

0.03

3.1

3.4

121.64

56.57

u/ml

0.36

344

3408

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

271

2728

0.99

0.03

2.2

3.0

44.96

45.34

u/ml

0.01

264

2633

Sequelae of injuries, of poisoning and of other consequences of external causes

420

4221

0.99

0.03

2.3

3.3

32.00

48.51

u/ml

2.28

397

4071

Type 2 diabetes, strict (exclude DM1)

2615

15375

1.00

0.03

2.9

3.4

56.48

49.37

u/ml

0.67

2502

14865

Hallux rigidus

336

3379

0.99

0.03

3.5

4.3

27.29

72.79

u/ml

4.75

327

3263

Other and unspecified iridocyclitis

782

0.98

0.03

2.8

3.3

34.29

56.91

u/ml

1.09

750

Infections of genitourinary tract in pregnancy

299

2972

1.01

0.03

2.6

3.2

39.37

46.05

u/ml

0.15

285

2874

Ulcer of lower limb, not elsewhere classified

182

1835

0.99

0.02

2.4

3.7

57.47

79.66

u/ml

0.65

174

1763

Fall on and from stairs and steps

534

5362

1.00

0.02

3.0

3.5

46.52

63.38

u/ml

1.05

517

5161

Open wound of shoulder and upper arm

239

0.96

0.02

3.3

2.4

24.22

48.45

u/ml

0.94

231

Amyloidosis, other/unspecified

261

1.04

0.02

1.7

3.5

40.81

84.89

u/ml

1.02

251

Thiazolidinediones

153

1544

0.99

0.02

3.7

4.2

57.93

71.98

u/ml

0.33

146

1489

Diabetes mellitus

2829

16507

1.00

0.02

2.9

3.3

60.38

48.30

u/ml

1.06

2709

15975

Failed induction of labour

171

1696

1.01

0.02

1.6

2.2

21.92

31.36

u/ml

2.31

157

1638

Rotator cuff syndrome

1471

10571

1.00

0.02

3.1

3.6

72.74

54.90

u/ml

0.36

1416

10219

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1095

8785

1.00

0.02

3.0

3.9

61.87

63.36

u/ml

0.06

1054

8463

Congenital malformations of the nervous system

379

0.98

0.02

2.1

23.22

39.92

u/ml

1.09

362

ILD, hospital admissions 1, main diag only

178

1793

0.99

0.02

2.9

3.9

57.24

75.41

u/ml

0.49

171

1721

Diseases of the myoneural junction and muscle

179

1803

0.99

0.02

2.7

3.5

51.08

63.34

u/ml

0.31

174

1736

Other congenital malformations of ear

202

1.04

0.02

2.6

1.9

73.46

44.34

u/ml

0.22

190

Demyelinating diseases of the central nervous system

194

1953

0.99

0.02

1.9

2.8

24.95

42.64

u/ml

2.55

188

1892

Other and unspecified paralytic syndromes

228

0.96

0.02

3.0

2.6

80.41

44.44

u/ml

0.31

217

Speech disturbances, not elsewhere classified

133

1341

0.99

0.02

3.3

3.4

44.12

60.88

u/ml

0.48

125

1297

Dermatophytosis

1321

13217

1.00

0.02

2.7

3.3

49.72

51.82

u/ml

0.07

1279

12757

Presence of other functional implants

1254

8711

1.00

0.02

3.0

3.8

43.83

66.79

u/ml

2.85

1191

8402

Type 2 diabetes, definitions combined

2606

15312

1.00

0.02

2.9

3.4

56.62

49.49

u/ml

0.67

2493

14804

Blindness, monocular

127

0.94

0.01

1.7

2.9

58.00

59.29

u/ml

0.01

122

Prurigo nodularis

418

0.98

0.01

3.3

3.4

33.24

70.74

u/ml

1.38

402

Previous suicide attempt

167

0.96

0.01

1.4

2.5

18.00

33.26

u/ml

1.09

161

Hyperparathyroidism

438

4317

1.00

0.01

2.9

3.9

76.22

82.17

u/ml

0.07

419

4136

Palindromic rheumatism

197

0.96

0.01

2.0

3.0

34.37

68.10

u/ml

0.73

190

Tibial collateral bursitis [Pellegrini-Stieda]

213

1.03

0.01

2.0

2.2

46.51

52.42

u/ml

0.07

205

Personality disorders, excluding more controls

603

6015

1.00

0.01

2.4

2.8

78.22

37.56

u/ml

0.38

578

5830

Conduct disorder

237

0.97

0.01

1.6

1.9

34.91

38.74

u/ml

0.09

226

Impacted cerumen

147

1461

1.01

0.01

4.3

3.6

28.34

67.08

u/ml

5.88

138

1403

Reactive arthropathies

163

1621

1.01

0.01

3.5

3.6

38.98

56.03

u/ml

0.93

157

1559

Intrahepatic Cholestasis of Pregnancy (ICP)

208

2089

1.00

0.01

2.6

2.4

23.96

33.81

u/ml

1.54

203

2025

Type 2 diabetes

2728

15922

1.00

0.01

2.9

3.3

61.20

48.98

u/ml

1.03

2610

15403

Other and unspecified nerve root and plexus disorders, also in other diseases

407

4080

1.00

0.01

2.3

3.5

23.58

52.11

u/ml

10.35

390

3943

Artificial joint operation, meniscal resection

2118

13754

1.00

0.01

3.0

3.6

52.71

56.80

u/ml

0.21

2038

13278

Speech and linguistic disorders

108

1043

0.99

0.00

2.4

26.06

40.70

u/ml

1.73

101

1000

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

146

0.96

0.00

2.0

2.3

14.06

47.43

u/ml

1.30

139

Childhood allergy (age < 16)

224

1852

1.00

0.00

1.6

1.8

21.59

28.72

u/ml

2.63

214

1774

Prominent ears

154

1.04

0.00

2.9

2.0

93.25

50.14

u/ml

0.25

145

Fracture of shoulder and upper arm

757

7569

1.00

0.00

2.8

3.7

56.34

66.64

u/ml

0.59

726

7283

Focal epilepsy, strict definition

323

3221

1.00

0.00

3.2

3.4

130.79

57.46

u/ml

0.37

312

3102

Other interstitial pulmonary diseases

199

1983

1.00

0.00

3.3

3.8

55.62

72.92

u/ml

0.53

192

1901

Calculus of lower urinary tract

284

1.02

0.00

1.3

3.1

35.96

59.34

u/ml

0.64

271

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

277

2777

1.00

0.00

3.9

3.5

32.46

49.62

u/ml

2.30

271

2680

Other secondary gonarthrosis

886

0.99

0.00

2.3

3.6

50.84

60.34

u/ml

0.20

857

Abnormal involuntary movements

244

2446

1.00

0.00

2.5

3.5

45.16

58.44

u/ml

0.36

232

2360

Poor fetal growth

384

3846

1.00

0.00

2.0

2.3

23.92

31.55

u/ml

2.29

374

3714

Human immunodeficiency virus [HIV] disease resulting in other conditions

125

1.04

0.00

1.4

2.3

23.31

31.48

u/ml

0.36

119

Gender identity disorders

165

0.97

0.00

1.4

2.1

36.29

24.88

u/ml

0.72

159

Interstitial lung disease

199

1985

1.00

0.00

3.3

3.8

55.62

72.86

u/ml

0.53

192

1903

Interstitial lung disease endpoints

199

1985

1.00

0.00

3.3

3.8

55.62

72.86

u/ml

0.53

192

1903

Heart failure and hypertrophic cardiomyopathy

174

0.98

0.00

1.2

3.3

49.12

55.63

u/ml

0.10

167

Failed attempted abortion

326

1.01

0.00

1.8

2.0

53.71

36.44

u/ml

0.25

313

Bullous keratopathy

112

0.98

0.00

1.4

2.5

30.18

31.54

u/ml

0.03

107

Other and unspecified hydrocephalus

273

0.99

0.00

4.0

2.8

45.46

67.76

u/ml

0.51

261

Benign neoplasm: Skin of ear and external auricular canal

516

1.01

0.00

1.9

3.3

21.28

57.22

u/ml

2.64

496

Hypotension due to drugs

142

0.99

0.00

6.1

3.1

32.74

47.90

u/ml

0.49

137

Anorexia

323

0.99

0.00

2.3

2.4

54.96

37.43

u/ml

0.33

307

Chronic myeloproliferative disease

162

0.99

0.00

2.3

3.3

16.59

61.07

u/ml

1.11

154

Cleft palate

178

1.01

0.00

4.1

2.1

45.74

30.92

u/ml

0.27

168

Intentional self-harm by unspecified means

198

1.01

0.00

1.7

2.1

24.20

40.10

u/ml

0.63

187

Infective bursitis

228

1.01

0.00

4.1

3.2

56.90

44.43

u/ml

0.13

217

Left ventricular outflow tract obstruction (LVOTO), broad definition

115

1155

1.00

0.00

2.3

3.2

65.38

52.65

u/ml

0.24

110

1113

Other diseases caused by chlamydiae

368

1.01

0.00

1.9

2.4

56.63

40.49

u/ml

0.23

350

Fall on and from ladder

528

1.00

0.00

3.7

3.2

128.15

64.63

u/ml

0.31

504

Benign neoplasm: Pharynx, unspecified

131

0.99

0.00

1.8

2.8

70.77

50.24

u/ml

0.20

126

Open wound of thorax

151

0.99

0.00

2.7

17.13

52.89

u/ml

1.36

143

Ulcerative colitis (strict definition, all Crohn cases excluded)

235

2347

1.00

0.00

2.2

3.0

48.74

46.79

u/ml

0.03

229

2262

Acute poliomyelitis

241

1.00

0.00

5.9

2.7

31.92

69.27

u/ml

0.97

234

Other bursal cyst

269

1.00

0.00

4.1

3.5

48.99

47.15

u/ml

0.02

260

Dissection of cerebral arteries, nonruptured

133

0.98

0.00

2.7

2.5

25.73

49.62

u/ml

0.61

128

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

144

1443

1.00

0.00

3.1

4.0

43.63

65.38

u/ml

0.71

138

1395

Ankle and foot

175

0.97

0.00

1.8

2.8

19.15

46.14

u/ml

1.11

168

Sclerodactyly

0.00

0.0

1.4

—

12.40

—

Conditions involving the integument and temperature regulation of fetus and newborn

0.00

0.0

3.0

—

20.71

—

Other neonatal haemorrhages

0.00

0.0

1.7

—

15.83

—

Disorders of sexual preference

0.00

0.0

2.4

—

119.25

—

Other respiratory conditions originating in the perinatal period

0.00

0.0

1.7

—

17.22

—

Microcephaly

0.00

0.0

2.2

—

215.67

—

Other disorders of kidney and ureter in diseases classified elsewhere

0.00

0.0

2.6

—

182.80

—

Laboratory evidence of human immunodeficiency virus [HIV]

0.00

0.0

1.4

—

207.60

—

Benign neoplasm: Mesothelial tissue of pleura

0.00

0.0

2.4

—

200.80

—

Immunodeficiency associated with other specified major defects, or unspecified

0.00

0.0

1.2

—

14.30

—

Other specified disorders of eye and adnexa in diseases classified elsewhere

0.00

0.0

4.7

—

155.50

—

Intentional self-harm by crashing of motor vehicle

0.00

0.0

1.9

—

24.56

—

Coccidioidomycosis

0.00

0.0

1.7

—

121.78

—

Rat-bite fevers

0.00

-0.00

0.0

1.7

—

26.00

—

Neuropathy in association with hereditary ataxia

0.00

-0.00

0.0

9.3

—

24.95

—

Reactive arthropathies, FINNGEN

128

1280

1.00

-0.00

3.5

3.3

34.28

52.43

u/ml

0.94

123

1237

Hyperalimentation, other specified

0.00

-0.00

0.0

1.4

—

21.25

—

Diastrofic dysplasy

0.00

-0.00

0.0

2.1

—

188.14

—

Juvenile Open Angle Glaucoma

0.96

-0.00

6.4

2.6

22.25

42.79

u/ml

—

Miliaria crystallina

0.00

-0.00

0.0

2.0

—

13.40

—

Bladder disorders in in diseases classified elsewhere

0.00

-0.00

0.0

1.3

—

14.67

—

Asphyxiation

0.00

-0.00

0.0

2.3

—

156.67

—

Occupant of three-wheeled motor vehicle injured in other and unspecified transport accidents

0.00

-0.00

0.0

3.5

—

15.46

—

Rabies

0.00

-0.00

0.0

12.6

—

73.80

—

Trachoma

0.00

-0.00

0.0

3.2

—

184.00

—

Strongyloidiasis

0.00

-0.00

0.0

1.9

—

127.75

—

Other and unspecified acantholytic disorders

0.00

-0.00

0.0

2.2

—

25.20

—

Exposure to noise

0.00

-0.00

0.0

1.2

—

33.00

—

Disorders of other digestive organs in diseases classified elsewhere

0.00

-0.00

0.0

11.0

—

27.60

—

Drowning to ice

0.00

-0.00

0.0

1.6

—

142.25

—

Human immunodeficiency virus [HIV] disease resulting in malignant neoplasms

0.00

-0.00

0.0

11.0

—

18.40

—

Disorders of visual cortex

0.00

-0.00

0.0

1.9

—

12.53

—

Sequelae of toxic effects of substances chiefly nonmedicinal as to source

0.00

-0.00

0.0

1.4

—

18.40

—

Traumatic amputation of hip and thigh

0.00

-0.00

0.0

1.8

—

123.83

—

Blepharochalasis

735

7350

1.00

-0.00

2.8

4.0

39.49

68.79

u/ml

3.19

709

7080

Taeniasis

0.00

-0.00

0.0

3.3

—

162.50

—

Hypopituitarism after medical therapy

0.00

-0.00

0.0

1.6

—

15.20

—

Unattended death

0.94

-0.00

1.3

3.0

152.50

60.31

u/ml

—

Mumps

390

1.00

-0.00

2.0

2.8

85.08

43.19

u/ml

0.36

379

Traumatic amputation of forearm

0.00

-0.00

0.0

1.6

—

14.00

—

Unspecified pneumoconiosis

0.00

-0.00

0.0

1.4

—

30.50

—

Drug-induced nonautoimmune haemolytic anaemia

0.00

-0.00

0.0

1.6

—

24.63

—

Hereditary factor XI deficiency

0.00

-0.00

0.0

2.3

—

109.33

—

Inflammatory diseases of prostate (prostatitis)

0.97

-0.00

1.0

1.3

13.67

119.13

u/ml

—

APECED

0.00

-0.00

0.0

2.6

—

68.71

—

Delta-beta thalassaemia

0.00

-0.00

0.0

2.5

—

119.13

—

Persistent hyperplasia of thymus

0.00

-0.00

0.0

1.2

—

14.00

—

Ectopic testis

0.00

-0.00

0.0

3.7

—

20.57

—

Melanocytic naevi of eyelid, including canthus

190

1.00

-0.00

5.2

2.9

27.43

36.21

u/ml

0.29

181

Disorders of glycosaminoglycan metabolism

0.00

-0.00

0.0

1.2

—

17.70

—

Dietary calcium deficiency

0.00

-0.00

0.0

2.2

—

33.60

—

Major histocompatibility complex class I deficiency

0.00

-0.00

0.0

8.4

—

16.43

—

Disseminated intravascular coagulation [defibrination syndrome]

0.98

-0.00

2.2

1.9

33.33

58.31

u/ml

—

Choroidal degeneration

0.00

-0.00

0.0

6.9

—

25.11

—

Alcoholic myopathy

0.00

-0.00

0.0

2.0

—

27.25

—

Lethal midline granuloma

0.00

-0.00

0.0

1.7

—

16.50

—

Other congenital infectious and parasitic diseases

0.00

-0.00

0.0

1.8

—

35.60

—

Organic amnesic syndrome, not induced by alcohol and other psychoactive substances

0.00

-0.00

0.0

1.6

—

130.06

—

Other perinatal haematological disorders

0.00

-0.00

0.0

1.4

—

23.71

—

Other disorders of peripheral nervous system

0.92

-0.00

5.3

2.9

11.44

46.47

u/ml

—

Haemolytic disease of fetus and newborn

0.00

-0.00

0.0

1.6

—

16.44

—

Reactive perforating collagenosis

0.00

-0.00

0.0

2.0

—

21.14

—

Gastroenterology and urology devices associated with adverse incidents

0.00

-0.00

0.0

2.0

—

21.57

—

Drowning and submersion, undetermined intent

0.00

-0.00

0.0

8.1

—

146.86

—

Drowning and submersion in swimming-pool or bath

0.00

-0.00

0.0

10.0

—

17.33

—

Other chorioretinal disorders in diseases classified elsewhere

0.00

-0.00

0.0

1.9

—

24.00

—

Hypervitaminosis D

0.00

-0.00

0.0

1.5

—

22.33

—

Hereditary factor IX deficiency

0.00

-0.00

0.0

2.6

—

120.75

—

Unspecified drowning and submersion

0.00

-0.00

0.0

4.7

—

13.29

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Cancer Ag 125 [Units/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS